Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3035637	p-acth	ng/l (ng/l)	6132	9756	0.43%
3035637	p-acth	ng/l______ (ng/l)	164	244	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Hypopituitarism

703

320

27.88

307.65

2.1

1.4

30.15

22.55

ng/l

1.78

695

320

Hypothyroidism (congenital or acquired)

574

290

11.43

307.65

1.9

1.4

41.36

53.00

ng/l

0.44

569

290

Hypothyroidism, levothyroxine purchases

560

287

11.28

307.65

1.9

1.4

40.90

53.29

ng/l

0.47

555

287

Benign neoplasm: Adrenal gland

437

361

13.87

307.65

1.7

1.5

20.31

29.05

ng/l

1.53

437

361

Hypothyroidism and >3 levothyroxin purchases

560

287

11.28

307.65

1.9

1.4

40.90

53.29

ng/l

0.47

555

287

Exclusions for E4_PCOS_BROAD

1631

889

22.55

307.65

2.4

1.3

58.03

23.06

ng/l

13.73

1619

889

Non-small cell lung cancer, adenocarcinoma

256

177

15.87

289.33

1.5

25.48

21.06

ng/l

0.68

256

177

General symptoms and signs

1638

2807

2.97

288.22

1.6

1.5

30.27

34.85

ng/l

0.97

1632

2800

Primary adrenocortical insufficiency

163

71.05

287.57

3.0

1.4

275.34

23.23

ng/l

10.00

163

Malignant neoplasm

1347

2628

3.05

262.08

1.7

1.6

29.42

34.45

ng/l

1.15

1342

2620

Metabolic disorders

1546

3371

2.80

260.54

1.8

1.5

40.06

28.47

ng/l

3.65

1539

3363

Malignant neoplasm

1340

2625

3.04

258.93

1.7

1.6

29.45

34.45

ng/l

1.13

1335

2617

Panhypopituitarism

171

35.36

258.38

2.3

1.3

42.34

28.67

ng/l

0.55

165

Malignant neoplasm, including Hilmo

1362

2714

2.97

252.88

1.7

1.6

29.24

34.71

ng/l

1.33

1357

2706

Malignant neoplasm, wide definition

1363

2718

2.97

252.46

1.7

1.6

29.32

34.70

ng/l

1.30

1358

2710

Any event in cancer register

1415

2930

2.86

247.13

1.7

1.6

28.80

34.62

ng/l

1.58

1409

2923

Non-small cell lung cancer, adenocarcinoma, helper endpoint

256

269

10.41

221.54

1.5

25.48

31.03

ng/l

0.47

256

269

Medical observation and evaluation for suspected diseases and conditions

1031

1644

3.26

211.94

1.6

1.5

25.29

34.53

ng/l

3.47

1031

1638

Other bacterial diseases

1429

4066

2.36

176.98

1.7

1.5

33.75

31.12

ng/l

0.49

1424

4056

Other bacterial diseases, including avohilmo

1510

4185

2.28

170.79

1.7

1.6

33.24

31.40

ng/l

0.32

1504

4176

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1301

3139

2.45

169.76

1.7

1.5

33.50

32.65

ng/l

0.10

1294

3134

1301

3139

2.45

169.76

1.7

1.5

33.50

32.65

ng/l

0.10

1294

3134

Hypothyroidism, drug reimbursement

222

149

10.66

165.95

1.9

1.3

52.70

58.11

ng/l

0.09

222

149

Pneumonia, organism unspecified

1382

4168

2.30

163.75

1.7

1.6

32.74

32.38

ng/l

0.04

1375

4160

Influenza and pneumonia

1563

4417

2.21

163.73

1.7

1.6

32.06

32.73

ng/l

0.09

1556

4409

Pneumonias (Asthma/COPD co-morbidities)

1503

4480

2.22

161.14

1.7

1.6

32.31

32.11

ng/l

0.03

1496

4472

All pneumoniae

1511

4489

2.21

161.02

1.7

1.6

32.22

32.33

ng/l

0.01

1504

4481

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1473

4498

2.21

156.89

1.7

1.6

32.41

31.88

ng/l

0.07

1466

4490

Hyperprolactinaemia

148

119

13.73

153.48

1.5

1.2

25.01

23.76

ng/l

0.16

148

119

Thyrotropin deficiency

101

32.69

149.18

2.1

1.4

29.09

28.82

ng/l

0.01

101

Abnormalities of breathing

1265

3176

2.30

143.53

1.5

1.6

26.93

35.09

ng/l

3.23

1265

3167

Hypertensive diseases (excluding secondary)

794

1620

2.90

141.70

1.8

1.6

30.08

39.96

ng/l

1.56

794

1613

Clear cell adenocarcinoma of kidney

150

141

11.48

140.17

1.6

1.5

41.01

21.55

ng/l

1.68

150

141

Asthma (only as main-diagnosis)

925

1986

2.63

137.69

1.6

27.69

34.63

ng/l

1.02

925

1981

Use of cabergoline

28.54

130.65

2.1

1.4

45.63

31.07

ng/l

0.43

All kidney diseases

1383

4489

2.09

128.45

1.6

29.46

32.73

ng/l

0.81

1377

4481

Renal tubulo-interstitial diseases

1236

4238

2.16

128.23

1.6

30.46

31.66

ng/l

0.21

1230

4231

Mood disorders, excluding more controls

1257

3438

2.17

125.19

1.6

27.94

36.11

ng/l

2.67

1251

3432

Care involving use of rehabilitation procedures

871

3344

2.37

117.72

1.6

27.68

32.34

ng/l

1.17

871

3332

Disorders of adrenal gland, other and/or unspecified

76.36

113.93

2.3

1.4

46.22

23.76

ng/l

0.78

Codeine or tramadol medication

1434

3947

1.99

111.98

1.6

24.30

36.50

ng/l

8.26

1427

3941

Depression

1301

4340

2.02

111.72

1.5

1.6

26.65

34.46

ng/l

3.41

1294

4332

Benzodiazepine use

1337

4570

1.99

110.33

1.5

1.6

25.88

34.32

ng/l

4.49

1330

4562

Hypertensive diseases

1043

2665

2.23

109.81

1.8

1.6

30.44

36.62

ng/l

1.21

1043

2656

Hypertension

1041

2663

2.23

109.26

1.8

1.6

30.44

36.63

ng/l

1.21

1041

2654

Mood disorders

1361

4437

1.98

108.86

1.6

27.51

34.25

ng/l

2.48

1354

4429

Mood [affective] disorders

1359

4437

1.98

108.83

1.6

27.52

34.25

ng/l

2.47

1352

4429

Dyspnoea

1204

4338

2.02

105.07

1.5

1.6

27.65

32.62

ng/l

1.62

1204

4324

Symptoms and signs concerning food and fluid intake

221

465

4.91

98.04

1.6

1.4

23.10

26.41

ng/l

0.53

221

465

Persons encountering health services in other circumstances, wide

1454

3977

1.90

97.31

1.6

27.25

33.87

ng/l

2.66

1448

3969

Disorders of thyroid, IBD co-morbidities

285

457

4.35

97.08

1.7

1.6

39.42

39.64

ng/l

0.01

285

457

Episodal and paroxysmal disorders

1365

3643

1.92

94.14

1.6

27.81

34.78

ng/l

2.14

1360

3638

Diabetes mellitus

1308

4032

1.89

89.42

1.6

33.04

32.12

ng/l

0.13

1303

4024

Symptoms and signs involving the circulatory and respiratory systems

1226

3185

1.94

88.03

1.6

27.42

35.09

ng/l

2.73

1226

3176

Any mental disorder

1322

3534

1.89

87.14

1.5

1.6

27.11

35.74

ng/l

3.11

1316

3528

Malignant neoplasm of adrenal gland, including Hilmo

21.89

87.06

4.3

1.6

75.61

22.51

ng/l

3.01

Short stature, not elsewhere classified

135

185

7.77

86.73

1.7

19.77

20.12

ng/l

0.08

135

185

Diabetes, varying definitions

1293

4036

1.87

86.23

1.6

32.56

32.22

ng/l

0.05

1288

4028

L01XE Protein kinase inhibitors

145

239

6.46

85.03

1.7

1.5

37.29

30.40

ng/l

0.46

145

239

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1195

3754

1.91

84.30

1.6

34.73

32.11

ng/l

0.41

1188

3746

Hyperaldosteronism

11.31

81.42

1.8

1.2

26.78

23.56

ng/l

0.22

Malignant neoplasm of adrenal gland

29.28

81.00

4.7

1.5

79.14

20.15

ng/l

2.82

Type 2 diabetes

1196

3716

1.88

80.52

1.6

31.16

32.69

ng/l

0.25

1191

3708

Pituitary-dependent Cushing's disease

259.03

80.49

8.5

1.5

131.31

17.21

ng/l

—

Sleep apnoea

1171

3992

1.87

78.63

1.5

1.6

28.38

33.80

ng/l

1.47

1166

3984

Diabetes medication

1291

4230

1.80

75.72

1.6

33.02

32.29

ng/l

0.10

1285

4222

Diabetes, insulin treatment (Kela reimbursement)

1247

4134

1.81

75.18

1.6

34.45

32.01

ng/l

0.40

1240

4126

Complications of surgical and medical care, not elsewhere classified

1218

4561

1.80

73.45

1.7

1.6

29.76

32.71

ng/l

0.59

1213

4552

Hyperkalaemia

120

197

6.33

70.26

1.4

1.5

44.68

25.38

ng/l

1.08

120

197

Infections, IBD-co-morbidities

236

436

3.88

70.20

1.6

1.5

27.57

37.34

ng/l

0.65

236

436

Use of hypnotics and sedatives

1283

4198

1.76

69.98

1.5

1.6

28.57

33.73

ng/l

1.44

1275

4191

Constipation

1116

4218

1.81

69.01

1.5

1.6

26.71

32.19

ng/l

1.81

1110

4210

Other diseases of pleura

565

2218

2.24

66.86

1.5

28.59

28.43

ng/l

0.02

565

2212

Isolated growth hormone deficiency

111

10.77

63.96

1.8

1.9

22.09

19.73

ng/l

0.58

111

Acute tubulo-interstitial nephritis

771

3374

1.95

62.69

1.6

1.5

30.07

30.14

ng/l

0.01

766

3368

Volume depletion

156

360

4.45

61.97

1.5

30.53

23.39

ng/l

0.82

156

360

Hypoglycaemia, other or unspecified

158

371

4.44

61.73

1.7

1.6

38.67

25.22

ng/l

0.90

158

371

Malignant neoplasm of bladder, including Hilmo

143

307

4.69

60.78

1.4

28.13

24.90

ng/l

0.33

143

307

Persons encountering health services in other circumstances

531

2466

2.16

58.61

1.7

1.5

30.85

32.21

ng/l

0.14

526

2461

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1192

4488

1.69

57.75

1.6

25.96

32.85

ng/l

2.92

1187

4478

Symptoms and signs involving the skin and subcutaneous tissue

889

4706

1.80

57.64

1.6

25.50

32.77

ng/l

2.40

889

4692

Disorders of calcium metabolism

124

256

5.02

56.69

1.5

1.4

33.64

22.02

ng/l

0.96

124

256

Type 2 diabetes, definitions combined

1056

3581

1.73

54.51

1.6

1.5

29.63

32.24

ng/l

0.47

1050

3573

Type 2 diabetes, strict (exclude DM1)

1059

3609

1.72

53.73

1.6

29.60

32.27

ng/l

0.49

1053

3601

Hypoplasia of dental enamel

168

7.41

53.38

2.4

1.8

19.54

21.47

ng/l

0.51

168

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

415

1820

2.29

52.89

1.8

1.6

33.25

32.32

ng/l

0.06

415

1815

Other adrenocortical overactivity

19.23

52.60

2.4

1.8

107.35

18.37

ng/l

1.81

Type 2 diabetes, definitions combined, including avohilmo

1052

3582

1.71

52.27

1.6

29.66

32.53

ng/l

0.53

1047

3574

Other (not insulin) diabetes medications

1087

3819

1.68

51.04

1.6

30.49

32.23

ng/l

0.28

1081

3811

Obesity, other/unspecified

444

2071

2.17

50.11

1.7

1.6

29.56

33.86

ng/l

0.54

444

2064

DVT of lower extremities and pulmonary embolism

487

2346

2.09

49.82

1.6

1.5

27.96

28.76

ng/l

0.11

487

2340

Venous thromboembolism

610

3090

1.92

48.82

1.6

1.5

28.35

30.08

ng/l

0.24

610

3079

Sleep disorders (combined)

1210

3910

1.63

48.75

1.5

1.6

27.26

34.82

ng/l

2.67

1205

3905

Exposure to unspecified factor

1184

5095

1.59

46.01

1.6

29.32

32.80

ng/l

0.80

1178

5086

Malignant neoplasm of oral cavity, including Hilmo

127

6.20

43.77

1.3

1.4

23.06

22.23

ng/l

0.15

127

Malignant neoplasm of bladder

155

5.53

43.43

1.3

1.5

24.57

22.40

ng/l

0.38

155

Haemorrhage from respiratory passages

395

1649

2.14

42.36

1.8

1.5

32.37

30.21

ng/l

0.20

395

1642

Molar incisor enamel hypoplasia, with caries

142

6.79

41.75

2.4

1.7

20.13

22.56

ng/l

0.55

142

Cough

479

2306

1.96

40.56

1.6

27.29

32.76

ng/l

1.00

479

2297

Postviral fatigue syndrome

12.78

40.31

1.7

1.4

23.04

30.30

ng/l

0.33

Malignant neoplasm of oral cavity

6.93

39.69

1.2

1.5

23.57

23.70

ng/l

0.02

Weight loss

169

566

3.06

38.73

1.5

1.6

22.68

27.43

ng/l

0.94

169

566

Acute upper respiratory infections

1126

4375

1.55

38.51

1.6

32.31

32.43

ng/l

0.02

1121

4369

Acute sinusitis

607

3123

1.78

38.15

1.6

27.69

32.53

ng/l

0.96

602

3118

Other disorders of lacrimal gland

443

2285

1.96

38.12

1.5

1.6

30.26

30.69

ng/l

0.04

443

2276

Renal cell carcinoma of kidney

7.50

37.92

1.7

1.6

49.51

23.08

ng/l

2.01

Thyrotoxicosis

323

1491

2.20

37.66

1.7

1.6

42.33

26.96

ng/l

1.68

323

1485

Abnormal weight loss

155

503

3.16

37.54

1.4

1.6

22.88

28.10

ng/l

0.93

155

503

Irritable bowel syndrome

336

1582

2.15

37.19

1.5

1.6

25.83

32.96

ng/l

1.54

336

1576

Ovarian dysfunction

114

306

3.81

37.07

2.1

1.3

51.96

21.80

ng/l

1.89

114

306

Speech and linguistic disorders, excluding more controls

131

376

3.34

34.36

2.0

1.6

23.44

30.16

ng/l

0.99

131

376

Disturbances of skin sensation

349

1740

2.03

33.24

1.5

1.6

23.97

33.78

ng/l

1.59

349

1733

Lack of expected normal physiological development

143

5.02

33.09

1.9

1.5

24.57

30.60

ng/l

0.30

143

Disorders of lacrimal system

504

2793

1.79

32.76

1.5

1.6

29.12

31.39

ng/l

0.27

504

2784

Unknown and unspecified causes of morbidity

232

4.05

32.68

1.8

1.4

20.14

28.17

ng/l

0.81

232

COPD, early/later onset

465

2135

1.84

32.42

1.5

23.01

28.96

ng/l

2.43

465

2130

Other pleural conditions

139

463

3.06

32.18

1.6

35.18

27.87

ng/l

0.43

139

463

COPD, hospital admissions

458

2115

1.84

31.76

1.5

22.97

29.00

ng/l

2.43

458

2110

Other/unspecified dorsalgia

407

2167

1.87

30.61

1.5

1.6

26.48

34.08

ng/l

1.68

407

2161

Implicit fungal Sepsis, including avohilmo

106

309

3.51

30.60

1.7

1.5

25.73

23.43

ng/l

0.24

106

309

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

135

456

3.03

30.56

1.8

1.5

28.44

24.25

ng/l

0.23

135

456

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

9.05

30.38

2.1

1.5

58.04

23.52

ng/l

0.67

Erysipelas

546

2754

1.72

30.38

1.6

1.5

31.87

28.66

ng/l

0.43

546

2747

Hypothyroidism due to medicaments and other exogenous substances

9.49

30.20

2.6

1.3

59.80

19.37

ng/l

1.24

Adverse effects, not elsewhere classified

272

1292

2.14

29.66

1.8

1.7

28.52

29.95

ng/l

0.12

272

1287

Hirsutism in women

6.43

29.57

2.8

1.7

39.63

20.43

ng/l

0.87

Other disorders of urethra and urinary system

738

3239

1.59

29.49

1.6

27.02

32.78

ng/l

1.40

738

3231

Hypertrichosis

100

5.78

29.26

2.6

1.6

38.55

20.43

ng/l

0.92

100

Fall on same level

1240

4609

1.44

29.21

1.6

28.67

33.56

ng/l

1.32

1234

4600

Malignant neoplasm of tongue, including Hilmo

6.83

29.12

1.4

1.5

24.61

25.64

ng/l

0.12

Postmenopausal osteoporosis with pathological fracture

276

3.61

29.11

1.3

1.5

26.57

22.50

ng/l

0.27

276

Mesothelioma, including Hilmo

11.79

27.80

1.9

1.8

41.59

23.59

ng/l

0.39

Hyperhidrosis

116

5.16

27.66

1.8

1.5

27.51

20.49

ng/l

0.46

116

Enterocolitis due to Clostridium difficile

136

490

2.82

27.36

1.5

27.99

28.69

ng/l

0.05

136

490

KRA_PSY_EATING, excluding more controls

115

376

3.08

27.03

1.6

32.11

34.41

ng/l

0.09

115

376

Other disorders starting during childhood or adolecense, excluding more controls

261

3.54

26.97

1.7

1.6

21.14

31.10

ng/l

1.09

261

Gingival hyperplasia

225

3.85

26.97

2.5

1.6

17.85

29.22

ng/l

1.41

225

Malignant neoplasm of heart, mediastinum and pleura

10.54

26.72

1.9

1.6

40.94

24.49

ng/l

0.36

Malignant neoplasm of tonsil and base of tongue

8.16

26.58

1.4

1.2

26.15

22.81

ng/l

0.48

Syndrome of inappropriate secretion of antidiuretic hormone

28.78

25.35

1.4

1.3

25.09

25.43

ng/l

0.03

Dependence on enabling machines and devices, not elsewhere classified

6.28

25.30

2.4

1.8

18.33

39.55

ng/l

0.78

Dialysis

200

3.89

24.91

2.1

1.5

26.04

29.49

ng/l

0.18

200

Other and unspecified drugs and medicaments

124

450

2.82

24.73

1.8

1.5

29.19

26.42

ng/l

0.12

124

450

Hypercalcemia

192

3.87

23.88

1.6

39.07

30.27

ng/l

0.29

192

Asthma and allergy

145

573

2.53

23.58

1.5

1.7

21.82

29.72

ng/l

1.74

145

573

Disorders of skin appendages

549

3442

1.60

23.55

1.8

1.6

28.29

32.27

ng/l

0.72

549

3431

Thyrotoxicosis with diffuse goitre

154

637

2.45

23.46

1.9

1.4

49.19

23.92

ng/l

1.93

154

637

Asthma and allergy, excluding more controls

145

575

2.52

23.43

1.5

1.7

21.82

30.44

ng/l

1.95

145

575

Candidiasis, including avohilmo

346

1951

1.79

22.75

1.6

26.38

31.85

ng/l

0.90

346

1945

Urticaria and erythema

416

2469

1.70

22.75

1.7

1.6

35.00

30.83

ng/l

0.26

416

2461

Polycystic ovarian syndrome

218

3.56

22.57

2.3

1.2

40.43

22.20

ng/l

1.36

218

Behavioural syndromes associated with physiological disturbances and physical factors

979

4692

1.42

22.30

1.5

1.6

27.23

33.81

ng/l

2.22

974

4682

Symptoms and signs involving speech and voice

353

2020

1.76

22.07

1.6

29.41

29.46

ng/l

0.01

353

2013

Postprocedural disorders of digestive system, not elsewhere classified

150

4.14

21.81

1.6

1.5

19.76

32.54

ng/l

0.94

150

Hypocalcemia

105

4.88

21.72

1.4

1.6

39.44

35.91

ng/l

0.07

105

Childhood asthma (age<16)

145

462

2.48

21.58

1.6

31.07

29.98

ng/l

0.06

145

462

Childhood asthma (age<16), excluding more controls

144

458

2.48

21.51

1.6

31.20

29.70

ng/l

0.08

144

458

Malignant neoplasm of tongue

6.79

21.45

1.4

1.2

25.77

27.20

ng/l

0.13

Respiratory conditions due to other external agents

5.73

20.73

1.7

1.5

30.21

28.82

ng/l

0.07

Vitamin deficiency

186

3.63

20.20

1.7

20.84

31.16

ng/l

0.91

186

Vitamin deficiency, wide

186

3.63

20.20

1.7

20.84

31.16

ng/l

0.91

186

Hepatocellular carcinoma, including Hilmo

5.66

20.17

1.4

18.96

23.65

ng/l

0.96

Hyperosmolality and hypernatraemia

7.32

20.12

1.7

1.3

39.59

29.45

ng/l

0.22

Abnormal findings on diagnostic imaging of central nervous system

261

3.19

20.10

2.0

1.4

37.84

24.70

ng/l

0.45

261

Fungal Sepsis

173

3.74

20.06

2.1

1.5

27.63

25.24

ng/l

0.14

173

Morphin

6.41

19.83

2.1

1.4

33.34

21.16

ng/l

0.39

Secondary malignant neoplasm of other and unspecified sites

7.08

19.66

1.4

1.8

24.44

23.35

ng/l

0.06

Emotional disorders starting during childhood or adolecense, excluding more controls

231

3.26

19.54

2.1

1.6

23.87

32.08

ng/l

0.66

231

Urticaria

342

2028

1.70

18.90

1.7

1.6

35.74

29.98

ng/l

0.31

342

2022

Pneumothorax

294

2.95

18.62

1.8

1.6

24.12

31.33

ng/l

0.73

294

Nephrotic syndrome

178

3.62

18.61

2.2

1.6

17.90

31.07

ng/l

1.25

178

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

136

3.97

18.54

1.9

1.5

19.72

22.54

ng/l

0.61

136

Viral hepatitis, IBD co-morbidity

150

3.79

18.42

2.0

1.5

40.34

34.71

ng/l

0.13

150

Respiratory insufficiency

268

3.02

18.39

1.7

1.6

19.97

29.12

ng/l

1.20

268

Unspecified kidney failure

113

455

2.52

18.37

1.5

1.7

25.80

30.17

ng/l

0.37

113

455

Adrenogenital disorders

26.31

18.36

4.3

1.5

123.00

24.15

ng/l

2.36

Malnutrition

134

4.07

18.29

1.6

18.86

24.65

ng/l

0.99

134

Adrenomedullary hyperfunction

30.12

18.26

1.9

1.4

89.18

25.36

ng/l

—

Implicit fungal Sepsis

161

3.70

18.22

1.9

1.5

27.03

25.38

ng/l

0.09

161

Immunodeficiencies

262

3.06

18.10

2.3

1.6

29.01

27.22

ng/l

0.09

262

Hepatocellular carcinoma

6.43

18.10

1.4

1.3

15.79

25.15

ng/l

2.33

Extracorporeal dialysis

300

2.90

18.02

1.8

1.6

22.16

33.28

ng/l

1.53

300

Sleep disorders

905

4527

1.38

17.98

1.5

1.6

27.50

34.05

ng/l

2.01

900

4517

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

6.16

17.88

1.4

24.37

26.95

ng/l

0.26

Injuries to the head

1131

5031

1.34

17.84

1.5

1.6

28.41

33.04

ng/l

1.32

1125

5023

Malignant neoplasm, without specification of site

5.25

17.74

1.6

1.5

26.55

22.80

ng/l

0.37

Disorders resulting from impaired renal tubular function

180

3.50

17.53

1.8

1.6

20.73

31.53

ng/l

0.94

180

Other diseases of lip and oral mucosa

435

2795

1.57

17.40

1.5

1.6

26.87

30.67

ng/l

0.64

435

2786

Primary ovarian failure

5.81

17.39

2.1

1.4

86.17

23.03

ng/l

1.02

Neuroendocrine tumor and carcinoma of pancreas

19.22

17.36

2.4

1.5

43.88

23.31

ng/l

0.67

Malignant neoplasm of oropharynx

7.40

17.06

1.4

1.2

25.48

25.75

ng/l

0.02

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

105

285

2.61

16.99

1.5

29.86

35.08

ng/l

0.21

105

285

Pain and other conditions associated with female genital organs and menstrual cycle

220

980

1.89

16.99

1.7

1.6

22.94

33.86

ng/l

1.77

220

975

Mesothelioma

17.36

16.80

2.0

1.1

43.62

24.41

ng/l

0.37

Malignant neoplasm of liver and intrahepatic bile ducts

4.74

16.64

1.7

1.5

16.28

23.56

ng/l

2.34

Disorders of puberty

5.03

16.56

1.6

22.96

20.68

ng/l

0.36

Subjective visual disturbances

274

1597

1.73

16.24

1.5

25.88

30.68

ng/l

0.55

274

1592

Specific personality disorders

251

1427

1.77

16.24

1.6

25.48

35.29

ng/l

2.08

251

1422

Malignant neoplasm of corpus uteri, including Hilmo

329

2.68

16.14

1.8

1.4

23.77

27.47

ng/l

0.38

329

Localized swelling, mass and lump of skin and subcutaneous tissue

329

2016

1.64

16.12

1.6

26.28

31.69

ng/l

0.85

329

2009

Malignant neoplasm, without specification of site, including Hilmo

118

3.96

16.10

1.5

26.06

21.61

ng/l

0.60

118

Other disorders of white blood cells

259

2.92

15.97

1.7

1.6

30.75

29.65

ng/l

0.03

259

Injuries to the knee and lower leg

1181

4892

1.31

15.79

1.6

28.48

33.33

ng/l

1.27

1174

4885

Extrapyramidal and movement disorders

369

2339

1.59

15.71

1.5

35.21

28.48

ng/l

0.64

369

2333

Malignant neoplasm of oropharynx, including Hilmo

6.04

15.34

1.4

1.5

25.39

24.03

ng/l

0.14

Other extrapyramidal and movement disorders in other diseases

255

1483

1.73

15.28

1.6

1.5

32.70

28.93

ng/l

0.28

255

1478

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

196

3.16

15.23

1.8

1.5

19.74

23.87

ng/l

0.81

196

Malignant neoplasm of stomach, including Hilmo

156

3.44

15.21

1.3

1.5

27.68

21.62

ng/l

0.31

156

Any operation in hilmo

8.70

15.05

1.4

1.6

36.03

37.09

ng/l

0.02

Other disorders of optic [2nd] nerve and visual pathways

361

2.54

14.92

1.7

1.6

24.38

26.76

ng/l

0.25

361

Immunodeficiency with predominantly antibody defects

135

3.68

14.91

2.0

1.6

32.72

24.65

ng/l

0.39

135

Acidosis

4.49

14.63

1.6

1.5

44.74

26.79

ng/l

0.31

Malignant neoplasm of corpus uteri

296

2.67

14.42

1.7

1.4

22.00

28.00

ng/l

0.67

296

Malignant neoplasm of renal pelvis, including Hilmo

12.52

14.25

1.2

1.7

42.00

25.48

ng/l

0.93

Melanocytic naevi

320

2010

1.60

14.24

1.5

1.6

26.61

30.53

ng/l

0.70

320

2003

Hypoplasia of dental enamel, prenatal

6.90

13.96

2.8

1.8

18.06

20.04

ng/l

0.31

Cauda equina syndrome

5.79

13.49

2.2

1.4

17.63

28.18

ng/l

0.70

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

144

3.38

13.43

1.9

1.5

17.28

21.37

ng/l

1.20

144

Excessive, frequent and irregular menstruation

354

1203

1.58

13.32

1.6

25.81

31.80

ng/l

0.93

354

1198

Delirium, not induced by alcohol and other psychoactive substances

117

550

2.14

13.32

1.8

1.5

37.64

29.27

ng/l

0.36

117

550

Malignant neoplasm of gum, including Hilmo

12.83

13.29

1.2

1.4

21.37

23.87

ng/l

0.29

Disorders of magnesium metabolism

10.06

13.27

1.3

1.2

33.30

20.15

ng/l

0.49

Malignant neoplasm of nasal cavity and sinuses

17.92

13.21

1.5

1.3

18.61

22.63

ng/l

0.42

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

353

2.43

13.18

1.6

1.4

21.61

26.10

ng/l

0.64

353

Optic atrophy

104

3.92

13.16

2.2

1.5

24.25

25.60

ng/l

0.09

104

Extreme obesity with alveolar hypoventilation

162

3.22

13.08

1.6

1.5

20.86

31.96

ng/l

0.85

162

Voice disturbances

266

1635

1.64

13.01

1.6

30.08

28.81

ng/l

0.10

266

1629

Other and unspecified disorders of white blood cells

173

3.13

13.00

1.7

35.52

30.74

ng/l

0.11

173

Optic atrophy, wide definition

106

3.83

12.81

2.2

1.5

24.25

25.31

ng/l

0.07

106

Wide developmental disorders, excluding more controls

196

2.96

12.80

1.6

22.17

33.26

ng/l

0.88

196

Motor disorders, excluding more controls

131

3.47

12.68

1.9

1.8

21.99

30.85

ng/l

0.44

131

Vitamin B12 deficiency anaemia

427

2.27

12.64

1.5

1.6

54.17

30.64

ng/l

0.88

427

Thyrotoxicosis with toxic multinodular goitre

270

2.64

12.63

1.6

26.69

28.07

ng/l

0.07

270

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

335

2.45

12.61

1.8

1.5

25.74

29.20

ng/l

0.30

335

Arthropathies in other diseases classified elsewhere

161

3.18

12.57

1.8

1.5

43.83

26.24

ng/l

0.86

161

Cramp and spasm

226

2.80

12.50

1.6

26.58

30.60

ng/l

0.19

226

Ovarian cyst

313

1130

1.59

12.43

1.4

1.6

36.20

31.06

ng/l

0.33

313

1125

Deficiency of other B group vitamins

4.28

12.33

1.6

19.84

41.38

ng/l

0.78

Hodgkin lymphoma, hilmo

114

3.60

12.20

1.5

23.62

35.79

ng/l

0.59

114

Malignant neoplasm of tonsil, including Hilmo

6.17

12.19

1.4

1.1

26.79

25.52

ng/l

0.10

Benign neoplasm of brain and other parts of central nervous system

312

2.48

12.07

1.7

1.6

18.51

27.48

ng/l

1.52

312

Malignant neoplasm of pancreas, including Hilmo

253

2.64

12.02

2.0

1.4

34.60

21.54

ng/l

1.21

253

Malignant neoplasm of base of tongue, including Hilmo

12.39

12.00

1.4

1.2

24.35

28.26

ng/l

0.39

Delayed milestone in childhood

283

2.59

12.00

2.0

1.9

24.21

19.83

ng/l

1.05

283

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

10.52

11.65

1.6

1.8

18.01

26.61

ng/l

1.76

Autonomic disorders

3.82

11.64

1.2

1.5

21.33

25.20

ng/l

0.42

Ehlers-Danlos syndrome, including avohilmo

5.20

11.58

1.5

1.4

16.77

20.92

ng/l

0.73

Disorders of lens

605

2749

1.37

11.47

1.5

1.6

25.81

33.17

ng/l

2.18

600

2744

Pneumonia due to other infectious organisms, not elsewhere classified

144

3.20

11.46

1.5

1.6

19.48

31.09

ng/l

0.81

144

Small fibre neuropathy

124

3.39

11.44

1.4

1.5

32.62

34.25

ng/l

0.04

124

105

3.62

11.38

1.5

1.6

48.08

25.34

ng/l

0.50

105

Speech therapy

249

1560

1.61

11.34

1.7

1.5

27.24

27.10

ng/l

0.02

249

1555

Malignant neoplasm of small intestine, including Hilmo

3.98

11.33

1.7

1.6

55.01

22.31

ng/l

0.65

Drug-induced osteoporosis

4.91

11.30

1.8

1.4

26.15

27.36

ng/l

0.05

Small cell lung cancer, including Hilmo

4.98

11.24

1.8

1.5

58.08

22.76

ng/l

1.38

Small cell lung cancer

4.98

11.24

1.8

1.5

58.08

22.76

ng/l

1.38

Vasomotor and allergic rhinitis

370

2471

1.47

11.20

1.7

1.6

31.14

33.45

ng/l

0.18

370

2463

Acetic acid derivatives and related substances

218

662

1.71

11.19

1.5

1.6

27.74

34.95

ng/l

0.72

218

662

Secondary polycythaemia

3.95

11.18

1.8

1.3

26.98

28.35

ng/l

0.09

Other skin changes

199

1183

1.70

11.17

1.7

1.5

27.20

28.39

ng/l

0.10

199

1178

Autoimmune hyperthyroidism

269

2.53

11.16

2.2

1.5

47.09

27.02

ng/l

0.77

269

Congenital iodine-deficiency syndrome/hypothyroidism

3.69

11.12

1.4

1.3

47.96

22.69

ng/l

1.12

Malignant neoplasm of pancreas

201

2.77

11.02

2.0

1.5

35.74

20.68

ng/l

1.17

201

Dermatographic urticaria

338

2.34

11.01

1.8

1.5

27.12

24.75

ng/l

0.18

338

Benign intracranial hypertension

5.61

10.98

1.5

1.4

20.89

22.59

ng/l

0.20

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

3.84

10.96

1.6

1.8

17.33

23.00

ng/l

1.26

Contact with and exposure to communicable diseases

313

2071

1.51

10.94

1.7

1.6

28.13

33.81

ng/l

0.92

313

2066

Other infectious diseases

347

2.31

10.81

1.4

1.6

38.14

30.51

ng/l

0.38

347

Spondylopathies in diseases classified elsewhere

5.44

10.68

1.3

1.8

21.74

50.67

ng/l

0.51

Malignant neoplasm of base of tongue

15.23

10.67

1.4

1.1

25.13

28.22

ng/l

0.21

Fenamates

132

469

1.93

10.63

1.5

1.6

26.27

33.26

ng/l

0.54

132

469

Diseases of inner ear

485

3362

1.39

10.57

1.5

26.85

30.85

ng/l

0.93

485

3351

Dermatitis due to substances taken internally

265

2.49

10.53

1.6

1.5

27.34

29.05

ng/l

0.07

265

Disorders of refraction and accommodation

301

1996

1.51

10.48

1.7

1.6

29.28

30.48

ng/l

0.10

301

1991

Unspecified misadventure during surgical and medical care

272

2.47

10.45

2.1

1.5

53.06

26.62

ng/l

0.80

272

Benign neoplasm: Stomach

476

2.09

10.45

1.7

1.6

22.89

27.37

ng/l

0.75

476

Malignant neoplasm of stomach

136

3.13

10.45

1.3

1.5

30.10

21.28

ng/l

0.37

136

Congenital malformations of gallbladder, bile ducts and liver

4.25

10.42

2.2

1.6

19.48

29.36

ng/l

1.04

Haemorrhoids and perianal venous thrombosis

286

1871

1.53

10.42

1.5

22.92

30.45

ng/l

2.57

286

1866

Other benign neoplasms of skin

330

2244

1.48

10.35

1.5

28.36

30.04

ng/l

0.22

330

2238

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

127

3.19

10.30

1.4

1.6

27.39

20.38

ng/l

0.95

127

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

11.94

10.21

1.7

1.3

16.96

23.22

ng/l

0.97

Anosmia

9.72

10.21

2.2

1.0

27.27

20.52

ng/l

0.33

Kela reimbursement Agammaglobulinemia (D80-84)

5.27

10.19

2.0

1.4

23.05

24.20

ng/l

0.10

Disorders of vestibular function (Vertigo)

414

2866

1.41

10.17

1.5

27.92

29.77

ng/l

0.28

414

2857

Malignant neoplasm of oesophagus, including Hilmo

3.75

10.17

1.7

1.4

45.14

22.92

ng/l

0.43

Exclusion endpoint for clefts

172

2.90

10.15

1.6

1.8

25.39

23.60

ng/l

0.19

172

Squamous cell neoplasms and carcinomas of the skin

263

2.45

10.13

1.6

1.4

22.23

22.56

ng/l

0.05

263

Other and unspecified immunodeficiencies with predominantly antibody defects

4.22

10.10

2.0

1.5

20.98

27.63

ng/l

0.56

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

11.61

10.04

4.1

1.3

94.01

25.51

ng/l

0.54

Anankastic personality disorder

184

2.77

9.98

1.5

1.4

24.38

23.85

ng/l

0.07

184

Disorders of lacrimal system and orbit in diseases classified elsewhere

3.69

9.87

2.0

1.7

42.40

27.92

ng/l

0.47

Congenital malformation of biliary tract

5.47

9.87

2.4

1.6

18.32

29.68

ng/l

0.80

Exposure to other specified factors

781

5245

1.28

9.86

1.5

1.6

31.95

31.85

ng/l

0.01

776

5235

Other dialysis

158

2.92

9.84

2.2

1.5

30.33

31.79

ng/l

0.05

158

Other and/or unspecified nontoxic goitre

336

2.26

9.83

1.5

1.4

30.75

22.09

ng/l

0.63

336

Hepatic failure, not elsewhere classified

158

2.91

9.80

1.2

1.7

20.06

34.19

ng/l

1.15

158

Atopic dermatitis, strict definition with reimbursement

310

2022

1.48

9.78

1.6

24.78

32.95

ng/l

2.04

310

2016

Sicca syndrome [Sjögren]

422

2.11

9.75

1.6

1.5

22.23

23.61

ng/l

0.27

422

Mixed hyperlipidaemia

149

2.94

9.58

1.3

1.4

26.17

25.02

ng/l

0.08

149

Other infectious diseases, including avohilmo

432

2.08

9.54

1.4

1.6

36.40

30.59

ng/l

0.31

432

Anaemia in chronic diseases classified elsewhere

3.53

9.53

1.8

1.4

23.95

25.77

ng/l

0.16

Failure and rejection of transplanted organs and tissues

4.01

9.52

2.2

1.7

25.04

23.41

ng/l

0.12

Other diseases of pancreas

406

2.12

9.52

1.5

1.6

23.70

30.27

ng/l

0.60

406

Abnormalities of gait and mobility

122

661

1.87

9.52

1.2

1.6

28.43

27.22

ng/l

0.07

122

661

Malignant neoplasm of renal pelvis

13.10

9.51

1.3

1.2

45.87

26.72

ng/l

0.65

Atypical facial pain

242

2.48

9.48

1.6

30.31

29.46

ng/l

0.03

242

Melanoma in situ

201

2.64

9.45

1.5

1.6

21.62

31.64

ng/l

0.91

201

Temporomandibular joint disorders, including avohilmo

421

2948

1.39

9.40

1.6

33.35

33.53

ng/l

0.01

421

2939

Artificial opening status

287

2.34

9.33

1.7

23.00

31.03

ng/l

0.81

287

Malignant neoplasm of other endocrine glands and related structures

28.58

9.27

5.3

1.0

122.50

25.60

ng/l

—

Benign neoplasm: Brain, supratentorial

4.01

9.22

1.6

17.05

28.96

ng/l

1.33

Other disorders of central nervous system

4.42

9.22

2.5

1.6

22.70

25.50

ng/l

0.15

Stroke, excluding SAH

499

2666

1.36

9.21

1.5

25.75

28.50

ng/l

0.64

499

2660

Neuroendocrine tumor and carcinoma of lung

8.72

9.21

2.9

1.9

81.12

25.90

ng/l

0.64

Drug-induced hypoglycaemia without coma

4.38

9.19

1.1

1.3

25.47

31.91

ng/l

0.41

Other specified congenital malformation syndromes affecting multiple systems

154

2.92

9.18

1.5

1.9

26.21

23.77

ng/l

0.24

154

Malignant neoplasm of other and ill-defined sites, including Hilmo

4.88

9.11

1.8

83.70

24.62

ng/l

0.74

Malignant neoplasm of nasal cavity and middle ear

13.51

9.05

1.5

1.2

17.68

22.62

ng/l

0.54

Malignant neoplasm of gum

13.48

9.04

1.1

1.5

18.83

25.97

ng/l

0.75

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

13.11

8.97

1.2

1.1

24.91

23.61

ng/l

0.10

Pyothorax

189

2.64

8.96

1.5

23.40

32.13

ng/l

0.71

189

Non-Hodgkin lymphoma, all

112

3.17

8.94

1.2

1.5

27.12

21.66

ng/l

0.80

112

Haemorrhage, not elsewhere classified

123

3.05

8.88

1.6

1.3

23.37

24.57

ng/l

0.12

123

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

156

2.81

8.85

1.5

1.6

19.53

26.23

ng/l

1.33

156

Malignant neoplasm of cervix uteri

3.87

8.85

2.1

1.8

22.12

23.04

ng/l

0.10

Magnesium deficiency

11.29

8.83

1.6

1.5

17.24

40.21

ng/l

0.50

Enteropathic arthropathies

3.34

8.82

1.4

1.6

23.15

25.11

ng/l

0.14

Pneumocystosis

3.75

8.80

1.6

1.4

19.14

29.61

ng/l

1.19

Pneumocystosis, including avohilmo

3.75

8.80

1.6

1.4

19.14

29.61

ng/l

1.19

Eosinophilic disease (BM)

4.49

8.67

1.5

2.0

18.10

45.59

ng/l

0.61

Rash and other nonspecific skin eruption

101

532

1.92

8.65

1.7

1.6

19.68

27.10

ng/l

1.95

101

532

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

856

4328

1.25

8.64

1.5

1.6

25.84

33.50

ng/l

2.92

851

4319

Hypoplasia of dental enamel, prenatal , including avohilmo

103

3.58

8.62

2.8

1.8

18.03

19.92

ng/l

0.34

103

Protozoal diseases

131

2.97

8.61

1.6

1.7

20.43

34.70

ng/l

0.89

131

Other specified and unspecified disorders of eye and adnexa

142

2.87

8.57

1.4

31.83

25.60

ng/l

0.19

142

Hemiplegia

205

2.52

8.57

1.6

23.78

29.53

ng/l

0.38

205

Congenital malformations of the musculoskeletal system, not elsewhere classified

3.67

8.49

1.6

1.8

16.41

21.69

ng/l

1.39

Polyarthrosis

189

1070

1.60

8.49

1.5

1.4

28.25

31.07

ng/l

0.27

189

1070

Erosion of teeth , including avohilmo

267

1818

1.48

8.44

1.8

1.6

39.07

32.63

ng/l

0.42

267

1813

Amputation

432

2.01

8.43

1.2

1.6

22.54

32.37

ng/l

1.93

432

Cholangitis (primary sclerosing, PSC), with reimbursement 202

3.39

8.42

1.5

18.83

27.84

ng/l

1.15

Menorrhagia

284

1072

1.48

8.37

1.4

1.6

24.23

31.14

ng/l

1.09

284

1067

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

9.83

8.37

1.1

1.4

18.59

28.15

ng/l

1.33

Malignant neoplasm of tonsil

7.24

8.31

1.4

1.1

27.06

24.97

ng/l

0.15

Conjunctivitis (acute, non atopic)

286

1972

1.45

8.28

1.7

1.6

39.36

29.05

ng/l

0.85

286

1966

Valvular heart disease excluding rheumatic fever

400

2079

1.38

8.27

1.5

1.6

25.03

28.46

ng/l

1.03

400

2071

Panniculitis affecting regions of neck and back

123

2.97

8.26

1.5

32.02

33.18

ng/l

0.03

123

Osteopathy in diseases classified elsewhere

7.20

8.22

1.3

1.4

34.53

22.76

ng/l

0.72

Autism spe, excluding more controls

118

3.02

8.22

1.7

1.5

22.05

37.15

ng/l

0.71

118

Ehlers-Danlos syndrome

4.91

8.19

1.3

1.4

15.19

20.98

ng/l

1.12

Viral pneumonia (known virus, not influenza)

124

2.97

8.18

2.0

1.7

33.56

33.05

ng/l

0.01

124

Protozoal diseases, including avohilmo

135

2.87

8.17

1.6

1.7

20.43

34.50

ng/l

0.90

135

Alkalosis

14.84

8.16

1.6

1.7

28.29

52.86

ng/l

—

Primary Sclerosing Cholangitis, IBD and UDCA required

3.24

8.15

1.5

1.4

20.54

23.41

ng/l

0.41

Bruxism

3.47

8.14

1.5

1.7

36.02

23.83

ng/l

0.44

Short stature starting before birth

4.15

8.13

1.1

1.9

20.25

18.52

ng/l

0.28

Graves ophthalmopathy, strict

3.38

8.13

1.4

1.7

29.32

26.64

ng/l

0.14

Malignant neoplasm of cervix uteri, including Hilmo

3.36

8.12

2.0

1.7

25.09

23.07

ng/l

0.20

Pemphigoid

3.29

8.12

1.4

1.5

20.15

38.48

ng/l

0.80

COPD-related respiratory insufficiency

100

537

1.88

8.09

1.4

1.6

17.86

29.41

ng/l

3.58

100

537

Paralytic strabismus

319

2.16

8.05

1.8

1.6

25.18

29.62

ng/l

0.39

319

Other epidermal thickening

206

2.47

8.02

1.4

1.6

19.41

30.42

ng/l

1.13

206

Astigmatism

420

2.00

8.02

1.8

1.7

20.46

28.58

ng/l

1.19

420

Malignant neoplasm of larynx

7.38

8.01

1.3

1.5

19.94

26.65

ng/l

1.01

Malignant neoplasm of eye and adnexa, including Hilmo

4.36

7.99

1.7

1.6

31.18

25.59

ng/l

0.34

Benign neoplasm: Endocrine pancreas

8.97

7.96

2.2

1.5

20.77

40.44

ng/l

0.51

Non-rheumatic valve diseases

391

2037

1.37

7.95

1.5

1.6

25.21

28.23

ng/l

0.85

391

2030

Obstructive hydrocephalus

3.69

7.93

1.5

1.7

23.66

26.17

ng/l

0.17

Precocious central puberty

6.78

7.89

2.8

1.5

26.58

20.65

ng/l

0.83

Abnormal findings in nipple discharge synovial fluid wound secretions

3.89

7.87

1.2

1.5

24.36

29.29

ng/l

0.32

Mature T/NK-cell lymphomas, hilmo

4.30

7.80

1.4

1.3

29.88

31.69

ng/l

0.07

Diffuse large B-cell lymphoma, helper endpoint

144

2.74

7.78

1.3

1.5

23.01

21.46

ng/l

0.17

144

Diffuse large B-cell lymphoma

144

2.74

7.78

1.3

1.5

23.01

21.46

ng/l

0.17

144

Diffuse large B-cell lymphoma, including Hilmo

144

2.74

7.78

1.3

1.5

23.01

21.46

ng/l

0.17

144

Other postsurgical states

357

2.07

7.77

1.9

1.6

21.66

26.99

ng/l

0.73

357

Sixth [abducent] nerve palsy

139

2.79

7.75

2.1

1.6

25.08

32.90

ng/l

0.39

139

Sequelae of other external causes

272

2.24

7.75

1.6

21.55

29.18

ng/l

0.93

272

Graves ophthalmopathy

3.19

7.73

1.5

1.6

42.78

27.27

ng/l

0.50

Osteonecrosis due to drugs

3.83

7.70

2.1

1.3

16.64

28.35

ng/l

1.11

Asthma mixed form (mode), excluding more controls

162

2.62

7.69

1.5

1.7

23.08

30.84

ng/l

0.40

162

Acute posthaemorrhagic anaemia

112

2.99

7.68

1.2

1.4

22.10

25.15

ng/l

0.35

112

Malignant neoplasm of other connective and soft tissue, including Hilmo

123

2.88

7.66

1.4

1.6

21.31

23.36

ng/l

0.22

123

Thyroiditis

373

2.04

7.64

1.6

37.63

26.04

ng/l

0.57

373

Other abnormal findings of blood chemistry

205

2.43

7.61

1.5

1.6

21.83

30.42

ng/l

0.77

205

Asthma mixed form (mode)

163

2.60

7.60

1.5

1.6

23.08

29.93

ng/l

0.35

163

Paraplegia, diplegia of upper limbs

3.45

7.57

1.7

1.5

34.80

26.40

ng/l

0.24

Third [oculomotor] nerve palsy

3.51

7.45

1.4

1.5

26.08

27.62

ng/l

0.06

Papilloedema, unspecified

109

3.00

7.45

1.4

1.5

22.92

26.64

ng/l

0.41

109

Toxic liver disease

3.83

7.41

1.6

1.5

20.70

28.58

ng/l

0.52

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

105

3.05

7.33

1.5

1.7

18.54

23.44

ng/l

0.62

105

Acute generalized exanthematous pustulosis

209

2.38

7.32

1.7

1.6

29.44

24.40

ng/l

0.21

209

Bullous disorders

253

2.24

7.31

1.4

1.6

46.17

28.74

ng/l

0.36

253

Generalized skin eruption due to drugs and medicaments

185

2.47

7.29

1.8

1.6

29.28

24.89

ng/l

0.16

185

Carcinoid syndrome

7.57

7.27

2.4

1.0

79.42

19.34

ng/l

0.57

Toxic effect of other and unspecified substances

4.04

7.22

1.4

1.6

20.38

27.88

ng/l

0.41

Malignant neoplasm of other and unspecified parts of tongue

4.58

7.22

1.4

1.2

26.41

29.22

ng/l

0.17

Malignant neoplasm of ureter, including Hilmo

8.23

7.19

1.1

1.7

19.32

24.19

ng/l

0.56

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

382

1.99

7.17

1.6

1.5

19.95

26.72

ng/l

1.11

382

Total colectomy operation

175

2.50

7.12

1.8

1.5

24.75

31.79

ng/l

0.44

175

Total colectomy

175

2.50

7.12

1.8

1.5

24.75

31.79

ng/l

0.44

175

Protein-energy malnutrition of moderate and mild degree

3.66

7.11

1.6

1.8

16.95

25.74

ng/l

0.79

Deviated nasal septum

276

1954

1.42

7.11

1.5

1.6

26.93

31.53

ng/l

0.65

276

1946

Other and unspecified coagulation defects

263

2.20

7.09

1.6

1.5

21.69

23.91

ng/l

0.41

263

Other specified/unspecified systemic involvement of connective tissue

263

2.20

7.09

1.7

1.6

22.96

27.95

ng/l

0.43

263

Cytomegalovirus infection, IBD co-morbidity

107

2.97

7.07

1.5

1.4

24.23

26.45

ng/l

0.20

107

Convalescence

220

2.30

6.96

1.4

1.5

20.22

22.39

ng/l

0.48

220

Other and unspecified follicular disorders

171

2.49

6.95

1.9

1.5

21.57

32.56

ng/l

0.89

171

Inflammatory disorders of male genital organs, not elsewhere classified

4.06

6.94

2.4

1.7

19.11

53.70

ng/l

0.79

Abnormal findings on examination of urine, without diagnosis

202

2.36

6.92

2.3

1.6

22.27

30.77

ng/l

0.71

202

Specific developmental disorder of motor function

198

2.41

6.92

1.9

21.95

26.74

ng/l

0.32

198

Atopic dermatitis, strict definition

297

2095

1.39

6.90

1.6

24.62

32.71

ng/l

1.96

297

2089

Other congenital malformations of urinary system

4.54

6.89

2.0

1.8

15.24

24.12

ng/l

1.58

Polyglandular hyperfunction

+∞

6.85

2.0

0.0

22.83

—

ng/l

—

Nontoxic diffuse goitre

120

2.80

6.84

1.8

1.3

25.09

22.92

ng/l

0.28

120

Allergic rhinitis

299

2138

1.39

6.80

1.7

28.98

32.77

ng/l

0.35

299

2131

Phakomatoses, not elsewhere classified

3.62

6.80

2.0

1.5

26.07

23.03

ng/l

0.24

Autoimmune thyroiditis

3.69

6.79

1.9

1.5

41.54

23.62

ng/l

0.32

Vitamin D deficiency

3.36

6.74

2.0

1.6

19.23

28.68

ng/l

0.95

Bronchiectasis

322

2.04

6.73

1.4

1.6

39.96

28.78

ng/l

0.28

322

Keratitis

313

2290

1.37

6.71

1.6

38.45

29.32

ng/l

0.92

313

2282

Injuries to the wrist and hand

942

5199

1.20

6.65

1.5

1.6

29.53

32.55

ng/l

0.62

935

5191

Other disorders involving the immune mechanism, not elsewhere classified

163

2.50

6.64

1.5

1.6

22.84

30.90

ng/l

0.51

163

Other abnormalities of plasma proteins

3.65

6.64

1.4

1.3

21.66

30.49

ng/l

0.68

Disorders of oesophagus in diseases classified elsewhere

3.16

6.63

2.6

1.6

25.68

41.09

ng/l

0.52

Endometriosis of pelvic peritoneum

140

794

1.61

6.62

1.5

1.6

27.78

32.87

ng/l

0.34

140

789

Eosinophilia

3.53

6.62

1.5

1.4

18.96

30.37

ng/l

1.16

Charcot foot

3.32

6.61

2.0

1.4

42.85

27.82

ng/l

0.45

Benign neoplasm: Spinal cord

3.90

6.58

2.1

1.4

18.58

30.04

ng/l

0.83

Disorders of puberty, other/unspecified

7.99

6.58

1.3

1.8

21.19

20.17

ng/l

0.07

Delayed puberty

5.54

6.56

1.8

1.6

22.76

24.71

ng/l

0.16

Peripheral arterial reconstruction

127

779

1.64

6.53

1.7

1.5

26.38

31.60

ng/l

0.49

127

779

Benign neoplasm: Pancreas

112

2.82

6.52

1.6

28.77

35.11

ng/l

0.24

112

Other specified/unspecified dorsopathies

129

2.67

6.51

1.8

1.5

55.55

33.39

ng/l

0.38

129

Malignant neoplasm of larynx, including Hilmo

5.39

6.49

1.3

1.4

19.94

23.27

ng/l

0.44

Other abnormal findings in urine

3.59

6.49

3.4

1.6

22.31

30.20

ng/l

0.52

Causalgia

3.58

6.48

1.7

1.8

18.11

29.70

ng/l

1.04

Cystic kidney disease

159

2.50

6.48

2.0

1.7

24.69

31.71

ng/l

0.43

159

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

172

1135

1.52

6.47

1.8

1.6

50.43

27.95

ng/l

0.74

172

1130

Other/unspecified cytomegaloviral diseases

3.04

6.44

1.6

1.5

24.24

27.56

ng/l

0.27

3.02

6.42

1.7

1.6

27.91

31.19

ng/l

0.18

Crohn's disease NAS

329

2.00

6.37

1.3

1.6

19.20

26.09

ng/l

1.05

329

Attention to artificial openings

154

2.50

6.37

1.7

1.5

29.26

24.01

ng/l

0.56

154

Malignant neoplasm of other and unspecified parts of mouth

11.50

6.37

1.1

1.5

18.32

26.44

ng/l

—

Cystic kidney disease, including avohilmo

173

2.41

6.33

2.0

1.6

24.63

31.30

ng/l

0.44

173

Other lack of coordination

3.32

6.33

1.7

1.6

52.02

25.96

ng/l

0.43

Other noninflammatory disorders of vulva and perineum

517

1.78

6.24

1.6

23.38

29.30

ng/l

0.75

512

Cytomegaloviral disease

115

2.75

6.23

1.5

1.4

24.23

25.92

ng/l

0.15

115

Oesophagitis

238

2.17

6.21

1.5

32.33

31.48

ng/l

0.03

238

Small cell lung cancer, helper endpoint

3.16

6.19

1.8

1.7

58.08

42.57

ng/l

0.31

Suppurative and unspecified otitis media

333

2203

1.34

6.17

2.0

1.6

39.54

33.89

ng/l

0.41

333

2197

Other diseases of spinal cord

127

2.64

6.17

1.2

1.4

23.01

24.67

ng/l

0.13

127

Haemolytic anaemias

163

2.43

6.15

1.8

1.7

39.16

30.69

ng/l

0.30

163

Benign neoplasm: Tongue

110

2.78

6.15

1.2

1.9

30.30

35.66

ng/l

0.16

110

Crohn's disease of large intestine

259

2.11

6.14

1.5

1.6

18.53

27.45

ng/l

1.16

259

Amputation of toe

306

2.01

6.14

1.2

1.6

24.04

34.05

ng/l

1.28

306

Decubitus ulcer and pressure area

253

2.12

6.09

1.5

23.51

32.11

ng/l

0.96

253

Acute peritonitis

287

2.04

6.07

1.9

1.6

30.22

30.59

ng/l

0.02

287

Trigeminal neuralgia

274

2.07

6.04

1.9

1.6

27.07

29.30

ng/l

0.10

274

Cytomegaloviral disease, including avohilmo

117

2.71

6.04

1.5

1.4

24.23

25.75

ng/l

0.14

117

Bullous pemphigoid

3.30

6.04

1.5

16.83

43.45

ng/l

0.89

Malignant neoplasm of small intestine

3.39

6.03

1.6

28.62

22.78

ng/l

0.67

Traumatic subdural haemorrhage

536

1.72

6.00

1.2

1.6

33.25

31.38

ng/l

0.15

536

Nonhereditary hypogammaglobulinemia

3.64

5.95

2.2

1.4

29.14

28.53

ng/l

0.02

Benign neoplasm: Other/unspecified site

3.47

5.91

1.6

1.4

32.22

29.11

ng/l

0.10

Malignant neoplasm of bone and articular cartilage, including Hilmo

3.35

5.90

1.7

15.53

27.65

ng/l

2.76

Disorder of external ear, unspecified

136

2.54

5.89

2.0

1.7

25.50

33.44

ng/l

0.41

136

Oter anti-inflammatory and antirheumatic agents, non-steroids

154

545

1.56

5.85

1.6

25.36

33.90

ng/l

0.64

154

545

Emphysema

298

2.00

5.84

1.4

1.6

22.54

30.63

ng/l

0.70

298

Mental retardation

359

1.91

5.83

1.8

22.39

26.04

ng/l

0.42

359

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

285

2.02

5.82

1.5

37.39

23.87

ng/l

0.75

285

Fall on and from stairs and steps

233

1666

1.41

5.82

1.5

1.6

26.49

29.89

ng/l

0.51

233

1661

Other and unspecified vasculitis limited to skin

2.91

5.82

1.4

1.6

22.23

39.84

ng/l

0.73

Benign neoplasm of other and unspecified sites

131

2.56

5.81

1.4

1.7

26.01

35.49

ng/l

0.40

131

Other rupture of muscle

6.36

5.77

2.3

1.1

36.73

34.10

ng/l

0.05

Other specified disorders of kidney and ureter

132

2.54

5.73

1.5

1.6

27.88

25.15

ng/l

0.18

132

Subacute thyroiditis

126

2.57

5.72

1.3

39.38

22.49

ng/l

0.51

126

Tongue abnormality

287

2.01

5.72

1.2

1.6

20.09

28.36

ng/l

1.12

287

Faecal incontinence

421

1.82

5.70

1.3

1.5

35.26

26.13

ng/l

0.33

421

Arthropathy in Crohn disease

4.88

5.67

1.1

1.4

22.88

20.40

ng/l

0.21

Benign neoplasm: Kidney

151

2.42

5.66

1.5

23.91

33.90

ng/l

0.64

151

Lactose intolerance

127

2.56

5.64

1.5

1.6

58.43

25.07

ng/l

0.65

127

Congenital malformations of the nervous system

158

2.40

5.63

1.7

22.18

21.92

ng/l

0.04

158

Barrett oesophagus

228

2.13

5.63

1.1

1.6

21.46

33.05

ng/l

1.36

228

Poisoning by narcotics and psychodysleptics [hallucinogens]

3.46

5.62

1.5

24.63

29.02

ng/l

0.21

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

6.06

5.60

1.4

1.3

21.19

24.32

ng/l

0.34

Localized skin eruption due to drugs and medicaments

3.91

5.58

1.3

1.5

25.26

22.28

ng/l

0.23

Disorder of the sleep-wake schedule

2.79

5.58

1.9

1.5

24.54

26.66

ng/l

0.19

Adenocarcinoma and Papillary adenocarcinoma of kidney

5.99

5.57

1.1

24.17

25.32

ng/l

0.10

Benign neoplasm of urinary organs

210

2.17

5.52

1.4

1.6

24.68

30.59

ng/l

0.48

210

Postinfectious hypothyroidism

7.42

5.52

1.6

1.2

23.45

18.20

ng/l

0.48

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

153

2.40

5.52

1.6

21.98

31.65

ng/l

0.59

153

Open wound of shoulder and upper arm

3.19

5.49

1.7

1.5

93.61

28.21

ng/l

0.80

Other and unspecified haemorrhagic conditions

3.30

5.49

1.7

1.3

77.20

28.52

ng/l

0.54

Postzoster neuralgia

3.41

5.48

2.1

1.3

19.02

28.71

ng/l

0.75

Disorders of breast

416

2869

1.28

5.48

1.6

30.60

32.55

ng/l

0.17

416

2860

Mental retardation, wide definition

368

1.87

5.43

1.8

22.39

25.81

ng/l

0.40

368

Other superficial mycoses

2.79

5.40

1.6

1.4

23.77

27.32

ng/l

0.29

Drug-induced hypopituitarism

16.69

5.37

2.5

2.0

127.75

81.50

ng/l

—

Abscess of lung

3.35

5.34

1.6

1.4

21.37

28.59

ng/l

0.51

Benign neoplasm: Brain, unspecified

6.97

5.33

1.3

1.8

13.77

39.94

ng/l

0.71

Other and unspecified disorders of skin and subcutaneous tissue

295

1.95

5.31

1.8

1.5

20.96

28.70

ng/l

1.01

295

Disorders of endocrine glands in diseases classified elsewhere

9.60

5.28

2.4

1.3

23.50

17.67

ng/l

—

Volvulus

102

2.69

5.26

1.5

2.0

20.56

32.54

ng/l

0.53

102

Chronic lymphocytic leukaemia, helper endpoint

3.08

5.23

1.3

1.5

24.19

22.26

ng/l

0.21

Chronic lymphocytic leukaemia

3.08

5.23

1.3

1.5

24.19

22.26

ng/l

0.21

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

3.08

5.23

1.3

1.5

24.19

22.26

ng/l

0.21

Other and unspecified trigeminal disorders

3.20

5.23

1.5

17.54

25.99

ng/l

0.75

Other and unspecified bullous disorders

3.57

5.23

1.5

1.6

91.60

28.89

ng/l

0.41

Endometriosis of intestine

3.19

5.22

2.5

1.6

19.57

25.41

ng/l

0.63

Testicular dysfunction, other/unspecified

7.68

5.21

1.3

1.1

19.94

26.93

ng/l

0.37

Other and unspecified disorders of autonomic nervous system

6.72

5.18

1.2

1.4

18.01

23.04

ng/l

0.33

Benign neoplasm: Carotid body

9.03

5.18

1.9

1.6

87.02

17.05

ng/l

—

Other disorders of nervous system

319

1.90

5.17

1.4

1.5

22.39

31.52

ng/l

0.99

319

Drug-induced headache, not elsewhere classified

5.94

5.15

1.3

1.4

32.10

29.31

ng/l

0.12

Manic episode

115

2.56

5.15

2.0

1.4

70.03

26.45

ng/l

0.57

115

Malignant neoplasm of eye and adnexa

5.85

5.12

1.9

1.7

24.50

23.16

ng/l

0.12

Vasculitis limited to skin, not elsewhere classified

104

2.64

5.09

1.4

1.6

21.55

37.86

ng/l

0.78

104

Other surgical follow-up care

140

2.39

5.09

1.2

1.4

22.65

23.04

ng/l

0.05

140

Restrictive cardiomyopathy

5.91

5.07

1.5

1.3

25.92

36.69

ng/l

0.31

Convergence insufficiency and excess

3.48

5.06

1.4

2.0

21.25

27.22

ng/l

0.56

Motor disorders

232

2.09

5.06

1.9

2.0

21.95

27.28

ng/l

0.44

232

Selective deficiency of immunoglobulin G [IgG] subclasses

5.22

5.02

1.7

2.0

18.81

32.19

ng/l

0.51

Malignant neoplasm of floor of mouth, including Hilmo

7.08

4.99

1.4

22.11

25.35

ng/l

0.33

Spinal instabilities

105

2.61

4.99

1.3

1.7

17.88

34.91

ng/l

0.90

105

Lactose intolerance, other/unspecified

111

2.56

4.98

1.6

49.39

24.50

ng/l

0.40

111

Other noninfective disorders of lymphatic vessels and lymph nodes

154

2.30

4.98

1.5

1.4

19.45

25.63

ng/l

1.00

154

Hepatomegaly and splenomegaly, not elsewhere classified

3.77

4.97

1.7

1.1

36.13

21.53

ng/l

0.64

Combined immunodeficiencies

3.76

4.97

3.1

1.7

22.13

29.26

ng/l

0.32

Other disorders of electrolyte and fluid balance, not elsewhere classified

4.70

4.92

1.2

1.3

26.18

31.40

ng/l

0.18

Hypersomnia

3.41

4.92

1.5

22.42

27.15

ng/l

0.21

Other and unspecified epidermal thickening

118

2.50

4.90

1.4

1.8

18.65

34.97

ng/l

0.92

118

Nonsuppurative otitis media, including avohilmo

288

1891

1.32

4.86

1.9

1.6

32.96

33.08

ng/l

0.01

288

1886

Other necrotizing vasculopathies

326

1.86

4.86

1.4

1.6

23.11

28.86

ng/l

0.53

326

Impingement syndrome of shoulder

189

1349

1.41

4.85

1.6

22.72

34.31

ng/l

3.63

189

1344

Unspecified protein-energy malnutrition

5.45

4.85

1.3

1.8

17.73

40.32

ng/l

0.85

Schizophrenia or delusion

262

1970

1.34

4.85

1.5

1.6

26.44

31.16

ng/l

1.00

262

1963

Acute lymphocytic leukaemia

3.10

4.82

1.5

1.9

12.49

21.74

ng/l

3.39

Acute lymphocytic leukaemia, including Hilmo

3.10

4.82

1.5

1.9

12.50

21.74

ng/l

3.39

Acute lymphocytic leukaemia, helper endpoint

3.10

4.82

1.5

1.9

12.50

21.74

ng/l

3.39

In situ neoplasms

315

2432

1.30

4.82

1.5

23.54

31.31

ng/l

2.78

315

2425

Melanoma in situ of trunk

3.47

4.78

1.6

1.7

21.73

51.98

ng/l

0.63

Lesion of radial nerve

157

2.26

4.77

1.5

1.7

43.07

32.71

ng/l

0.22

157

Marginal zone B-cell lymphoma, including Hilmo

4.50

4.77

1.6

19.14

21.96

ng/l

0.35

Other peripheral vascular diseases

416

1.75

4.77

2.0

1.6

34.42

27.31

ng/l

0.25

416

Sulfasalazine

211

1540

1.38

4.74

1.5

1.6

25.74

34.29

ng/l

1.56

211

1535

Angina pectoris

434

2300

1.25

4.74

1.5

25.91

28.78

ng/l

0.61

434

2294

Schizophrenia, schizotypal and delusional disorders

262

1977

1.33

4.74

1.5

1.6

26.44

31.11

ng/l

0.99

262

1971

6-mercaptopurine

177

2.17

4.74

1.9

1.6

20.66

30.17

ng/l

0.64

177

Nonalcoholic steatohepatitis

4.43

4.68

1.7

22.13

31.37

ng/l

0.42

Acute drug-induced interstitial lung disorder

6.31

4.65

2.2

1.6

35.86

42.69

ng/l

0.11

Other symptoms and signs involving general sensations and perceptions

172

2.18

4.64

1.4

1.6

22.82

31.14

ng/l

0.56

172

Secondary malignant neoplasm of respiratory and digestive organs

3.54

4.63

1.5

1.6

26.88

25.31

ng/l

0.11

Tracheo-bronchomalasia

8.51

4.61

1.6

1.3

39.78

19.45

ng/l

—

Shock, not elsewhere classified

4.64

4.60

1.4

1.2

24.21

24.95

ng/l

0.04

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

10.65

4.60

1.5

1.4

29.50

18.20

ng/l

—

Other specified/unspecified soft tissue disorders

193

2.09

4.56

1.4

1.5

21.54

30.68

ng/l

0.76

193

Toxic colitis

7.12

4.56

2.2

1.5

19.50

20.97

ng/l

—

Congenital vesicoureteral reflux

3.42

4.55

2.3

1.8

14.81

19.55

ng/l

1.23

Burn and corrosion of trunk

129

2.36

4.53

1.3

1.4

19.92

26.39

ng/l

1.11

129

Family history of other specific disorders

3.22

4.52

1.4

1.9

23.05

30.78

ng/l

0.50

ILD, hospital admissions 3, with pneumonia sepsis

349

1.79

4.50

1.7

1.6

24.61

28.22

ng/l

0.41

349

Other and unspecified paralytic syndromes

3.33

4.50

1.9

1.4

18.31

28.23

ng/l

0.67

Disorders in reading

130

2.37

4.49

1.6

1.7

18.64

30.98

ng/l

0.69

130

Other disorders of bone density and structure

2.56

4.49

1.6

21.30

27.29

ng/l

0.63

Behavioural disorders, excluding more controls

2.62

4.47

1.9

1.5

19.70

37.52

ng/l

0.68

Benign neoplasm: Other and unspecified parts of mouth

130

2.34

4.45

1.7

41.74

34.25

ng/l

0.15

130

Injury of nerves and spinal cord at neck level

2.73

4.44

1.4

1.6

24.75

40.27

ng/l

0.50

181

2.11

4.44

1.4

1.6

21.37

31.14

ng/l

0.81

181

Other hypertrichosis

7.96

4.43

3.8

1.7

24.74

24.95

ng/l

—

Peroneal tendinitis

3.05

4.42

2.2

1.4

19.52

27.13

ng/l

1.46

Other infective otitis externa

315

1.83

4.42

1.5

1.6

41.96

27.90

ng/l

0.32

315

Oxicams

152

593

1.46

4.41

1.6

32.54

34.23

ng/l

0.08

152

593

Torsion of ovary, ovarian pedicle and fallopian tube

2.59

4.41

1.4

1.6

41.76

22.06

ng/l

0.56

Traumatic subarachnoid haemorrhage

131

2.31

4.37

1.1

1.6

34.88

36.52

ng/l

0.05

131

Encephalitis

125

2.35

4.36

1.9

1.6

20.79

26.12

ng/l

0.74

125

Malignant neoplasm of palate, including Hilmo

6.47

4.34

1.3

1.4

20.40

22.34

ng/l

—

Other encephalitis

113

2.42

4.33

1.9

1.7

19.70

26.73

ng/l

0.99

113

Melanocytic naevi of lower limb, including hip

211

2.01

4.33

1.4

1.6

18.38

30.07

ng/l

1.32

211

Other and unspecified nail disorders

101

2.52

4.32

1.5

20.38

25.96

ng/l

0.70

101

Carcinoma in situ of skin of upper limb, including shoulder

2.57

4.32

1.4

1.6

23.86

38.03

ng/l

0.55

Personal history of risk-factors, not elsewhere classified

3.01

4.32

1.5

1.4

28.79

29.93

ng/l

0.06

Congenital malformations of trachea and bronchus

3.14

4.30

2.4

1.9

18.16

27.23

ng/l

0.67

Other abnormal uterine and vaginal bleeding

177

912

1.40

4.27

1.4

1.5

22.64

31.18

ng/l

1.06

177

907

Other and unspecified mental retardation

205

2.05

4.26

2.0

1.7

22.50

20.97

ng/l

0.21

205

Sexual dysfunction

2.88

4.25

2.0

1.3

24.72

27.67

ng/l

0.21

Neuroendocrine tumor and carcinoma of small intestine

4.20

4.23

1.6

1.4

26.69

24.57

ng/l

0.13

Nonpyogenic thrombosis of intracranial venous system

3.51

4.22

1.4

1.6

23.26

29.45

ng/l

0.26

Other and unspecified pemphigoid

4.94

4.22

1.4

22.62

32.32

ng/l

0.28

Paget disease

7.22

4.21

1.2

1.4

21.38

46.20

ng/l

—

Polycystic ovarian syndrome, broad definition

462

1.65

4.21

1.4

1.3

24.70

22.18

ng/l

0.62

462

conjunctival haemorrhage

372

1.73

4.20

1.5

1.4

35.02

31.27

ng/l

0.16

372

Alopecia areata

134

2.27

4.18

1.3

1.6

25.57

25.54

ng/l

0.00

134

Pneumonitis due to solids and liquids

350

1.75

4.18

1.7

1.5

34.03

29.87

ng/l

0.17

350

Other immunodeficiencies

2.88

4.17

2.1

1.6

25.09

21.00

ng/l

0.55

Paralytic ileus

134

2.26

4.16

1.7

1.8

17.90

30.42

ng/l

0.82

134

Corns and callosities

329

1.78

4.15

1.6

1.5

23.86

28.40

ng/l

0.52

329

Thrombocytopenia, unspecified

366

1.74

4.14

1.5

1.6

23.23

27.97

ng/l

0.60

366

Dystonia

271

1.86

4.14

1.2

1.6

45.96

23.38

ng/l

0.45

271

Colonic or urogenital fistula

217

1629

1.34

4.14

1.4

1.6

26.73

30.21

ng/l

0.55

217

1624

Malignant neoplasm of vagina, including Hilmo

8.44

4.12

1.1

1.4

14.88

24.34

ng/l

—

Any event in hilmo or specialist outpatient

+∞

4.12

1.2

0.0

18.60

—

ng/l

—

Malignant neoplasm of oropharyng

11.02

4.11

1.3

21.86

24.51

ng/l

—

Cerebral atherosclerosis

4.07

4.11

1.9

1.3

24.08

33.31

ng/l

0.38

Malignant neoplasm of nasopharynx, including Hilmo

8.31

4.10

1.1

28.94

26.10

ng/l

—

Other localized connective tissue disorders

2.67

4.09

1.6

1.3

43.08

26.39

ng/l

0.27

Malignant neoplasm of hypopharynx, including Hilmo

8.21

4.09

1.3

1.5

21.10

27.30

ng/l

—

Suggestive for eosinophilic asthma

428

1.67

4.08

1.4

1.6

28.27

27.33

ng/l

0.06

428

Drug-induced thyroiditis

10.66

4.08

1.7

1.4

27.27

19.14

ng/l

—

Central nervous system disorder causing precocious puberty

4.50

4.08

2.8

1.3

26.76

20.60

ng/l

0.73

Viral infections of central nervous system, not elsewhere classified/unspecified

3.41

4.07

2.0

1.5

23.61

32.16

ng/l

0.41

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

5.91

4.06

2.5

1.6

19.35

23.37

ng/l

—

Other necrotizing vasculopathies (FG)

266

1.86

4.04

1.4

1.6

23.52

29.28

ng/l

0.49

266

Late syphilis, including avohilmo

2.98

4.03

1.2

1.3

44.35

30.38

ng/l

0.27

Disorders of parathyroid gland, other and/or unspecified

5.73

4.01

2.1

1.2

33.01

27.24

ng/l

—

Other and unspecified mononeuropathies of upper limb

130

2.26

4.01

1.1

1.6

22.05

26.26

ng/l

0.21

130

Chromosomal abnormalities, not elsewhere classified

204

2.00

4.00

1.6

1.8

21.96

23.73

ng/l

0.23

204

FESS (DNB20)

105

698

1.51

4.00

1.6

24.65

27.98

ng/l

0.36

105

698

Zoster [herpes zoster], including avohilmo

420

3313

1.23

3.99

1.5

28.99

30.37

ng/l

0.18

420

3305

Pyoderma gangrenosum

4.58

3.98

1.5

1.6

25.92

35.16

ng/l

0.29

Special screening examination for neoplasms

268

1.84

3.95

1.7

1.5

40.19

31.45

ng/l

0.27

268

Pustulosis palmaris et plantaris

184

2.03

3.95

1.5

21.75

23.58

ng/l

0.23

184

Abnormality of white blood cells, not elsewhere classified

3.90

3.94

1.6

1.3

16.39

28.34

ng/l

0.61

Melanoma of uvea

4.17

3.94

1.5

1.3

38.01

32.28

ng/l

0.15

Other nonscarring hair loss

3.87

3.92

1.4

1.5

20.94

20.70

ng/l

0.03

Additional codes for the location of defect, injury or illness

284

1.81

3.90

1.4

1.6

35.15

27.95

ng/l

0.32

284

Neuroendocrine tumor and carcinoma of stomach

7.54

3.90

1.1

1.3

14.63

25.78

ng/l

—

Preparatory care for dialysis

199

1.98

3.89

1.4

1.5

31.81

32.44

ng/l

0.02

199

Lichen simplex chronicus

132

2.22

3.88

1.3

1.6

22.90

25.74

ng/l

0.28

132

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

3.02

3.87

1.9

1.5

22.67

29.36

ng/l

0.39

Marginal zone B-cell lymphoma

4.39

3.85

1.7

21.01

22.76

ng/l

0.17

Ethmoidectomy

107

721

1.49

3.84

1.6

24.42

28.95

ng/l

0.54

107

721

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

133

2.22

3.84

1.9

1.6

20.07

24.80

ng/l

0.56

133

Peripheral artery operations in Hilmo

568

1.56

3.84

1.2

1.6

22.25

32.81

ng/l

2.64

568

Blindness, monocular

4.04

3.83

1.8

1.3

26.88

32.19

ng/l

0.14

Malignant neoplasm of nasopharynx

9.22

3.83

1.1

31.93

24.63

ng/l

—

Benign neoplasm: Skin, unspecified

173

2.05

3.81

1.6

53.48

33.02

ng/l

0.45

173

Kyphosis

3.24

3.80

1.2

1.4

20.43

22.03

ng/l

0.19

Right bundle-branch block

153

2.11

3.79

1.5

40.25

27.48

ng/l

0.29

153

Focal brain injury

243

1.86

3.79

1.2

1.6

27.64

40.14

ng/l

0.87

243

Constitutional tall stature

4.02

3.77

1.8

1.9

26.23

20.26

ng/l

0.75

Autoimmune hepatitis

3.69

3.74

1.6

1.3

12.26

20.17

ng/l

2.78

Pure hyperglyceridaemia

2.53

3.73

1.5

1.3

44.27

26.09

ng/l

0.36

Sequelae of injuries of neck and trunk

115

2.29

3.73

1.2

1.7

25.53

35.29

ng/l

0.41

115

Hereditary hypogammaglobulinemia

5.95

3.73

2.7

1.6

14.40

20.94

ng/l

—

Encephalopathy

3.92

3.73

1.2

1.5

23.44

33.45

ng/l

0.41

Congenital malformations of the respiratory system

155

2.12

3.72

2.2

1.7

18.40

22.38

ng/l

0.67

155

Narcolepsy and cataplexy

5.15

3.72

1.2

1.4

25.02

39.16

ng/l

—

Duodenal ulcer

486

1.59

3.72

1.6

23.81

32.09

ng/l

1.44

486

Uterine polyps

214

942

1.33

3.72

1.4

1.6

29.76

31.48

ng/l

0.13

214

937

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

3.06

3.71

1.3

1.4

28.99

32.89

ng/l

0.13

Disorders of other and unspecified cranial nerves

5.83

3.70

1.1

1.5

15.62

43.19

ng/l

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

464

1.61

3.69

1.3

1.5

34.23

27.28

ng/l

0.29

464

Anorexia

2.66

3.67

1.9

1.5

20.53

27.09

ng/l

0.58

Disorders of myoneural junction and muscle in diseases classified elsewhere

4.53

3.66

1.6

19.39

36.03

ng/l

0.51

Localized scleroderma [morphea]

2.91

3.65

1.6

1.3

52.84

28.59

ng/l

0.31

Other hereditary haemolytic anaemias

3.87

3.65

2.0

1.5

55.75

19.42

ng/l

0.68

Benign neoplasm: Skin of trunk

190

1.97

3.64

1.2

1.6

21.57

32.03

ng/l

0.95

190

Disorders of phosphorus metabolism and phosphatases

4.96

3.61

2.1

1.4

20.80

17.84

ng/l

—

Implicit parasitic Sepsis, including avohilmo

4.93

3.60

1.4

1.5

15.86

36.65

ng/l

—

Malignant neoplasm of hypopharynx

8.09

3.60

1.1

1.3

19.40

26.67

ng/l

—

Malignant neoplasm of accessory sinuses, including Hilmo

8.04

3.59

1.9

1.6

19.57

21.52

ng/l

—

Endometriosis ASRM stages 1,2

146

1057

1.39

3.58

1.5

1.6

27.11

31.94

ng/l

0.36

146

1052

Dislocation, sprain and strain of joint and ligaments of hip

157

2.06

3.57

2.0

1.5

35.41

30.99

ng/l

0.13

157

Nephropathy induced by other drugs, medicaments and biological substances

10.82

3.57

1.5

1.7

32.67

77.83

ng/l

—

Juvenile cataract

5.54

3.56

1.8

20.56

21.24

ng/l

—

Cerebral oedema

10.69

3.56

1.8

1.5

20.82

14.67

ng/l

—

Malignant neoplasm of vagina

10.65

3.55

1.0

1.5

16.17

23.43

ng/l

—

Polyp of the female genital tract

224

968

1.31

3.55

1.5

1.6

28.76

31.27

ng/l

0.19

224

963

Colitis, primary sclerosing

2.86

3.55

1.1

1.4

21.85

30.12

ng/l

0.55

Malignant neoplasm of accessory sinuses

10.59

3.55

1.7

1.5

20.00

19.27

ng/l

—

Other and unspecified disorders of adult personality and behaviour

5.46

3.54

1.8

1.5

23.83

20.71

ng/l

—

Mechanical strabismus

10.53

3.54

1.7

1.8

43.83

20.93

ng/l

—

IBD (strict) with PSC

3.70

3.53

1.2

1.4

21.35

27.77

ng/l

0.59

Ulcer of vagina/vulva

118

2.23

3.53

1.4

1.8

18.43

22.64

ng/l

0.81

118

Viral meningitis, including avohilmo

172

2.00

3.50

1.5

26.83

26.88

ng/l

0.00

172

Pustular psoriasis

207

1.90

3.50

1.5

1.6

21.74

28.39

ng/l

0.54

207

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

416

1.62

3.50

2.0

1.7

38.63

30.62

ng/l

0.29

416

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.94

3.49

1.1

1.3

23.41

27.03

ng/l

0.19

Congenital malformations of the respiratory system, including avohilmo

166

2.03

3.49

2.2

1.7

18.00

22.30

ng/l

0.78

166

Other disorders of binocular movement

106

2.30

3.48

1.3

1.6

18.74

25.45

ng/l

1.15

106

Laparoscopic right hemicolectomy

258

1.80

3.47

1.5

23.49

31.44

ng/l

0.88

258

Dementia in Alzheimer disease

643

0.57

3.47

1.2

1.4

21.58

28.24

ng/l

1.59

643

Flat foot [pes planus] (acquired)

551

1.53

3.46

1.7

1.5

21.14

28.22

ng/l

1.28

551

Medical abortion

508

2307

1.19

3.46

1.6

30.07

34.58

ng/l

0.52

508

2299

Bursitis of shoulder

100

2.33

3.45

1.5

18.54

37.17

ng/l

0.91

100

SLE (Finngen)

139

2.11

3.45

1.4

1.5

29.17

20.63

ng/l

0.59

139

Idiopathic hypercalciuria

4.24

3.45

1.8

1.3

39.05

34.28

ng/l

0.09

Meckel's diverticulum

4.22

3.44

1.6

24.75

33.02

ng/l

0.26

Intentional self-harm by unspecified means

3.03

3.43

1.5

1.6

30.65

31.45

ng/l

0.03

Malignant neoplasm of oesophagus

2.79

3.43

1.4

21.31

23.18

ng/l

0.27

Other and unspecified nonscarring hair loss

4.18

3.42

1.1

1.7

21.14

22.83

ng/l

0.20

Benign neoplasm: Endocrine gland, other/unspecified

7.34

3.41

3.3

1.5

25.14

54.69

ng/l

—

Melanoma in situ, other sites/unspecified

7.33

3.41

1.3

1.2

20.34

15.90

ng/l

—

Non-follicular lymphoma

466

1.58

3.40

1.3

1.6

22.98

29.60

ng/l

0.93

466

Carcinoma in situ of other and unspecified sites

167

2.00

3.40

1.5

24.16

35.97

ng/l

0.87

167

Hereditary sideroblastic anaemia

7.29

3.40

1.6

23.71

53.40

ng/l

—

Hidradenitis suppurativa

174

1.97

3.40

1.7

1.4

22.05

24.45

ng/l

0.25

174

Moderate visual impairment, binocular

107

2.27

3.40

1.6

1.5

21.35

25.46

ng/l

0.44

107

Striae atrophicae

3.16

3.39

1.3

1.5

23.14

29.21

ng/l

0.28

Gluteal tendinitis

188

1.93

3.39

1.4

1.5

48.15

30.01

ng/l

0.24

188

Disorder of thyroid, unspecified

3.15

3.39

1.4

1.3

14.35

22.93

ng/l

1.44

Adenocarcinomas of cervix

5.94

3.38

1.4

29.31

27.05

ng/l

—

Other and unspecified erythematous conditions

147

2.07

3.38

1.6

1.5

25.03

26.02

ng/l

0.07

147

Other disorders of Eustachian tube

127

2.15

3.37

2.3

1.7

29.33

33.25

ng/l

0.15

127

Carcinoma in situ, bladder

154

2.04

3.37

1.5

1.6

22.82

37.09

ng/l

1.03

154

Viral meningitis

154

2.03

3.36

1.4

1.5

27.78

26.52

ng/l

0.09

154

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

4.51

3.35

1.4

1.5

16.98

23.16

ng/l

—

Malignant neoplasm of bone and articular cartilage

3.51

3.34

1.7

1.5

17.06

27.41

ng/l

1.35

Corneal scars and opacities

108

2.25

3.33

1.6

1.3

21.70

26.56

ng/l

0.54

108

Infection of intervertebral disc (pyogenic)

2.97

3.32

1.6

34.96

48.90

ng/l

0.24

Other bullous disorders

115

2.20

3.30

1.4

1.6

77.17

25.22

ng/l

0.53

115

Other female pelvic inflammatory diseases

124

888

1.40

3.28

1.7

1.5

23.36

27.58

ng/l

0.32

124

883

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

337

2722

1.23

3.27

1.6

27.45

33.72

ng/l

0.97

337

2713

Melanoma in situ of other and unspecified parts of face

3.08

3.27

1.2

1.3

21.02

30.11

ng/l

0.50

Tobacco use

256

1.77

3.26

1.2

1.6

18.37

29.06

ng/l

1.43

256

Other erythematous conditions

170

1.96

3.25

1.6

1.7

24.36

31.39

ng/l

0.41

170

Diseases of spleen

2.71

3.24

1.8

1.4

46.19

28.02

ng/l

0.35

Hypothyroidism, autoimmune, DX-based

5.55

3.23

1.5

1.7

17.50

21.81

ng/l

—

Other meningitis

2.54

3.23

1.3

1.5

45.41

25.62

ng/l

0.44

Melanoma in situ of lower limb, including hip

4.29

3.23

1.8

1.5

23.61

37.14

ng/l

—

Endocarditis

150

2.02

3.21

2.0

1.5

35.19

28.37

ng/l

0.58

150

Nystagmus and other irregular eye movements

2.40

3.18

1.8

29.26

27.28

ng/l

0.08

Vitiligo

2.78

3.18

1.5

1.7

232.24

30.37

ng/l

1.17

Defects in the complement system

3.06

3.18

2.5

1.7

24.07

18.77

ng/l

0.54

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

4.24

3.16

1.3

1.9

21.50

17.70

ng/l

—

Implicit parasitic Sepsis

4.67

3.15

1.4

1.5

16.40

37.58

ng/l

—

Secondary right heart disease

165

1.96

3.15

1.6

17.79

32.79

ng/l

1.34

165

Entropion and trichiasis of eyelid

342

1.65

3.15

1.2

1.6

33.43

31.92

ng/l

0.04

342

Hypertensive Renal Disease

124

2.11

3.15

1.7

1.4

18.75

26.66

ng/l

1.08

124

Androgenic alopecia

3.51

3.13

2.1

1.5

23.27

23.70

ng/l

0.03

Cyst of kidney

335

1.65

3.13

1.7

1.5

21.63

28.48

ng/l

0.97

335

Galactorrhea

3.50

3.13

1.2

2.0

24.61

21.49

ng/l

0.39

Deformity of finger(s)

4.13

3.12

1.4

16.94

31.37

ng/l

—

Viral conjunctivitis

2.31

3.12

1.5

1.6

19.56

25.75

ng/l

0.68

Thyrotoxicosis with toxic single thyroid nodule

3.76

3.11

1.4

1.5

17.85

31.12

ng/l

0.55

Benign neoplasm: Descending colon

336

1.65

3.10

1.4

1.6

20.40

29.69

ng/l

1.57

336

Malignant neoplasm of palate

7.87

3.09

1.0

1.4

22.17

24.83

ng/l

—

Malignant neoplasm of ureter

7.85

3.09

1.2

1.3

23.67

20.57

ng/l

—

Other abnormal immunological findings in serum

2.26

3.08

1.4

1.6

46.84

23.85

ng/l

0.46

Granulomatous disorders of skin and subcutaneous tissue

112

2.17

3.08

1.5

1.7

18.33

25.71

ng/l

1.07

112

Fall involving bed

132

2.07

3.08

1.3

1.7

18.19

34.64

ng/l

1.12

132

Paracetamol or NSAID medication

125

449

1.41

3.06

1.5

1.7

36.44

36.28

ng/l

0.00

125

449

Temporal arteritis

146

2.01

3.06

1.5

24.77

33.10

ng/l

0.35

146

Mixed connective tissue disease

2.54

3.06

1.5

1.7

15.47

28.28

ng/l

1.58

Other factor of the environment

2.94

3.04

1.6

1.3

19.65

29.82

ng/l

0.60

Late syphilis

2.94

3.04

1.2

1.3

53.23

32.58

ng/l

0.31

Other disorders of thyroid

2.94

3.04

1.4

1.5

14.35

23.75

ng/l

1.71

Periodontal disease, other/unspecified

106

2.19

3.04

1.6

1.4

22.08

25.92

ng/l

0.36

106

Asthma and opportunity respiratory infection

196

1.85

3.03

1.3

1.6

26.57

29.51

ng/l

0.18

196

Amblyopia ex anopsia

270

1.72

3.03

2.1

1.7

22.39

27.30

ng/l

0.45

270

Arnold-Chiari syndrome

2.82

3.02

1.1

1.4

19.79

23.05

ng/l

0.56

Hydrocephalus in other diseases

3.98

3.02

1.3

1.8

22.66

37.10

ng/l

—

Oesophageal obstruction

140

2.02

3.01

1.2

1.5

26.13

35.32

ng/l

0.49

140

Acquired haemolytic anaemia

100

2.23

3.01

1.7

1.5

31.30

25.07

ng/l

0.32

100

Liposarcoma, including Hilmo

4.36

3.01

1.3

26.91

25.30

ng/l

—

Malignant neoplasm of lip, including Hilmo

4.35

3.01

1.6

1.7

19.11

26.86

ng/l

—

Diffuse brain injury

120

2.10

2.99

1.2

1.5

41.96

29.39

ng/l

0.33

120

Polyarteritis nodosa and related conditions

2.68

2.99

1.4

1.5

16.13

27.18

ng/l

1.02

Benign neoplasm: Parotid gland

379

1.59

2.97

1.6

26.97

30.48

ng/l

0.29

379

Other/unspecified soft tissue disorders related to use, overuse and pressure

134

2.04

2.97

1.6

1.4

49.50

25.61

ng/l

0.51

134

Other and unspecified acquired haemolytic anaemias

3.32

2.96

1.4

37.71

31.56

ng/l

0.16

Chronic hepatitis, not elsewhere classified

148

1.98

2.96

1.9

1.5

20.47

25.96

ng/l

0.87

148

Injury of nerves at lower leg level

3.31

2.96

1.2

1.5

10.04

31.64

ng/l

1.43

Benign neoplasm: Duodenum

101

2.21

2.95

2.0

1.4

15.70

25.67

ng/l

1.65

101

Other specified/unspecified bacterial intestinal infections

341

1.63

2.94

1.7

1.5

20.77

28.38

ng/l

1.24

341

Polycystic kidney disease

121

2.09

2.94

2.3

1.5

24.32

25.98

ng/l

0.15

121

Bronchitis, not specified as acute or chronic

372

1.59

2.94

1.3

1.6

21.91

28.37

ng/l

0.99

372

Other acute viral hepatitis

2.88

2.94

3.2

1.3

84.21

23.38

ng/l

0.50

Other and unspecified types of non-Hodgkin lymphoma, hilmo

170

1.90

2.91

1.3

1.5

25.15

30.98

ng/l

0.34

170

Embolic stroke with flimmer

2.39

2.90

1.2

1.4

16.16

31.68

ng/l

1.73

Malignant neoplasm of oropharynx, including Hilmo

5.55

2.90

1.3

1.2

21.86

25.89

ng/l

—

Mild mental retardation

178

1.88

2.89

1.5

1.8

22.69

30.89

ng/l

0.55

178

Benign neoplasm: Retina

5.53

2.89

4.0

1.6

19.43

45.77

ng/l

—

Malignant neoplasm of lip

5.48

2.88

1.7

1.2

18.86

23.95

ng/l

—

Other obstructive and reflux uropathy

185

1.85

2.88

1.5

1.6

27.33

28.27

ng/l

0.05

185

Other and unspecified abdominal hernia

178

1.87

2.87

2.3

1.6

32.36

31.36

ng/l

0.03

178

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

171

1.89

2.87

2.0

1.7

21.48

31.20

ng/l

0.72

171

Giant cell arteritis

171

1.89

2.87

1.5

23.49

30.93

ng/l

0.35

171

Arterial embolism and thrombosis

222

1.77

2.85

1.8

1.5

26.69

34.24

ng/l

0.54

222

Chronic Coagulation defects

116

2.10

2.84

2.4

1.7

23.24

25.85

ng/l

0.24

116

Isolated proteinuria

116

2.09

2.84

1.4

1.6

19.64

35.57

ng/l

0.84

116

Pneumonia due to Streptococcus pneumoniae

186

1.84

2.84

2.0

1.7

21.50

29.35

ng/l

0.65

186

Universal erythroderma, KELA reimbursement

2.81

2.83

1.5

1.4

19.57

29.38

ng/l

0.62

Chromophobe cell carcinoma of kidney

4.58

2.82

2.6

1.3

26.29

29.03

ng/l

—

Biological medicines for asthma

2.25

2.81

1.4

1.6

150.30

23.25

ng/l

0.46

Primary biliary cholangitis, wide definition

2.25

2.81

1.6

1.4

18.50

22.34

ng/l

0.63

Complications of other internal prosthetic devices, implants and grafts

165

1.89

2.81

1.3

1.6

22.81

24.42

ng/l

0.19

165

Maxillary retrognathism

110

2.13

2.81

1.5

1.8

66.67

21.01

ng/l

0.76

110

Defect, injury or illness of neck

4.03

2.80

1.4

1.9

17.13

36.38

ng/l

—

Myasthenia gravis

2.58

2.80

1.3

1.4

18.35

27.56

ng/l

0.77

Use of bromocriptine

8.95

2.80

1.8

17.40

77.67

ng/l

—

Carcinoma in situ of cervix uteri, exocervix

4.02

2.80

1.6

1.9

24.89

20.99

ng/l

—

Right hemicolectomy

246

1.72

2.80

1.2

1.5

20.50

31.57

ng/l

1.39

246

Nutritional marasmus

5.40

2.80

1.6

1.5

21.06

19.19

ng/l

—

Impacted maxillary canine

2.38

2.79

1.8

17.31

19.92

ng/l

0.40

Whooping cough, including avohilmo

2.30

2.79

1.7

1.5

31.00

26.58

ng/l

0.16

Adenocarcinoma and papillary adenocarcinoma of stomach

2.56

2.79

1.5

49.41

22.81

ng/l

0.40

Gastrojejunal ulcer

3.13

2.79

1.0

1.3

22.40

34.32

ng/l

0.65

Meningitis

247

1.71

2.76

1.2

1.6

31.63

29.93

ng/l

0.06

247

Giant cell arteritis with polymyalgia rheumatica

152

1.93

2.76

1.5

24.77

32.05

ng/l

0.30

152

Embolic stroke

166

1.88

2.76

1.8

1.5

22.42

34.60

ng/l

0.84

166

Chronic tubulo-interstitial nephritis

145

1.95

2.75

1.5

1.6

26.71

30.19

ng/l

0.14

145

Other proliferative retinopathy

5.15

2.75

1.0

1.5

22.19

45.39

ng/l

—

Cutaneous lupus erythematosus

2.17

2.72

1.3

1.6

35.31

28.31

ng/l

0.26

Urethritis and urethral syndrome

2.26

2.72

1.8

1.3

66.94

25.23

ng/l

0.40

Meralgia paraesthetica

153

1.91

2.71

1.2

1.6

19.90

25.10

ng/l

0.88

153

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

3.51

2.71

2.0

1.6

14.53

23.54

ng/l

—

Abdominal aortic aneurysm (AAA)

354

1.58

2.69

1.8

1.6

27.97

34.70

ng/l

0.52

354

Bilateral cryptorchidism (undescended testicles)

3.04

2.69

1.8

1.7

23.58

19.18

ng/l

0.72

Malignant neoplasm of rectum

318

1.61

2.68

1.4

30.74

24.62

ng/l

0.39

318

Other renal tubulo-interstitial diseases

2.20

2.68

2.3

1.7

17.74

20.72

ng/l

0.54

Anxious personality disorder

2.36

2.66

1.5

30.44

28.98

ng/l

0.04

Other and unspecified diseases of blood and blood-forming organs

2.14

2.66

2.1

1.4

34.05

25.60

ng/l

0.43

Infections with a predominantly sexual mode of transmission

237

1914

1.24

2.65

1.5

1.6

28.22

34.08

ng/l

0.85

237

1908

Hydrocephalus

359

1.57

2.64

1.5

24.31

28.24

ng/l

0.38

359

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.70

2.64

1.5

98.92

30.97

ng/l

0.39

Family history of other conditions

2.49

2.63

1.1

1.6

20.03

29.84

ng/l

0.78

Schizoid personality disorder

2.49

2.63

1.3

1.5

39.27

28.76

ng/l

0.29

Malignant neoplasm of ovary, including Hilmo

228

1.72

2.63

1.2

1.5

29.07

20.79

ng/l

0.88

228

Dronedarone medication

113

2.06

2.63

1.1

1.5

19.27

29.12

ng/l

1.47

113

Drug-induced gout

4.82

2.62

1.0

1.4

21.90

42.17

ng/l

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

2.28

2.62

1.8

1.4

26.07

28.38

ng/l

0.15

Necrotizing fasciitis

4.79

2.62

3.6

1.2

45.86

49.88

ng/l

—

Pyogenic arthritis

313

1.61

2.61

1.7

1.6

44.27

28.19

ng/l

0.32

313

Personal history of malignant neoplasm

481

1.49

2.61

1.6

1.5

20.27

26.26

ng/l

0.98

481

Transepidermal elimination disorders

7.72

2.60

1.0

1.6

19.80

15.71

ng/l

—

Infections with a predominantly sexual mode of transmission, including avohilmo

318

2429

1.20

2.58

1.6

27.93

34.94

ng/l

1.38

318

2422

Lagophthalmos

3.10

2.58

2.3

1.9

25.40

67.63

ng/l

0.69

Other chromosome abnormalities, not elsewhere classified

2.33

2.58

1.3

1.9

18.54

22.10

ng/l

0.58

Fluid overload

5.67

2.57

1.5

24.83

50.42

ng/l

—

Other congenital malformations of nervous system

2.48

2.57

1.2

1.5

20.60

23.22

ng/l

0.36

Benign neoplasm: Skin of ear and external auricular canal

149

1.89

2.57

1.4

1.6

33.11

35.61

ng/l

0.06

149

Contact with other hot fluids

171

1.83

2.56

1.5

1.6

80.80

23.66

ng/l

0.87

171

Mantle cell lymphoma

5.53

2.55

1.0

2.1

30.50

24.33

ng/l

—

Monoplegia

2.54

1.5

20.49

27.96

ng/l

0.48

Malignant neoplasm of rectosigmoid junction, including Hilmo

2.44

2.54

1.4

1.6

20.75

24.32

ng/l

0.57

Unspecified urinary incontinence

419

1.51

2.54

1.6

24.48

29.32

ng/l

0.36

419

Flatulence and related conditions

3.28

2.53

1.5

1.3

19.89

22.21

ng/l

—

Pervasive developmental disorders excl. Autism + Asperger

163

1.86

2.53

1.8

1.7

22.91

28.77

ng/l

0.33

163

Other pulmonary heart/vessel disease

201

1.76

2.53

1.6

19.55

31.28

ng/l

1.20

201

Pre-eclampsia or eclampsia

164

1280

1.29

2.52

1.4

1.6

27.46

33.02

ng/l

0.54

164

1274

Precocious puberty

3.57

2.51

1.4

1.8

25.10

19.70

ng/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

3.54

2.50

1.4

1.5

26.48

31.95

ng/l

—

Cutis laxa senilis

3.54

2.50

2.1

1.5

18.31

33.71

ng/l

—

Colorectal neuroendocrine tumor and carcinoma

3.01

2.50

1.1

1.7

19.06

23.18

ng/l

0.53

Polyarthritis, unspecified

165

1.83

2.50

1.3

1.5

20.93

23.12

ng/l

0.26

165

Factitial dermatitis

4.49

2.50

1.1

1.7

27.87

25.54

ng/l

—

SLE, strict definition

158

1.85

2.49

1.4

1.6

29.55

24.38

ng/l

0.29

158

SLE, ICD10

158

1.85

2.49

1.4

1.6

29.55

24.38

ng/l

0.29

158

Thiamine deficiency

3.91

2.49

1.1

1.4

28.78

38.28

ng/l

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

180

1.79

2.48

1.9

1.7

28.59

31.18

ng/l

0.14

180

Other disorders of peripheral nervous system

3.90

2.48

1.5

19.13

35.65

ng/l

—

Complications of genitourinary prosthetic devices, implants and grafts

2.22

2.48

1.4

1.7

15.51

26.31

ng/l

1.57

Open wound of abdomen, lower back and pelvis

144

1.89

2.47

1.6

26.07

26.57

ng/l

0.04

144

Congenital ovarian cysts

210

1.73

2.47

1.5

25.47

25.65

ng/l

0.01

210

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

2.71

2.47

1.4

1.6

16.23

29.60

ng/l

1.82

Von Willebrand disease

2.59

2.46

2.5

1.9

21.77

20.29

ng/l

0.10

Exfoliative dermatitis

3.18

2.45

1.6

1.2

20.24

34.26

ng/l

—

Thyrotoxicosis factitia

5.20

2.43

1.2

1.8

24.60

47.64

ng/l

—

Benign neoplasm: Small intestine

174

1.80

2.43

1.8

1.5

17.15

32.13

ng/l

1.41

174

Other congenital malformations of heart

2.29

2.43

2.2

1.8

26.92

18.94

ng/l

0.54

Chronic thyroiditis

5.16

2.42

1.7

1.2

48.35

18.19

ng/l

—

Other specified and unspecified disorders of iris and ciliary body

5.15

2.42

1.0

1.9

17.33

19.47

ng/l

—

Benign neoplasm: Anus and anal canal

103

2.06

2.42

1.4

1.6

29.42

36.04

ng/l

0.17

103

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.31

2.42

1.4

1.3

24.64

29.18

ng/l

0.29

Injury of blood vessels at lower leg level

5.14

2.42

2.2

1.6

22.17

49.08

ng/l

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

6.70

2.42

1.6

2.8

16.80

61.33

ng/l

—

Sequelae of poliomyelitis, including avohilmo

3.40

2.41

1.8

1.4

16.50

34.94

ng/l

—

Cystic fibrosis

6.53

2.40

2.6

1.1

16.64

19.38

ng/l

—

Other or unspecified immunodeficiency

3.78

2.40

1.0

1.8

23.21

19.71

ng/l

—

Erythrasma

6.53

2.40

1.0

1.3

27.40

22.25

ng/l

—

Hyperprolactinaemia, drug-induced

3.74

2.39

1.0

1.5

24.38

23.40

ng/l

—

Other specific arthropathies, wide

2.23

2.38

1.5

1.7

40.39

25.20

ng/l

0.30

Chronic mastoiditis

2.08

2.38

2.5

1.5

38.68

39.29

ng/l

0.01

Other specified/unspecified nutritional deficiencies

3.71

2.38

2.4

1.5

17.70

41.03

ng/l

—

Hypothermia

2.44

2.38

1.2

1.3

16.96

30.57

ng/l

1.40

Use of antiglaucoma preparations and miotics

321

1.57

2.38

1.4

21.29

30.98

ng/l

1.51

321

Benign neoplasm: Spinal meninges

2.87

2.36

1.8

1.4

15.20

30.71

ng/l

0.98

Malignant neoplasm of rectosigmoid junction

2.85

2.35

1.4

1.5

21.75

24.71

ng/l

0.33

Other diseases of peritoneum

191

1.74

2.34

1.7

1.6

28.58

29.59

ng/l

0.03

191

Retinal haemorrhage

2.11

2.34

1.5

1.6

24.63

39.47

ng/l

0.56

Neovascular glaucoma

169

1.79

2.33

1.2

1.6

19.50

32.31

ng/l

1.07

169

Neurofibromatosis, type 1

3.29

2.33

2.1

1.3

22.44

25.28

ng/l

—

Achalasia of cardia

2.34

2.33

1.5

1.3

20.35

28.89

ng/l

0.64

Burn and corrosion confined to eye and adnexa

2.06

2.33

1.5

1.4

27.23

27.31

ng/l

0.00

Other inflammation of vagina/vulva

184

1.75

2.33

1.8

1.6

54.63

23.38

ng/l

0.57

184

Mixed disorders of conduct and emotions, excluding more controls

2.06

2.32

1.6

1.4

19.34

39.14

ng/l

0.82

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

3.27

2.32

1.4

1.6

21.14

38.09

ng/l

—

Myositis

105

2.02

2.32

1.7

1.6

20.83

36.65

ng/l

0.73

105

Other congenital malformations of circulatory system

119

1.95

2.32

1.7

1.8

21.04

34.58

ng/l

0.73

119

Secondary parkinsonism, excluding more controls

2.20

2.31

1.1

1.5

25.06

30.45

ng/l

0.43

Burns and corrosions confined to eye and internal organs

112

1.98

2.31

1.4

1.5

30.58

26.67

ng/l

0.32

112

Injury of cranial nerves

3.56

2.29

1.1

1.5

21.66

35.46

ng/l

—

Posteruptive colour changes of dental hard tissues

4.75

2.29

3.2

1.3

15.93

20.70

ng/l

—

Malignant neoplasm of floor of mouth

4.72

2.29

1.3

21.70

27.20

ng/l

—

Acquired absence of organs, not elsewhere classified

2.79

2.28

1.8

43.18

60.20

ng/l

0.20

Benign neoplasm: Skin of lip

2.59

2.28

1.3

1.5

21.47

30.21

ng/l

0.52

Ovarian dysfunction, other/unspecified

4.71

2.28

1.2

1.7

39.50

21.62

ng/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

414

1.48

2.27

1.5

30.55

27.49

ng/l

0.18

414

Nutritional and metabolic disorders in diseases classified elsewhere

6.85

2.26

1.6

1.4

23.66

20.00

ng/l

—

Viral encephalitis, not elsewhere classified/unspecified

2.18

2.26

1.8

1.4

27.25

28.47

ng/l

0.07

Problems related to social environment

113

1.96

2.26

2.3

1.5

18.34

25.91

ng/l

1.25

113

Pregnancy hypertension

312

2357

1.19

2.25

1.7

1.6

30.36

32.17

ng/l

0.18

312

2349

Drug-induced acute pancreatitis

5.90

2.25

1.8

2.0

13.72

38.78

ng/l

—

Routine general health check-up of defined subpopulation

2.29

2.25

1.4

17.13

19.95

ng/l

0.42

Cicatricial alopecia [scarring hair loss]

3.16

2.24

1.4

1.6

21.89

22.92

ng/l

—

Occupational exposure to risk-factors

142

1.85

2.24

1.3

1.7

22.25

35.28

ng/l

0.86

142

Reduction defects of lower limb

5.79

2.24

1.4

22.64

35.29

ng/l

—

Other disorders affecting eyelid function

3.16

2.24

1.1

1.3

18.86

37.26

ng/l

—

Sudden idiopathic hearing loss

506

1.43

2.24

1.4

1.6

57.71

29.56

ng/l

0.37

506

Malignant neoplasm of other and unspecified urinary organs

5.74

2.23

1.4

1.1

21.92

22.07

ng/l

—

Heart failure and hypertrophic cardiomyopathy

2.36

2.23

1.4

1.3

27.64

29.89

ng/l

0.11

Hereditary motor and sensory neuropathy

2.91

2.22

1.6

1.4

18.57

35.73

ng/l

—

Other articular cartilage disorders

2.06

2.22

1.1

1.5

14.33

24.95

ng/l

1.56

Melanocytic naevi of scalp and neck

2.06

2.22

1.4

1.6

23.02

27.13

ng/l

0.36

Primary biliary cholangitis (PBC)

2.21

2.22

1.5

20.13

21.77

ng/l

0.16

Varus deformity, not elsewhere classified

2.54

2.20

2.7

2.0

100.86

25.57

ng/l

0.46

Unspecified contracted kidney

3.42

2.20

1.0

1.8

28.54

33.82

ng/l

—

Whooping cough

3.41

2.20

1.4

1.9

19.50

21.32

ng/l

—

Amputation of ankle bones

2.15

2.19

1.3

1.4

24.23

41.59

ng/l

0.58

Behavioural disorders

129

1.88

2.18

1.9

1.7

19.70

34.51

ng/l

0.81

129

Schizotypal disorder

2.09

2.18

1.4

1.3

25.71

25.72

ng/l

0.00

Hypertrophic cardiomyopathy

188

1.72

2.18

1.3

1.5

24.26

31.52

ng/l

0.51

188

L02BX Other hormone antagonists and related agents

273

1.59

2.18

3.2

1.6

44.94

35.47

ng/l

0.25

273

Benign neoplasm of thyroid gland

129

1.88

2.17

1.7

1.6

23.50

25.15

ng/l

0.17

129

Sequelae of transport accidents

3.78

2.17

2.7

1.5

31.00

47.11

ng/l

—

Disorders of purine and pyrimidine metabolism

3.77

2.17

1.0

1.3

28.66

38.28

ng/l

—

Lung transplant status

2.84

2.16

1.7

1.6

27.95

31.99

ng/l

—

Lung transplantation

2.84

2.16

1.7

1.6

27.95

31.99

ng/l

—

Spinal osteochondrosis

3.04

2.16

1.2

22.03

27.64

ng/l

—

Use of rotigotine

2.82

2.15

1.1

1.3

20.40

30.41

ng/l

—

Benign neoplasm: Skin of upper limb, including shoulder

2.12

2.14

1.4

1.5

17.32

27.13

ng/l

1.22

Glaucoma secondary to other eye disorders

174

1.74

2.14

1.2

1.5

19.50

31.84

ng/l

1.06

174

Discitis, unspecified

2.39

2.13

1.4

1.6

26.39

43.89

ng/l

0.38

Need for immunization against other single viral diseases

2.07

2.13

1.9

1.4

58.72

26.60

ng/l

0.65

Other aneurysm

220

1.65

2.12

1.4

1.5

16.67

34.04

ng/l

2.40

220

Systemic lupus erythematosus

167

1.75

2.12

1.4

1.6

29.17

24.42

ng/l

0.27

167

Ectopic pregnancy

131

1020

1.29

2.12

1.5

1.6

35.47

32.69

ng/l

0.10

131

1014

Previous suicide attempt

2.49

2.12

1.7

1.5

33.02

29.25

ng/l

0.16

Haemophagocytic lymphohistiocytosis

5.40

2.12

1.2

2.1

26.60

18.90

ng/l

—

Horner syndrome

2.49

2.12

1.2

1.3

22.67

33.46

ng/l

0.67

Sequelae of other and unspecified effects of external causes

3.28

2.11

1.0

1.6

16.43

32.71

ng/l

—

Congenital absence, atresia and stenosis of large intestine

3.43

2.11

3.1

1.8

15.00

27.08

ng/l

—

Hypertension, Pulmonary Arterial

3.25

2.11

1.8

1.6

20.15

36.54

ng/l

—

Pneumonia derived septicemia

160

1.77

2.10

2.1

1.6

23.68

32.63

ng/l

0.58

160

!Aliquae complicationes praecoces traumatis

190

1.70

2.10

1.3

1.6

34.15

32.19

ng/l

0.05

190

Early complications of trauma

190

1.70

2.10

1.3

1.6

34.15

32.19

ng/l

0.05

190

Sequelae of inflammatory diseases of the central nervous system

5.17

2.09

1.2

1.5

14.80

18.80

ng/l

—

Adult respiratory distress syndrome

2.59

2.09

1.6

1.3

21.70

33.06

ng/l

0.69

Benign neoplasm: Transverse colon

581

1.38

2.09

1.4

1.6

19.19

30.98

ng/l

3.64

581

Idiopathic peripheral autonomic neuropathy

5.14

2.09

1.8

2.8

19.86

51.30

ng/l

—

Toxic effect of carbon monoxide

2.28

2.09

1.5

29.09

30.08

ng/l

0.04

Disorders of eyelid in diseases classified elsewhere

131

1.85

2.09

1.4

1.6

20.28

25.12

ng/l

0.70

131

Actinomycosis

5.13

2.08

1.4

1.7

22.60

55.40

ng/l

—

Synovial hypertrophy, not elsewhere classified

2.95

2.08

1.2

1.4

31.61

36.05

ng/l

—

Colitis due to radiation

2.95

2.08

1.2

1.3

26.37

23.11

ng/l

—

Malignant neoplasm of penis, including Hilmo

5.08

2.08

1.2

1.1

18.02

28.90

ng/l

—

Necrobiosis lipoidica, not elsewhere classified

3.58

2.07

1.6

1.4

16.91

20.11

ng/l

—

Intentional self-harm by jumping from a high place

3.58

2.07

1.1

1.5

26.00

36.55

ng/l

—

Common variable immunodeficiency

3.58

2.07

2.4

1.4

17.44

17.68

ng/l

—

Follicular lymphoma, hilmo

176

1.72

2.06

1.8

1.5

31.19

29.99

ng/l

0.05

176

Left bundle-branch block

333

1.51

2.06

1.7

1.5

36.82

26.22

ng/l

0.39

333

Maze procedure for atrial fibrillation

4.11

2.06

1.8

1.6

20.17

47.20

ng/l

—

Ectropion of eyelid

139

1.81

2.05

1.9

1.5

21.99

37.09

ng/l

0.93

139

Synovial cyst of popliteal space [Baker]

342

1.50

2.04

1.2

1.7

21.02

32.37

ng/l

1.73

342

Other congenital malformations of intestine

2.28

2.04

1.3

1.5

20.95

24.24

ng/l

0.36

Congenital malformations of posterior segment of eye

2.72

2.03

2.1

1.8

36.30

18.34

ng/l

—

Microscopic polyangiitis

3.15

2.03

1.5

1.6

16.87

35.56

ng/l

—

Erythema nodosum

125

1.86

2.03

2.3

1.6

46.45

25.15

ng/l

0.42

125

Spasmodic torticollis

147

1.78

2.03

1.1

1.6

69.06

24.30

ng/l

0.46

147

Sequelae of poliomyelitis

3.13

2.03

1.8

1.5

17.31

35.32

ng/l

—

Other bacterial agents as the cause of diseases classified to other chapters

2.54

2.03

3.1

1.4

87.25

34.41

ng/l

0.34

Other congenital malformations of upper alimentary tract

2.69

2.02

1.5

1.8

20.55

30.97

ng/l

—

Somnolence

2.53

2.02

1.9

1.4

19.47

27.22

ng/l

0.42

Unspecified nephritic syndrome

2.02

2.01

1.4

25.57

27.22

ng/l

0.08

Carcinoma in situ of vulva

2.86

2.01

2.4

1.6

19.00

22.07

ng/l

—

Drug-induced obesity

2.86

2.01

2.1

1.3

18.18

35.36

ng/l

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

2.65

2.01

1.3

1.5

22.34

24.09

ng/l

—

Amputation of thigh

2.01

2.00

1.1

1.5

18.11

40.39

ng/l

1.03

Congenital malformations of pulmonary and tricuspid valves

2.05

2.00

1.5

2.0

74.93

19.16

ng/l

0.57

Need for immunization against other single infectious diseases

4.11

2.00

2.3

1.6

15.67

19.81

ng/l

—

Carcinoma in situ of prostate

3.43

1.99

1.0

1.2

30.03

39.70

ng/l

—

Slow fetal growth and fetal malnutrition

105

1.98

1.7

1.8

27.40

20.23

ng/l

0.35

105

Localized adiposity

3.42

1.98

1.1

1.4

28.17

19.65

ng/l

—

Oral lichen planus

119

1.87

1.98

1.3

1.6

23.97

24.85

ng/l

0.08

119

Other congenital malformations of respiratory system

4.80

1.97

1.2

2.0

16.60

25.55

ng/l

—

Post-traumatic wound infection, not elsewhere classified

112

1.89

1.97

1.3

1.6

39.80

36.66

ng/l

0.05

112

Alopecia universalis

4.71

1.96

1.0

2.0

15.22

19.00

ng/l

—

Shoulder region

2.38

1.96

1.2

1.4

26.74

26.67

ng/l

0.00

Beningn neoplasm: Meninges, unspecified

2.38

1.96

1.0

1.6

17.45

29.08

ng/l

0.95

Glaucoma secondary to drugs

4.69

1.96

2.0

1.5

24.60

20.36

ng/l

—

Acquired pure red cell aplasia [erythroblastopenia]

4.65

1.95

1.4

1.5

34.44

25.45

ng/l

—

Actinomycosis, including avohilmo

4.65

1.95

1.4

1.6

22.60

51.00

ng/l

—

Acquired keratosis [keratoderma] palmaris et plantaris

3.85

1.95

2.3

1.1

21.98

23.91

ng/l

—

Onycholysis

2.79

1.95

1.9

1.5

25.30

31.27

ng/l

—

UC patients in KELA-register (code 208), prior to 1994

187

1.67

1.94

1.6

25.57

31.46

ng/l

0.37

187

Other congenital malformations of intestine, including avohilmo

2.15

1.94

1.3

1.5

21.89

29.25

ng/l

0.62

Palindromic rheumatism

2.77

1.94

2.0

1.3

21.03

32.04

ng/l

—

HSIL lesion of the vulva

2.14

1.93

2.1

1.9

27.27

22.17

ng/l

0.18

Peripheral retinal degeneration

120

1.85

1.93

1.4

1.5

24.58

24.97

ng/l

0.03

120

Vasomotor rhinitis (mode)

363

1.47

1.93

1.8

1.5

44.72

27.98

ng/l

0.34

363

Fracture of neck

258

1.56

1.92

1.4

1.6

33.33

32.01

ng/l

0.07

258

Pre-eclampsia superimposed on chronic hypertension

3.25

1.89

1.6

1.3

16.66

22.99

ng/l

—

Thrombotic microangiopathy

3.25

1.89

2.1

1.4

27.50

39.30

ng/l

—

Corneal degeneration

2.18

1.89

1.2

1.4

22.31

25.99

ng/l

0.25

Inflammation of lacrimal passages (acute and unspecified)

2.18

1.89

1.6

1.3

20.99

27.78

ng/l

0.37

Operations for atrial fibrillation

2.34

1.89

1.4

1.8

20.92

51.51

ng/l

0.73

Malignant neoplasm of parotid gland, including Hilmo

3.22

1.89

1.4

1.5

28.01

23.69

ng/l

—

Herpesviral keratitis and keratoconjunctivitis

166

1.70

1.88

1.9

1.6

38.00

32.20

ng/l

0.13

166

Other and unspecified spinal muscular atrophies

2.90

1.87

1.8

1.5

16.50

31.80

ng/l

—

Atypical mycobacterium lung infection

2.68

1.87

1.4

144.60

31.10

ng/l

—

Benign neoplasm: Nasopharynx

2.90

1.87

1.9

1.8

22.20

19.09

ng/l

—

Ménière disease

474

1.40

1.87

1.4

1.5

33.28

27.98

ng/l

0.29

474

Serous carcinoma of ovary, including Hilmo

107

1.88

1.87

1.1

1.5

21.61

20.16

ng/l

0.18

107

Pre-eclampsia

149

1200

1.25

1.86

1.4

1.6

28.02

31.14

ng/l

0.26

149

1194

Chronic conjunctivitis

159

1.71

1.86

1.9

1.4

23.91

24.25

ng/l

0.02

159

Pneumococcal septicemia

159

1.71

1.86

2.1

1.6

23.59

32.18

ng/l

0.54

159

Henoch-Schönlein purpura nephritis (HSPN)

3.64

1.86

1.2

1.5

31.30

46.53

ng/l

—

Toxic effect of organic solvents

3.63

1.85

1.3

1.7

16.50

51.46

ng/l

—

Neurofibromatosis, type 2

4.40

1.85

2.0

1.3

18.60

18.22

ng/l

—

Enduring personality changes

3.63

1.85

1.0

1.5

18.50

17.21

ng/l

—

Need for immunization against single bacterial diseases

2.72

1.85

1.6

2.1

92.56

19.11

ng/l

—

Right ventricular outflow tract obstruction

101

1.94

1.85

1.5

2.0

77.51

20.21

ng/l

0.64

101

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

3.61

1.85

1.0

1.3

30.93

38.72

ng/l

—

Guillain-Barre syndrome

2.23

1.85

1.5

1.4

26.65

28.84

ng/l

0.10

Abnormal reflex

3.61

1.85

1.7

1.6

17.83

42.24

ng/l

—

Toxic effect of corrosive substances

3.60

1.85

1.2

1.6

39.02

17.48

ng/l

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

2.23

1.85

1.5

1.4

147.92

28.88

ng/l

0.69

Acne conglobata

3.60

1.85

1.8

1.2

11.70

24.88

ng/l

—

Liposarcoma

3.58

1.84

1.3

1.4

22.73

25.14

ng/l

—

Urolithiasis

228

1918

1.19

1.84

1.8

1.6

22.21

29.13

ng/l

2.73

228

1913

Malignant neoplasm of thymus

4.28

1.84

3.0

1.5

181.86

26.39

ng/l

—

Reduction defects of lower limb, including avohilmo

4.28

1.84

1.4

22.64

28.80

ng/l

—

Motor- or nonmotor-vehicle accident in traffic area

3.09

1.81

1.6

1.5

20.13

39.61

ng/l

—

Prophylactic surgery

3.09

1.81

1.1

1.4

34.70

18.12

ng/l

—

Symptoms and signs involving appearance and behaviour

3.09

1.81

2.7

2.0

73.71

35.94

ng/l

—

Crystalline deposits in vitreous body

3.08

1.81

2.1

1.4

22.43

35.25

ng/l

—

Leiomyosarcoma, including Hilmo

3.08

1.81

1.0

1.2

24.24

29.33

ng/l

—

Benign neoplasm: Rectum/anal canal icd-9

3.08

1.80

1.4

19.86

34.19

ng/l

—

Seminoma of testis, including Hilmo

3.08

1.80

1.4

1.3

37.19

33.50

ng/l

—

Scarlet fever

2.81

1.80

2.6

1.7

78.29

21.99

ng/l

—

Hypertrophy of breast in women and men

146

1179

1.24

1.80

1.5

1.6

34.43

27.86

ng/l

0.30

146

1172

Other congenital malformations, not elsewhere classified

2.14

1.78

2.0

1.6

22.71

22.36

ng/l

0.03

Other/unspecified disorders of vestibular function

169

1.67

1.77

1.6

1.4

23.85

23.41

ng/l

0.03

169

Other misadventures during surgical and medical care

1.91

1.76

1.6

14.84

26.37

ng/l

1.97

Unspecified renal colic

3.39

1.76

2.0

1.4

19.93

41.22

ng/l

—

Dependent personality disorder

2.00

1.75

1.3

1.6

20.46

27.60

ng/l

0.53

Undescended testicle

132

1.78

1.75

1.7

1.8

22.35

33.13

ng/l

0.55

132

Other or unspecified paralytic strabismus

3.38

1.75

1.0

1.6

17.95

48.48

ng/l

—

Panniculitis, unspecified

2.53

1.75

1.2

18.14

29.99

ng/l

—

Unspecified severe protein-energy malnutrition

4.04

1.74

1.6

2.1

26.20

17.85

ng/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

340

2569

1.15

1.74

1.7

1.6

29.58

32.23

ng/l

0.32

340

2561

Ulcerative enterocolitis

132

1.76

1.74

1.6

1.5

18.80

32.86

ng/l

0.90

132

3.00

1.74

1.7

1.3

23.61

21.65

ng/l

—

Selective deficiency of immunoglobulin A [IgA]y

3.00

1.74

1.4

1.5

78.86

21.77

ng/l

—

Exposure to other and unspecified forces of nature

2.72

1.74

1.6

1.5

13.56

33.67

ng/l

—

Other/unspecified rheumatoid arthritis

601

1.34

1.74

1.6

1.5

26.74

25.91

ng/l

0.07

601

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

330

1.46

1.74

1.4

30.29

24.39

ng/l

0.35

330

Nosocomial condition (hospital)

2.98

1.73

1.1

1.3

16.03

21.14

ng/l

—

Unspecified parasitic disease

2.71

1.73

1.6

1.3

13.89

23.71

ng/l

—

Unspecified parasitic disease, including avohilmo

2.71

1.73

1.6

1.3

13.89

23.71

ng/l

—

Idiopathic hypoparathyroidism

3.97

1.73

3.0

2.0

215.20

43.46

ng/l

—

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

3.97

1.73

3.0

1.8

13.76

51.00

ng/l

—

Other or unspecified common variable immunodeficiency

3.96

1.73

2.8

1.5

20.22

18.43

ng/l

—

L02BB Anti-androgens

397

1.42

1.73

2.8

1.5

43.62

32.29

ng/l

0.38

397

Apocrine sweat disorders, other sweat gland disorders

3.94

1.73

2.0

1.5

119.02

16.74

ng/l

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

3.93

1.72

1.0

2.3

21.98

41.91

ng/l

—

Felty syndrome

3.91

1.72

1.8

1.4

55.86

46.89

ng/l

—

Unspecified threat to breathing

2.33

1.72

1.6

1.4

15.93

31.55

ng/l

1.19

Benign neoplasm: Caecum

568

1.34

1.71

1.4

1.6

33.23

29.21

ng/l

0.14

568

Other injuries of upper limb, level unspecified

2.32

1.71

4.0

1.4

24.17

26.99

ng/l

0.13

Prurigo nodularis

1.89

1.71

1.3

1.7

20.35

25.34

ng/l

0.39

Injury of intra-abdominal organs

1.89

1.71

1.1

1.4

24.06

40.05

ng/l

0.57

Background retinopathy and retinal vascular changes

2.08

1.71

2.1

1.3

21.87

30.09

ng/l

0.66

Marasmic kwashiorkor

3.31

1.69

2.2

15.17

35.61

ng/l

—

All dysplastic lesions of the vulva

195

1.60

1.69

1.5

1.6

21.70

21.39

ng/l

0.02

195

Campylobacter enteritis

126

1.76

1.69

2.7

1.5

59.20

27.74

ng/l

0.40

126

Wegener granulomatosis

2.21

1.68

1.2

1.3

22.42

29.79

ng/l

0.52

Hypersensitivity pneumonitis due to organic dust

2.21

1.68

2.3

1.4

38.30

31.35

ng/l

0.18

Adenocarcinoma and papilloma adenocarcinoma of rectum

316

1.46

1.68

1.4

31.09

24.63

ng/l

0.38

316

Congenital hydrocephalus

3.24

1.68

1.3

19.92

25.40

ng/l

—

Wilms' tumor, including Hilmo

2.64

1.67

1.4

1.5

29.13

18.50

ng/l

—

Other and unspecified medical devices associated with adverse incidents

3.22

1.67

1.7

34.67

39.16

ng/l

—

3.20

1.67

1.2

1.4

19.48

38.45

ng/l

—

Allergic purpura

134

1.73

1.67

2.0

1.5

29.93

24.95

ng/l

0.48

134

Chronic myeloid leukaemia, including Hilmo

3.19

1.67

1.0

1.3

17.58

25.20

ng/l

—

therapeutic use

119

1.78

1.67

1.4

1.5

27.69

24.60

ng/l

0.27

119

Follow-up care involving plastic surgery

157

1.67

1.66

1.7

1.5

20.32

22.22

ng/l

0.28

157

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

359

1.43

1.65

1.4

1.6

36.04

24.86

ng/l

0.48

359

Personal history of medical treatment

2.47

1.65

1.3

2.0

13.40

55.73

ng/l

—

Lifestyle-related condition

2.47

1.65

1.7

1.3

20.84

31.25

ng/l

—

Malignant neoplasm of other connective and soft tissue

2.04

1.65

1.2

1.8

26.60

24.93

ng/l

0.08

Mandibular prognathia

105

1.83

1.64

1.6

53.61

23.89

ng/l

0.42

105

Parkinson's disease, strict definition, excluding more controls

501

1.34

1.63

1.3

1.7

57.75

30.26

ng/l

0.69

501

Short Achilles tendon (acquired)

105

1.82

1.63

2.1

1.3

18.51

26.24

ng/l

0.93

105

Ptosis of eyelid

573

1.33

1.63

1.7

1.6

19.94

29.33

ng/l

2.09

573

Failure of sterile precautions during surgical operation

3.68

1.63

3.0

1.6

14.22

43.76

ng/l

—

Acanthosis nigricans

3.67

1.63

1.4

16.78

33.57

ng/l

—

Benign neoplasm: Connective and other soft tissue, unspecified

2.41

1.62

1.3

1.5

27.40

33.60

ng/l

—

Hypersensitivity angiitis

3.64

1.62

1.2

1.5

17.00

46.71

ng/l

—

Other and unspecified disorders of orbit

3.64

1.62

1.2

1.5

12.60

48.19

ng/l

—

Amputation of foot

1.85

1.62

1.2

1.6

25.13

40.48

ng/l

0.64

Exposure to other and unspecified animate mechanical forces

166

1.64

1.62

2.2

1.6

48.18

24.85

ng/l

0.33

166

Malignant neoplasm of testis, including Hilmo

2.40

1.62

1.8

1.5

31.05

26.39

ng/l

—

Other and unspecified injuries of abdomen, lower back and pelvis

2.16

1.62

1.2

1.4

17.85

30.18

ng/l

0.99

Oral leukoplakia, including avohilmo

113

1.78

1.61

1.1

1.4

21.91

27.62

ng/l

0.68

113

Other arterial embolism and thrombosis

1.88

1.61

1.6

20.52

38.50

ng/l

0.75

Endometriosis of fallopian tube

2.54

1.61

1.6

12.49

26.55

ng/l

—

Valgus deformity, not elsewhere classified

2.54

1.61

2.1

1.4

9.88

29.87

ng/l

—

Ulcerative colitis (strict) with PSC

2.54

1.61

1.1

1.5

23.84

27.37

ng/l

—

Follicular adenocarcinoma of thyroid gland, including Hilmo

2.53

1.60

1.1

1.7

20.30

22.20

ng/l

—

Lesion of lateral popliteal nerve

230

1.53

1.60

1.2

1.7

21.49

31.39

ng/l

0.85

230

Disorders of optic nerve, not elsewhere classified

1.97

1.60

1.4

21.33

28.70

ng/l

0.62

Essential (haemorrhagic) thrombocythaemia

106

1.80

1.59

1.3

1.5

26.82

22.03

ng/l

0.40

106

Arthropathy in ulcerative colitis

2.23

1.58

2.0

1.4

28.59

23.87

ng/l

0.20

Parkinson's disease, excluding more controls

545

1.32

1.58

1.3

1.7

55.12

29.73

ng/l

0.69

545

Other disorders of binocular vision

2.23

1.58

1.2

1.9

26.07

33.83

ng/l

0.39

Social disorders starting during childhood or adolecense, excluding more controls

2.31

1.57

1.9

1.3

17.90

47.52

ng/l

—

Conditions involving the integument and temperature regulation of fetus and newborn

3.62

1.57

1.0

2.8

23.80

21.93

ng/l

—

Other peripheral vertigo

465

1.36

1.57

1.6

1.5

23.21

26.31

ng/l

0.43

465

Migraine without aura, drug-induced

2.30

1.56

1.1

2.1

23.29

36.51

ng/l

—

Carcinoma in situ of skin of other and unspecified parts of face

355

1.41

1.56

1.4

23.63

30.19

ng/l

0.73

355

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

2.75

1.55

2.3

1.6

18.71

24.19

ng/l

—

Pyoderma

1.94

1.55

1.5

1.4

18.08

27.04

ng/l

0.86

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

449

1.36

1.55

1.4

1.5

33.69

24.29

ng/l

0.49

449

Benign neoplasm: Other parts of oropharynx

2.46

1.54

1.3

13.13

23.15

ng/l

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

2.46

1.54

1.5

1.3

58.61

21.41

ng/l

—

Spinal enthesopathy

2.11

1.54

1.8

1.7

19.47

46.09

ng/l

0.72

Habitual aborter

1.99

1.54

1.3

1.6

21.69

24.41

ng/l

0.22

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

2.04

1.54

1.2

1.6

16.72

23.90

ng/l

1.44

Multiple myeloma

2.04

1.54

1.2

1.6

16.72

23.90

ng/l

1.44

Enteropathogenic Escherichia coli infection

3.42

1.54

1.0

1.5

23.40

40.20

ng/l

—

Chondrocostal junction syndrome [Tietze]

153

1.64

1.53

1.6

1.5

19.86

24.26

ng/l

0.70

153

Malignant neoplasm of thymus, including Hilmo

3.40

1.53

3.0

1.4

181.86

28.71

ng/l

—

Familial erythrocytosis

3.39

1.53

2.8

1.5

20.52

41.71

ng/l

—

Cachexia

3.39

1.53

1.0

1.3

20.00

20.05

ng/l

—

Use of rivastigmine

690

0.72

1.53

1.2

1.5

32.42

29.59

ng/l

0.16

690

Recurrent and persistent haematuria

2.63

1.52

2.0

1.4

22.97

36.59

ng/l

—

Other and unspecified injuries of neck

2.62

1.52

1.3

1.6

24.10

35.56

ng/l

—

Other specified and unspecified retinal disorders

138

1.68

1.52

1.4

1.7

21.13

33.44

ng/l

0.77

138

Tick-borne viral encephalitis

2.92

1.52

1.2

1.3

26.17

25.12

ng/l

—

Mild or no visual impairment, binocular

2.92

1.52

2.3

1.4

27.65

39.74

ng/l

—

Contact with hypodermic needle

2.91

1.51

1.2

1.3

22.52

23.34

ng/l

—

Nail dystrophy

2.90

1.51

1.2

1.5

19.18

37.50

ng/l

—

Contracture of joint

2.18

1.51

2.2

1.8

19.30

27.71

ng/l

0.49

Follicular adenocarcinoma of thyroid gland

2.90

1.51

1.0

1.6

21.15

23.00

ng/l

—

Other specified and unspecified disorders of eyelid

2.18

1.51

1.3

1.4

17.83

30.23

ng/l

0.99

Foreign body in alimentary tract

291

1.45

1.51

1.3

1.6

24.77

28.05

ng/l

0.25

291

Dermatopolymyositis

2.09

1.50

1.5

1.4

17.54

31.54

ng/l

0.94

Granuloma annulare

2.09

1.50

1.6

1.8

18.80

28.23

ng/l

0.69

Cardiovascular disorders originating in the perinatal period

2.02

1.49

1.7

1.9

18.79

19.14

ng/l

0.04

Other hammer toe(s) (acquired)

118

867

1.24

1.48

1.6

1.4

21.72

29.23

ng/l

1.32

118

867

Chorioretinal inflammation

124

1.71

1.48

3.1

1.6

30.76

35.25

ng/l

0.11

124

Other disorders originating in the perinatal period

164

1.63

1.47

1.9

15.05

20.76

ng/l

2.22

164

Congenital malformation of optic disc

3.35

1.47

2.6

2.4

30.60

18.94

ng/l

—

Other and unspecified aplastic anaemias

2.25

1.47

1.2

1.4

20.30

29.21

ng/l

—

Other disorders of iris and ciliary body

109

1.76

1.47

1.2

1.7

36.57

36.56

ng/l

0.00

109

Pleural plaque

368

1.39

1.47

1.4

1.5

25.56

31.34

ng/l

0.71

368

Atrial septal defect

316

1.43

1.47

1.7

1.8

30.77

21.62

ng/l

0.46

316

Other and unspecified vaccines and biological substances

2.54

1.46

1.6

1.5

17.64

37.35

ng/l

—

Complications peculiar to reattachment and amputation

2.54

1.46

1.1

1.4

18.61

37.91

ng/l

—

Malignant neoplasm of ovary

171

1.59

1.46

1.2

1.5

30.06

21.44

ng/l

0.59

171

Complications following myocardial infarction

2.53

1.46

1.6

1.4

13.37

36.51

ng/l

—

Acquired absence of limb

2.53

1.46

1.0

1.5

27.24

34.89

ng/l

—

Other congenital malformations of kidney

2.39

1.46

1.7

27.61

22.47

ng/l

—

Gastrointestinal stromal tumor and sarcoma

2.52

1.45

2.0

1.5

21.14

25.76

ng/l

—

Benign neoplasm: Bladder

2.53

1.45

1.3

1.4

29.56

37.34

ng/l

—

Congenital retinoschisis

3.23

1.45

1.6

42.00

17.81

ng/l

—

Other and unspecified mononeuropathies, also in other diseases

117

1.72

1.45

1.1

1.8

47.61

36.05

ng/l

0.13

117

Epiphora

1.89

1.45

1.5

1.4

18.33

25.84

ng/l

0.85

Assault by blunt object

2.14

1.45

2.0

1.3

38.20

24.27

ng/l

0.75

Thyroiditis, unspecified

2.14

1.45

1.8

1.3

21.00

20.49

ng/l

0.05

Benign neoplasm: Peripheral nerves and autonomic nervous system

2.14

1.45

1.1

1.4

14.52

30.83

ng/l

1.50

Pre-eclampsia or poor fetal growth

219

1873

1.17

1.45

1.5

1.7

25.29

33.91

ng/l

1.50

219

1867

Mental and behavioural disorders due to hallucinogens

3.17

1.44

2.0

1.5

21.20

22.81

ng/l

—

Pyogenic granuloma

1.94

1.44

1.1

1.4

26.29

28.74

ng/l

0.12

Cardiomyopathy, Hypertrophic obstructive

1.94

1.44

1.4

1.5

28.29

29.15

ng/l

0.04

Infarction of spleen

3.17

1.44

2.0

1.4

19.24

48.12

ng/l

—

Other and unspecified glaucoma

302

1.43

1.44

1.3

1.4

19.15

30.77

ng/l

1.83

302

Cystic disease of liver

2.77

1.44

1.7

1.5

23.73

37.57

ng/l

—

Cerebral palsy

110

1.75

1.44

2.2

1.7

18.58

25.25

ng/l

0.72

110

Benign neoplasm of other and unspecified intrathoracic organs

2.34

1.44

3.1

1.4

118.72

31.76

ng/l

—

Anomalies of pupillary function

1.81

1.44

1.2

1.7

18.24

25.67

ng/l

0.93

Tic and related disorders

1.84

1.42

1.3

1.5

28.06

39.48

ng/l

0.34

Pulmonary eosinophilia, not elsewhere classified

2.20

1.41

1.0

1.4

30.05

30.45

ng/l

—

Disorders of porphyrin and bilirubin metabolism

2.20

1.41

1.5

21.04

28.57

ng/l

—

Intracranial and intraspinal abscess and granuloma

2.28

1.41

1.7

1.3

16.37

34.84

ng/l

—

Episcleritis

254

1.46

1.41

1.7

1.5

22.87

23.86

ng/l

0.11

254

Benign neoplasm: Rectosigmoid junction

173

1.57

1.40

1.6

48.40

30.95

ng/l

0.38

173

Systemic atrophies primarily affecting the central nervous system

189

1.54

1.40

1.3

1.6

19.97

30.36

ng/l

0.90

189

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

2.46

1.40

1.1

1.4

32.71

29.99

ng/l

—

Explicit fungal Sepsis

2.45

1.40

3.1

1.4

31.29

30.68

ng/l

—

Explicit fungal Sepsis, including avohilmo

2.45

1.40

3.1

1.4

31.29

30.68

ng/l

—

Urticaria due to cold and heat

2.44

1.40

1.3

1.9

20.17

21.27

ng/l

—

Undefined dementia

350

1.37

1.40

1.1

1.5

24.17

33.46

ng/l

0.94

350

Xerosis cutis

1.91

1.40

1.1

1.6

17.64

43.32

ng/l

0.95

Superficial injury of neck

1.79

1.39

1.2

1.6

23.18

25.89

ng/l

0.22

Aggressive periodontitis

1.79

1.39

1.4

1.8

50.35

37.94

ng/l

0.14

Respiratory tuberculosis, clinically confirmed

2.43

1.39

1.0

1.4

22.56

36.08

ng/l

—

Benign neoplasm: Tonsil

2.10

1.39

1.5

1.4

28.28

29.98

ng/l

0.06

Secondary parkinsonism

1.78

1.39

1.1

1.5

25.06

39.16

ng/l

0.56

Other specified/unspecified deforming dorsopathies

2.02

1.38

1.4

1.5

33.26

22.95

ng/l

0.49

Mitochondrial myopathy

2.67

1.38

1.2

1.3

16.55

18.96

ng/l

—

Hereditary corneal dystrophies

158

1.59

1.38

2.2

1.6

39.81

32.37

ng/l

0.22

158

Tick-borne viral encephalitis, including avohilmo

2.65

1.37

1.2

1.3

26.17

24.81

ng/l

—

Acute poliomyelitis

2.22

1.37

1.2

1.4

18.38

22.53

ng/l

—

Hereditary factor VIII deficiency

3.04

1.37

1.4

29.36

19.18

ng/l

—

Use of levodopa decarbox-comt-inhibitor

123

0.40

1.37

1.4

1.5

156.80

35.04

ng/l

—

123

Lupus nephritis

3.01

1.37

1.2

1.5

12.60

19.04

ng/l

—

Acute inflammation of orbit

2.98

1.36

2.0

1.5

12.40

17.24

ng/l

—

Malignant neoplasm of gallbladder, including Hilmo

2.98

1.36

1.4

1.6

13.32

26.61

ng/l

—

Congenital malformations of great veins

2.13

1.36

1.5

1.9

20.76

20.44

ng/l

0.02

Arterial embolism and thrombosis of lower extremity artery

135

1.64

1.36

1.9

1.5

26.47

35.55

ng/l

0.39

135

Idiopathic thrombocytopenic purpura

143

1.62

1.36

2.3

1.6

19.05

24.82

ng/l

0.93

143

Exposure to other and unspecified man-made environmental factors

1.88

1.35

1.9

1.5

16.94

28.80

ng/l

1.33

Congenital malformations of anterior segment of eye

2.18

1.35

1.7

24.78

29.58

ng/l

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

2.15

1.34

1.8

2.1

24.73

23.19

ng/l

—

Biomechanical lesions, not elsewhere classified

232

1.47

1.34

1.5

23.93

29.95

ng/l

0.47

232

Acute poliomyelitis, including avohilmo

2.16

1.34

1.2

1.4

18.38

22.45

ng/l

—

Hypotension due to drugs

2.16

1.34

1.3

19.32

30.85

ng/l

—

Ulcer of oesophagus

291

1.41

1.32

1.3

1.6

28.45

33.97

ng/l

0.43

291

Oral lichen planus and hypothyroidism or thyroxine medication

1.82

1.32

1.9

1.8

30.11

26.14

ng/l

0.28

Maternal care for cervical incompetence

176

1.54

1.32

1.7

1.6

24.56

21.50

ng/l

0.42

176

Toxic effect of alcohol

1.82

1.32

1.6

1.4

19.39

28.24

ng/l

0.97

Other diseases of gallbladder

168

1.56

1.31

1.7

1.4

52.82

28.63

ng/l

0.33

168

Vaginal lichen planus

2.54

1.31

1.2

1.6

40.00

24.54

ng/l

—

Dacryoadenitis

2.53

1.31

2.2

1.4

12.25

34.22

ng/l

—

Myelodysplastic syndrome

2.52

1.30

1.2

1.6

17.05

22.76

ng/l

—

Chylothorax

2.89

1.30

1.8

1.9

18.00

17.44

ng/l

—

Inflammatory bowel disease, strict (require KELA)

172

1466

1.18

1.29

1.7

1.6

23.35

32.18

ng/l

2.34

172

1461

Qualitative platelet defects

2.84

1.29

1.0

1.8

32.74

36.67

ng/l

—

Injury of nerves at hip and thigh level

2.84

1.29

1.4

32.20

23.70

ng/l

—

Malaria

2.82

1.29

1.6

1.7

40.40

39.28

ng/l

—

Enteritis due to Yersinia enterocolitica

2.82

1.29

1.6

1.9

49.60

39.67

ng/l

—

Discontinuity and dislocation of ear ossicles

2.82

1.29

4.0

1.6

19.04

42.20

ng/l

—

Superficial injury of ankle and foot, unspecified

2.82

1.29

2.2

1.7

17.98

24.23

ng/l

—

Carcinoma in situ of skin of lower limb, including hip

1.90

1.29

2.3

1.3

24.47

26.72

ng/l

0.10

Bullous keratopathy

2.81

1.29

2.2

1.3

26.00

40.17

ng/l

—

Other congenital malformations of limb(s)

2.04

1.29

1.6

1.7

15.73

22.81

ng/l

1.22

Other osteochondrodysplasias

2.03

1.28

1.6

1.7

20.01

19.67

ng/l

0.04

Ankylosing hyperostosis [Forestier]

2.10

1.28

1.4

1.6

21.20

47.33

ng/l

—

Generalized epilepsy

243

1.45

1.28

1.2

1.6

50.03

23.67

ng/l

0.49

243

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

2.02

1.28

3.1

1.4

87.25

32.44

ng/l

0.35

Dermatopolymyositis (FG)

2.02

1.28

1.5

18.50

29.08

ng/l

0.60

Myotonic disorders

2.32

1.28

1.5

17.66

37.47

ng/l

—

Disorders of brain, other and unspecified

2.31

1.27

2.1

1.3

73.00

30.65

ng/l

—

Exposure to unspecified smoke, fire and flames

2.31

1.27

1.3

1.4

23.68

34.58

ng/l

—

Malignant neoplasm of vulva, including Hilmo

2.06

1.27

1.2

1.6

14.67

22.38

ng/l

—

Malignant neoplasm of testis

2.30

1.27

1.9

1.5

22.90

28.69

ng/l

—

Reactive arthropathies

483

1.31

1.27

1.3

1.6

32.96

29.89

ng/l

0.12

483

Vertical strabismus

146

1.59

1.26

1.4

1.6

30.21

23.91

ng/l

0.38

146

Calcific tendinitis of shoulder

269

1.42

1.26

1.2

1.7

16.20

34.71

ng/l

2.82

269

Burn and corrosion, body region unspecified

2.44

1.25

1.2

1.5

19.17

36.84

ng/l

—

Pityriasis rosea

2.25

1.25

2.6

1.4

22.25

19.25

ng/l

—

2.25

1.25

1.4

1.5

22.53

34.62

ng/l

—

Contact with venomous snakes and lizards

2.02

1.24

1.9

1.4

25.24

30.85

ng/l

—

Exposure to other specified electric current

100

1.71

1.24

2.2

1.7

20.56

28.95

ng/l

1.17

100

Exposure to smoke, fire and flames

100

1.71

1.24

1.2

1.3

27.58

29.66

ng/l

0.12

100

Immunodeficiency associated with other major defects

2.72

1.23

2.2

19.92

41.84

ng/l

—

Contact with sharp object, undetermined intent

108

1.68

1.23

2.6

1.5

34.78

26.52

ng/l

0.64

108

Acute epiglottitis

1.98

1.22

2.0

1.4

21.65

29.95

ng/l

0.60

Other specified/unspecified diseases of inner ear

2.67

1.22

2.0

1.4

16.60

38.08

ng/l

—

Acquired clawhand, clubhand, clawfoot and clubfoot

2.67

1.22

1.2

17.20

21.40

ng/l

—

Unspecified dementia

357

1.33

1.22

1.1

1.4

23.88

30.34

ng/l

0.73

357

Benign neoplasm: Scapula and long bones of upper limb

2.19

1.22

1.8

1.4

19.06

30.29

ng/l

—

Benign neoplasm: Appendix

2.18

1.22

1.0

1.5

20.75

31.60

ng/l

—

Seminoma of testis

2.66

1.22

1.4

1.3

26.60

33.56

ng/l

—

Colitis, primary sclerosing, strict definition

2.18

1.22

1.0

1.4

27.00

27.75

ng/l

—

Malignant neoplasm of other and ill-defined digestive organs

2.65

1.22

1.0

1.2

25.08

25.81

ng/l

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

188

1.50

1.22

2.0

1.7

29.08

29.54

ng/l

0.02

188

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

124

1.62

1.21

1.8

17.92

21.36

ng/l

0.77

124

Other salmonella infections, including avohilmo

180

1.51

1.21

1.5

1.6

29.40

32.68

ng/l

0.14

180

Alzheimer’s disease (Atypical or mixed)

403

0.68

1.21

1.4

1.5

20.71

33.07

ng/l

1.93

403

LSIL lesion of the vulva

132

1.60

1.21

1.1

1.5

18.31

22.26

ng/l

0.99

132

Carcinoma in situ of skin of trunk

132

1.60

1.21

1.8

1.5

18.16

35.71

ng/l

1.20

132

Helminthiases

1.85

1.20

1.5

1.7

29.24

28.39

ng/l

0.04

Hyphaema and other vascular disorders of iris and ciliary body

1.84

1.20

1.2

1.6

45.45

43.97

ng/l

0.02

Polymyositis

2.33

1.19

1.5

1.4

22.87

39.45

ng/l

—

Xanthelasma of eyelid

2.33

1.19

1.2

1.4

28.52

37.95

ng/l

—

Assault by other specified means

2.13

1.19

1.4

47.46

35.17

ng/l

—

Other nutritional anaemias

2.32

1.19

1.2

1.5

17.17

32.00

ng/l

—

Other vitreous opacities

181

1.50

1.18

1.4

1.6

24.20

30.61

ng/l

0.38

181

Fracture of forearm

435

3555

1.10

1.18

1.5

1.6

26.90

31.82

ng/l

0.79

435

3546

Benign neoplasm: Conjunctiva

133

1.59

1.17

1.1

1.6

29.57

25.60

ng/l

0.17

133

Other bursitis of knee

1.95

1.17

2.2

1.2

20.11

29.33

ng/l

0.69

Premenstrual syndrome

1.95

1.17

1.9

1.6

68.18

26.53

ng/l

0.41

Perichondritis of external ear

1.95

1.17

1.8

1.4

24.25

26.95

ng/l

0.15

Car occupant injured in noncollision transport accident

149

1.55

1.17

1.2

1.7

21.66

42.34

ng/l

1.10

149

Interstitial emphysema and related conditions originating in the perinatal period

2.51

1.17

1.7

2.2

16.71

19.27

ng/l

—

Secondary parkinsonism+Parkinsonism in other disease

102

1.68

1.16

1.1

1.5

25.06

37.92

ng/l

0.54

102

Benign neoplasm: Central nervous system, other parts/unspecified

2.55

1.16

2.2

1.5

29.28

37.05

ng/l

—

Other and unspecified hydrocephalus

1.74

1.16

1.3

27.86

26.11

ng/l

0.11

Haemorrhagic disorder due to circulating anticoagulants

2.07

1.15

1.0

1.2

18.94

29.88

ng/l

—

Ductal carcinoma of pancreas

2.53

1.15

1.2

1.3

24.28

25.23

ng/l

—

Artificial joint re-operation

334

1.35

1.15

1.6

24.67

27.92

ng/l

0.31

334

Other and unspecified vascular occlusions

404

1.32

1.13

1.8

1.6

22.67

29.36

ng/l

0.89

404

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.76

1.13

1.4

1.8

19.07

23.40

ng/l

0.54

Peptic ulcer

2.36

1.13

1.9

1.3

18.46

33.10

ng/l

—

Haemangioma, any site

484

1.29

1.12

1.6

17.61

25.33

ng/l

2.08

484

Chondromalacia

111

1.63

1.12

1.3

1.5

33.92

25.39

ng/l

0.28

111

Bacterial meningitis

143

1.55

1.12

1.1

1.7

24.55

34.23

ng/l

0.52

143

Other disturbances of cerebral status of newborn

2.33

1.11

2.4

2.2

13.47

23.18

ng/l

—

Epidural haemorrhage

2.28

1.11

1.9

1.5

27.71

30.34

ng/l

—

Perioral dermatitis

104

1.65

1.10

1.9

1.6

24.56

26.36

ng/l

0.13

104

Surgical ablation of atrial fibrillation

2.42

1.09

1.0

1.3

24.20

20.97

ng/l

—

Other and unspecified mononeuropathies of lower limb

104

1.64

1.09

1.8

1.7

29.93

26.68

ng/l

0.17

104

Benign neoplasm: Ill-defined sites within the digestive system

2.41

1.09

1.6

1.4

72.80

36.20

ng/l

—

Asymmetry of jaw

1.84

1.09

1.0

1.6

26.52

21.23

ng/l

0.51

Muscle wasting and atrophy, not elsewhere classified

2.41

1.09

1.0

1.2

30.20

37.70

ng/l

—

Atlantoaxial subluxation

2.41

1.09

2.0

1.2

32.44

23.69

ng/l

—

Drug-induced tremor

2.41

1.09

1.2

1.5

13.78

17.79

ng/l

—

Contact with other and unspecified heat and hot substances

2.41

1.09

1.2

1.9

46.34

38.50

ng/l

—

Leiomyosarcoma

2.41

1.09

1.0

1.2

27.54

29.64

ng/l

—

Impaction of intestines

2.41

1.09

1.2

1.3

28.12

19.65

ng/l

—

Hereditary deficiency of other clotting factors

1.97

1.09

3.9

1.5

26.25

29.36

ng/l

—

Congenital malformations of spine and bony thorax

1.91

1.09

2.1

1.6

14.44

20.41

ng/l

2.24

Calcific tendinitis

1.97

1.09

1.1

1.3

19.11

27.88

ng/l

—

Acquired stenosis of external ear canal

1.97

1.09

1.1

1.4

21.26

31.16

ng/l

—

Other injuries of lower limb, level unspecified

1.97

1.09

1.3

16.01

32.50

ng/l

—

Benign neoplasm: Bronchus and lung

1.97

1.09

2.0

1.4

23.01

32.96

ng/l

—

Other superficial injuries of ankle and foot

2.22

1.09

1.1

1.7

24.61

33.66

ng/l

—

Dislocation, sprain and strain of joints and ligaments of thorax

144

1.54

1.09

1.1

1.7

24.93

34.95

ng/l

0.57

144

Other and unspecified injuries of shoulder and upper arm

128

1.57

1.08

1.3

1.6

22.20

25.87

ng/l

0.37

128

Trichomoniasis, including avohilmo

2.21

1.08

1.1

1.5

10.47

34.27

ng/l

—

Leukaemia of unspecified cell type

2.21

1.08

1.7

1.8

24.04

31.89

ng/l

—

Severe visual impairment, monocular

2.21

1.08

1.0

1.4

24.46

34.35

ng/l

—

Vascular dementia (mixed)

1.88

1.07

1.4

1.5

34.31

50.64

ng/l

0.34

Acute myeloid leukaemia and myelodysplastic syndromes

1.87

1.07

1.6

1.5

17.03

26.87

ng/l

2.25

Foreign body in ear

1.66

1.07

1.6

1.8

87.00

25.24

ng/l

0.45

Pleural plaque with presence of asbestos

304

1.35

1.07

1.5

1.6

25.43

34.61

ng/l

0.93

304

Myelodysplastic syndrome, including Hilmo

1.76

1.07

1.1

1.5

19.14

22.65

ng/l

0.68

Hereditary ataxia

1.94

1.07

1.1

1.4

14.88

31.74

ng/l

—

Infection due to other mycobacteria

1.94

1.06

1.4

1.3

133.34

28.08

ng/l

—

Congenital stenosis of pulmonary valve

1.83

1.06

1.5

2.1

101.17

20.10

ng/l

0.54

Other congenital malformations of face and neck

145

1.53

1.06

1.3

1.6

28.46

24.70

ng/l

0.26

145

Glaucoma secondary to eye inflammation

2.14

1.06

1.3

12.91

34.82

ng/l

—

Isolated proteinuria with specified morphological lesion

2.14

1.06

2.3

1.6

40.43

33.65

ng/l

—

Progressive vascular leukoencephalopathy

137

1.54

1.06

1.7

1.6

24.02

34.95

ng/l

0.51

137

Other infestations, including avohilmo

1.72

1.05

1.6

1.4

35.13

28.13

ng/l

0.30

Fetus and newborn affected by other complications of labour and delivery

2.15

1.05

2.3

2.0

44.86

17.38

ng/l

—

Other and specified injuries of hip and thigh

1.72

1.05

1.2

1.4

21.20

25.46

ng/l

0.35

Other benign neoplasm of uterus: Cervix uteri

2.30

1.04

1.4

1.5

18.88

23.53

ng/l

—

Polyarteritis nodosa

2.30

1.04

1.0

1.4

12.80

34.07

ng/l

—

Keratoconus

1.64

1.03

1.3

1.4

20.69

26.84

ng/l

0.58

Unspecified event, undetermined intent

1.64

1.03

1.6

19.97

27.44

ng/l

0.59

Tetraplegia

2.09

1.03

1.7

1.4

34.51

36.88

ng/l

—

Psoriasis (vulgaris), strict definition

146

1.51

1.03

1.5

1.7

46.68

34.18

ng/l

0.23

146

Fistulae involving female genital tract

1.75

1.03

1.3

1.6

27.22

24.52

ng/l

0.15

ILD medications: pirfenidone

2.08

1.03

2.0

1.8

55.46

66.44

ng/l

—

Foreign body in genitourinary tract

2.08

1.03

4.4

1.5

11.29

29.34

ng/l

—

Impacted cerumen

625

1.24

1.03

1.6

39.22

28.94

ng/l

0.30

625

Parapsoriasis

1.70

1.02

2.2

1.3

19.21

27.13

ng/l

0.70

Other bursitis of hip

1.70

1.02

1.1

1.5

18.29

37.51

ng/l

0.71

Burns classified according to extent of body surface involved

1.90

1.01

1.1

1.5

49.18

31.57

ng/l

—

Melanocytic naevi of upper limb, including shoulder

1.66

1.01

2.1

1.8

22.95

24.29

ng/l

0.10

Erythema multiforme

1.63

1.00

1.9

1.7

26.49

25.69

ng/l

0.05

Conotruncal defects

156

1.50

1.00

1.6

2.0

66.48

20.29

ng/l

0.62

156

Atrial septal defect, secundum type

273

1.36

1.00

1.8

1.9

35.10

22.70

ng/l

0.53

273

Sequelae of tuberculosis

2.01

1.00

1.4

1.3

20.96

31.05

ng/l

—

Burns and corrosions of multiple and unspecified body regions

107

1.60

1.00

1.3

1.5

41.98

26.69

ng/l

0.42

107

Congenital malformations of spine and bony thorax, including avohilmo

1.84

1.00

2.1

1.6

14.44

20.58

ng/l

2.39

Secondary thrombocytopenia

1.85

0.99

1.4

23.31

30.14

ng/l

—

Tuberculosis, IBD comorbidity

274

1.35

0.99

1.2

1.5

23.23

30.93

ng/l

0.82

274

Other disorders of amino-acid metabolism

2.21

0.98

1.4

1.8

290.56

20.85

ng/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

325

1724

1.11

0.98

1.7

1.6

31.67

33.38

ng/l

0.15

325

1716

Assault by unspecified means

1.68

0.98

2.4

1.5

19.43

42.60

ng/l

0.79

Moderate mental retardation

1.89

0.98

1.5

1.9

19.33

26.55

ng/l

—

Disturbances of smell and taste

173

1.45

0.97

1.9

1.6

26.03

29.48

ng/l

0.14

173

Other and unspecified injuries of forearm

1.96

0.97

1.7

1.6

13.14

32.58

ng/l

—

Other bursitis of elbow

1.96

0.97

1.0

1.4

25.00

30.40

ng/l

—

Diastasis of muscle

1.96

0.97

4.0

1.3

174.20

36.88

ng/l

—

Other retinal artery occlusion

1.64

0.97

1.2

1.6

22.17

38.17

ng/l

0.62

Injury of nerves at forearm level

1.81

0.97

1.6

1.4

27.32

34.18

ng/l

—

Other disorders of choroid

1.81

0.97

1.7

1.3

29.28

28.99

ng/l

—

Memory loss

407

1.28

0.96

1.7

1.5

40.31

28.53

ng/l

0.23

407

Pregnancy with abortive outcome

484

2326

1.08

0.95

1.6

28.92

34.54

ng/l

0.72

484

2318

Down's syndrome

1.94

0.95

2.3

1.9

18.71

36.71

ng/l

—

Fatigue fracture of vertebra

1.92

0.95

1.3

1.7

17.43

22.01

ng/l

—

Benign neoplasm: Short bones of lower limb

1.91

0.94

1.4

32.33

29.20

ng/l

—

Sequelae of tuberculosis, including avohilmo

1.90

0.94

1.4

1.3

20.96

30.02

ng/l

—

Intercostal neuropathy

2.25

0.94

2.2

1.4

23.33

33.59

ng/l

—

Palatinal maxillary operation

1.74

0.93

2.0

1.7

25.33

19.82

ng/l

0.16

Scarlet fever, including avohilmo

1.84

0.93

2.5

1.8

65.15

20.35

ng/l

—

Abscess of external ear

1.74

0.92

1.8

1.3

20.67

29.87

ng/l

—

Other congenital musculoskeletal deformities, including avohilmo

2.19

0.92

1.5

2.1

21.00

28.32

ng/l

—

Burn and corrosion of ankle and foot

1.74

0.92

1.3

1.5

101.20

31.47

ng/l

—

Pulmonary oedema

1.74

0.92

1.3

1.2

18.78

27.21

ng/l

—

Pneumoconiosis due to asbestos and other mineral fibres

1.83

0.92

1.1

1.8

15.59

52.55

ng/l

—

Cardiomyopathies, Secondary/extrinsic

2.17

0.92

2.2

1.4

18.50

38.24

ng/l

—

Trichomoniasis

2.17

0.92

1.2

1.6

8.55

36.88

ng/l

—

Melanoma in situ of upper limb, including shoulder

2.17

0.92

1.2

1.5

28.92

33.11

ng/l

—

Systemic lupus erythematosus, unspecified

134

1.50

0.92

1.3

1.7

26.22

24.38

ng/l

0.07

134

Tuberculosis, wide

278

1.33

0.92

1.2

1.5

23.23

30.81

ng/l

0.81

278

Mantle cell lymphoma, including Hilmo

2.16

0.91

1.0

1.5

30.50

25.12

ng/l

—

Idiopathic urticaria

110

1.56

0.91

1.4

1.7

18.34

26.03

ng/l

1.10

110

Other osteochondrodysplasias, including avohilmo

1.76

0.91

1.6

1.7

20.01

19.49

ng/l

0.06

Atrioventricular septal defect

2.11

0.90

1.8

2.2

19.83

33.07

ng/l

—

Benign lipomatous neoplasm of other sites/unspecified

402

1.27

0.90

1.5

26.89

28.38

ng/l

0.09

402

2.09

0.90

1.3

1.8

19.67

32.40

ng/l

—

Other benign neoplasm of uterus: Corpus uteri

2.09

0.90

1.5

1.8

22.05

21.42

ng/l

—

Other and unspecified primary disorders of muscles

1.93

0.89

2.6

1.4

59.13

23.51

ng/l

—

Other papulosquamous disorders

1.92

0.89

2.1

1.8

16.13

31.04

ng/l

—

Alzheimer’s disease (Early onset)

152

0.59

0.88

1.0

1.5

19.20

33.56

ng/l

—

152

Complications predominantly related to the puerperium

181

1604

1.13

0.88

1.5

1.6

21.07

33.07

ng/l

3.36

181

1598

Operations 1 for CAVS

2.06

0.88

1.2

1.7

19.33

25.70

ng/l

—

Other benign neoplasms of uterus

211

1.38

0.88

1.2

1.5

20.69

22.75

ng/l

0.26

211

Respiratory tuberculosis

194

1.40

0.88

1.2

1.5

25.65

31.70

ng/l

0.39

194

Respiratory tuberculosis, confirmed and not-confirmed

194

1.40

0.88

1.2

1.5

25.65

31.70

ng/l

0.39

194

Vertigo of central origin

1.80

0.88

2.1

1.3

20.16

26.18

ng/l

—

Inguinal of femoral hernia, unilateral

111

1.54

0.88

1.4

1.5

23.54

37.46

ng/l

0.66

111

Inguinal hernia, unilateral

111

1.54

0.88

1.4

1.5

23.54

37.46

ng/l

0.66

111

Femoral hernia, unilateral

111

1.54

0.88

1.4

1.5

23.54

37.46

ng/l

0.66

111

Other specified/unspecified disorders of bone/cartilage

111

1.54

0.88

1.6

1.5

20.45

26.53

ng/l

0.78

111

Benign neoplasm: Skin of lower limb, including hip

111

1.54

0.88

2.2

1.7

16.16

36.99

ng/l

1.23

111

Congenital hypothyroidism without goiter

2.03

0.87

1.3

1.6

16.65

19.05

ng/l

—

Alzheimer’s disease (Late onset), excluding more controls

439

0.80

0.87

1.1

1.7

27.68

26.89

ng/l

0.05

439

Erythema intertrigo

1.59

0.87

1.6

1.4

18.92

27.70

ng/l

1.14

Other and unspecified disorders of pigmentation

2.02

0.87

1.2

1.6

20.83

34.02

ng/l

—

Malignant neoplasm of vulva

2.02

0.87

1.2

1.7

13.33

24.58

ng/l

—

Benign neoplasm: Choroid

316

1.30

0.87

1.8

1.5

22.74

28.84

ng/l

0.49

316

Presbycusis

596

1.21

0.85

1.6

1.5

58.89

31.54

ng/l

0.36

596

Other congenital malformations of brain

1.80

0.85

2.2

1.7

30.60

17.79

ng/l

—

Benign neoplasm: Skin of scalp and neck

112

1.53

0.85

1.2

1.8

25.16

37.63

ng/l

0.55

112

Tuberculosis, wide, including avohilmo

282

1.32

0.85

1.2

1.5

23.23

30.82

ng/l

0.83

282

Palatinal maxillary canine

1.78

0.84

1.8

12.00

19.51

ng/l

—

Tibial collateral bursitis [Pellegrini-Stieda]

1.95

0.84

1.2

1.3

17.30

23.67

ng/l

—

Disorders of synovium and tendon in diseases classified elsewhere

1.60

0.84

2.4

1.3

32.36

27.82

ng/l

0.34

Procedures for purposes other than remedying health state

1.60

0.84

1.2

1.7

23.08

21.53

ng/l

0.10

Tuberculosis

213

1.37

0.84

1.3

1.5

25.91

32.51

ng/l

0.48

213

Scleritis

1.77

0.84

1.8

24.10

31.21

ng/l

—

Complex cardiac defects

1.73

0.84

1.7

1.6

32.09

19.20

ng/l

0.59

Respiratory tuberculosis, confirmed

1.76

0.84

1.1

1.3

29.37

29.00

ng/l

—

Other salmonella infections

154

1.43

0.83

1.4

1.6

24.85

33.72

ng/l

0.52

154

Toxic effect of contact with venomous animals

205

1.37

0.83

1.3

1.5

22.02

24.30

ng/l

0.38

205

Use of galantamine

308

0.71

0.83

1.4

21.02

30.43

ng/l

1.25

308

Other spirochaetal diseases, including avohilmo

205

2281

0.90

0.82

1.5

24.58

29.72

ng/l

1.78

205

2274

Inflammation of lacrimal passages (chronic)

1.71

0.81

1.5

1.3

25.35

28.76

ng/l

—

Benign neoplasm: Larynx

122

1.48

0.80

1.4

1.5

24.56

34.59

ng/l

0.48

122

Spirochaetal infections, other/unspecified, including avohilmo

201

2234

0.90

0.80

1.5

24.66

29.64

ng/l

1.65

201

2227

Infection due to other mycobacteria, including avohilmo

1.73

0.80

1.4

1.3

133.34

26.92

ng/l

—

Shigellosis, including avohilmo

1.84

0.79

1.5

27.18

33.02

ng/l

—

1.83

0.79

1.0

1.3

25.62

37.50

ng/l

—

Deep bite that required surgery

1.68

0.79

1.4

1.5

30.02

21.75

ng/l

—

Calcaneal spur

1.68

0.79

1.3

1.2

15.14

28.10

ng/l

—

Alzheimer disease, excluding more controls

558

0.83

0.79

1.1

1.7

25.92

27.32

ng/l

0.11

558

Melanocytic naevi of lip

0.00

0.79

0.0

1.6

—

34.00

—

Lyme disease

199

2210

0.90

0.78

1.5

24.72

29.52

ng/l

1.55

199

2203

Lyme disease, including avohilmo

199

2210

0.90

0.78

1.5

24.72

29.52

ng/l

1.55

199

2203

Other and unspecified rosacea

474

1.23

0.78

1.7

1.5

23.20

25.59

ng/l

0.34

474

Glaucoma

383

3015

1.08

0.77

1.5

28.75

29.53

ng/l

0.08

383

3009

Benign neoplasm: Brain, infratentorial

1.79

0.77

2.8

1.6

16.45

32.93

ng/l

—

Respiratory tuberculosis, confirmed, including avohilmo

1.70

0.76

1.1

1.3

29.37

28.71

ng/l

—

Benign neoplasm: other/unspecified salivary gland

1.52

0.76

1.3

1.4

18.00

25.05

ng/l

0.89

Vascular dementia (undefined)

1.52

0.75

1.2

1.5

33.66

39.17

ng/l

0.15

Other spirochaetal diseases

203

2245

0.90

0.75

1.5

24.64

29.78

ng/l

1.75

203

2238

Carcinoma in situ of other and unspecified genital organs

1.58

0.75

2.2

1.8

18.31

22.97

ng/l

0.77

Benign neoplasm: Lip

1.61

0.75

2.7

1.4

33.38

28.58

ng/l

0.16

Crohn disease (strict definition, all UC cases excluded)

253

1.31

0.75

1.3

1.6

19.68

27.51

ng/l

0.87

253

Malignant neoplasm of anus and anal canal, including Hilmo

2.09

0.74

1.4

1.5

21.98

21.52

ng/l

—

Other nonthrombocytopenic purpura

1.86

0.74

1.1

1.5

28.07

34.56

ng/l

—

Dementia in other diseases classified elsewhere

184

1.36

0.74

1.5

1.4

16.36

27.96

ng/l

3.21

184

Adhesive middle ear disease

1.65

0.73

1.7

1.3

19.72

28.85

ng/l

—

Other and unspecified degenerative diseases of nervous system

108

1.49

0.73

1.2

1.6

18.21

36.84

ng/l

1.02

108

Other congenital musculoskeletal deformities

2.04

0.73

1.6

2.1

20.60

16.04

ng/l

—

Vascular dementia (subcortical)

108

1.49

0.73

1.1

1.5

21.54

37.63

ng/l

0.71

108

Contact with other specified venomous animals

2.02

0.73

1.0

1.6

15.92

34.51

ng/l

—

Other and unspecified hypertrophic disorders of skin

2.02

0.73

1.0

1.4

39.20

21.48

ng/l

—

Cholesteatoma of external ear

2.02

0.73

1.0

1.4

16.80

32.74

ng/l

—

Endometroid carcinoma of ovary, including Hilmo

2.02

0.73

1.2

1.8

54.60

23.87

ng/l

—

Vascular dementia

322

1.26

0.72

1.1

1.5

26.77

34.69

ng/l

0.64

322

Benign neoplasm: Other and unspecified parts of small intestine

1.62

0.72

1.3

1.8

20.68

46.99

ng/l

—

Patent foramen ovale

185

1.36

0.72

2.2

1.6

21.30

23.02

ng/l

0.17

185

Benign neoplasm: Bones of skull and face

1.76

0.71

1.1

1.5

27.61

23.62

ng/l

—

Syphilis, including avohilmo

109

1.48

0.71

1.1

1.3

48.26

38.28

ng/l

0.16

109

Syphilis

109

1.48

0.71

1.1

1.3

48.26

38.28

ng/l

0.16

109

Disorders of plasma-protein metabolism, not elsewhere classified

1.94

0.71

1.6

1.7

15.00

34.80

ng/l

—

Sequelae of intentional self-harm, assault and events of undetermined intent

1.94

0.71

1.2

1.3

20.62

21.22

ng/l

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

1.94

0.71

6.8

1.3

27.88

20.52

ng/l

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

1.72

0.70

1.1

1.4

32.71

27.02

ng/l

—

Carcinoma in situ of skin, other sites/unspecified

1.72

0.70

1.1

1.2

17.44

29.71

ng/l

—

Other bursal cyst

1.56

0.70

1.1

1.3

20.80

26.91

ng/l

—

Other specified/unspecified hearing loss

436

1.22

0.69

1.6

32.23

29.22

ng/l

0.11

436

Chronic iridocyclitis

239

1.30

0.69

1.6

20.73

29.44

ng/l

0.94

239

Congenital ptosis, including avohilmo

1.88

0.69

1.0

2.1

16.80

26.37

ng/l

—

Abscess of tendon sheath

1.87

0.69

2.0

1.1

23.40

33.18

ng/l

—

Tularaemia, including avohilmo

1.57

0.69

2.8

1.5

78.52

27.77

ng/l

0.44

Pseudomembranous colitis

1.86

0.68

1.2

1.3

14.38

22.36

ng/l

—

Traction detachment of retina

1.86

0.68

1.0

1.4

91.40

38.81

ng/l

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

1.65

0.68

1.1

1.3

29.37

28.49

ng/l

—

Tularaemia

1.68

0.68

3.7

1.3

27.17

30.37

ng/l

—

Chronic respiratory disease originating in the perinatal period

1.68

0.68

1.1

2.1

19.24

20.44

ng/l

—

Monoarthritis, not elsewhere classified

196

1.33

0.67

1.3

1.5

15.17

23.38

ng/l

2.68

196

Disorder of visual pathways, unspecified

1.85

0.67

1.0

1.6

25.40

32.39

ng/l

—

Benign neoplasm: Liver

1.50

0.67

1.5

1.6

19.16

26.03

ng/l

0.62

Congenital varicose veins

1.81

0.66

2.0

14.00

33.25

ng/l

—

Other autoimmune haemolytic anaemias

1.60

0.65

1.7

1.6

20.29

27.58

ng/l

—

Motor neuron disease (with DMD)

1.58

0.65

1.5

27.03

26.97

ng/l

0.00

Motor neuron disease ALS

1.62

0.65

1.5

27.93

28.06

ng/l

—

Sacrococcygeal disorders, not elsewhere classified

120

1.42

0.64

2.4

1.5

16.04

24.00

ng/l

1.62

120

Congenital malformations of great arteries

264

1.27

0.64

2.1

1.9

25.94

21.18

ng/l

0.59

264

Dissection of cerebral arteries, nonruptured

1.74

0.64

1.6

1.5

75.44

31.13

ng/l

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

1.74

0.64

2.4

1.4

22.42

34.19

ng/l

—

Atypical virus infections of central nervous system

1.73

0.64

1.2

1.4

21.42

21.86

ng/l

—

Exclusion endpoint for supernumerary teeth

1.51

0.64

1.8

1.9

19.47

24.74

ng/l

0.53

Infliximab

1.50

0.63

2.0

1.5

28.08

40.13

ng/l

0.37

Unspecified chronic bronchitis

112

1.43

0.63

1.8

1.5

20.13

34.36

ng/l

0.74

112

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

1.53

0.63

1.1

1.7

22.87

19.48

ng/l

0.52

Dysplasia of cervi uteri

146

920

1.12

0.63

1.6

40.88

32.33

ng/l

0.35

146

915

Myeloid leukaemia

104

1.45

0.62

1.5

1.4

18.37

27.25

ng/l

1.26

104

Glaucoma, exfoliation

451

1.20

0.62

1.3

1.4

22.57

30.55

ng/l

0.98

451

Inhalation and ingestion of food causing obstruction of respiratory tract

1.65

0.62

1.5

14.40

30.82

ng/l

—

Other disorders of breast and lactation associated with childbirth

1.56

0.62

1.3

1.4

14.35

24.03

ng/l

1.83

Other abnormal auditory perceptions

1.64

0.62

2.0

1.5

23.28

29.47

ng/l

—

Benign neoplasm: Vagina

1.64

0.62

1.1

1.4

18.66

22.38

ng/l

—

Tuberculosis of other organs

1.59

0.62

1.3

16.70

31.89

ng/l

—

Other and unspecified disorders of binocular movement

1.68

0.62

1.0

1.3

20.80

27.37

ng/l

—

Other mosquito-borne viral fevers, including avohilmo

1.68

0.61

1.8

1.6

99.30

20.23

ng/l

—

Benign neoplasm: Pharynx, unspecified

1.68

0.61

1.2

1.3

36.70

22.90

ng/l

—

Fibrosarcoma, including Hilmo

1.68

0.61

1.4

1.5

36.40

24.69

ng/l

—

IgA nephropathy (IgA glomerulonephritis)

1.47

0.61

1.3

1.5

32.11

38.83

ng/l

0.19

Atypical virus infections of central nervous system, including avohilmo

1.68

0.61

1.2

1.5

21.42

33.33

ng/l

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

1.61

0.61

2.5

1.5

34.15

21.70

ng/l

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

1.61

0.61

3.5

1.6

23.10

25.15

ng/l

—

Other intracranial haemorrhages

113

1.42

0.61

1.4

1.6

21.72

37.99

ng/l

0.86

113

Carcinoma in situ of breast, other/unspecified

1.58

0.60

1.0

1.4

20.79

22.27

ng/l

—

Glaucoma secondary to eye trauma

0.00

0.60

0.0

1.5

—

41.60

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.57

0.60

1.3

1.4

48.51

30.89

ng/l

—

Oral lichen planus, including avohilmo , including avohilmo

371

1.22

0.60

1.6

1.5

26.67

26.24

ng/l

0.03

371

Benign neoplasm: Liver/bile ducts

105

1.43

0.60

1.5

1.6

33.89

26.08

ng/l

0.20

105

Alzheimer’s disease (Atypical or mixed), excluding more controls

250

0.78

0.60

1.4

1.7

20.61

29.11

ng/l

1.54

250

Habit and impulse disorders

1.57

0.59

2.9

1.3

27.44

28.78

ng/l

—

Brain glioblastoma and astrocytoma

1.52

0.58

1.4

19.65

25.89

ng/l

—

Congenital obstruction of the pelviureteric junction

1.73

0.58

1.0

1.4

34.17

31.66

ng/l

—

Pedestrian injured in collision with pedal cycle

123

1.39

0.58

1.5

1.6

25.37

26.01

ng/l

0.04

123

Gout due to impairment of renal function

1.72

0.58

1.5

1.3

22.17

32.23

ng/l

—

HSIL lesion of the vagina

1.49

0.57

1.8

1.9

14.74

23.37

ng/l

—

Other noninflammatory disorders of vagina

410

1.20

0.57

1.4

1.6

30.60

27.61

ng/l

0.10

405

Communicating hydrocephalus

1.44

0.56

1.7

1.5

20.85

25.52

ng/l

0.47

Congenital malformations of larynx

1.57

0.56

2.9

2.0

19.33

19.44

ng/l

—

Stenosis and insufficiency of lacrimal passages

494

1.18

0.56

1.6

20.51

27.37

ng/l

1.50

494

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

150

1.34

0.56

2.2

1.5

18.56

25.48

ng/l

0.93

150

Other drug-induced secondary parkinsonism

1.63

0.56

1.0

1.4

31.82

31.22

ng/l

—

Other protozoal intestinal diseases

1.55

0.56

1.2

18.05

25.16

ng/l

—

Pigmented purpuric dermatosis

1.63

0.55

1.2

1.4

15.00

34.96

ng/l

—

Benign neoplasm: Short bones of upper limb

1.55

0.55

2.0

1.6

44.20

27.00

ng/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.55

0.55

1.6

1.5

49.05

28.53

ng/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

262

0.76

0.55

1.4

1.6

16.01

22.19

ng/l

1.79

262

Malignant immunoproliferative diseases

1.59

0.54

2.3

1.2

15.17

35.17

ng/l

—

Prolapse and hernia of ovary and fallopian tube

132

1.35

0.54

1.5

1.4

22.83

22.12

ng/l

0.11

132

Use of levodopa decarboxylase inhibitor

683

1.14

0.54

1.3

1.6

58.26

28.73

ng/l

0.86

683

Contact with lifting and transmission devices, not elsewhere classified

1.49

0.53

1.1

1.6

21.08

44.52

ng/l

0.81

Mesial bite

1.46

0.53

1.8

1.9

29.40

19.08

ng/l

—

Mandibular retrognathia AND surgery (BSSO)

108

1.39

0.53

1.2

1.6

67.02

23.90

ng/l

0.45

108

Venous complications and haemorrhoids in the puerperium

1.55

0.53

1.0

2.1

18.65

24.93

ng/l

—

Acute otitis externa, noninfective

1.46

0.53

1.2

1.5

21.23

28.93

ng/l

—

Benign neoplasm: Oesophagus

1.55

0.53

1.2

1.3

20.03

33.70

ng/l

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.54

0.53

1.3

14.80

33.32

ng/l

—

Benign neoplasm: Cranial nerves

117

1.37

0.52

1.3

1.6

22.81

34.70

ng/l

0.57

117

Hypospadias

1.52

0.52

1.0

1.5

19.83

32.65

ng/l

—

Maxillary prognathism

1.51

0.52

1.8

1.6

19.50

20.46

ng/l

—

Glaucoma suspect

235

2184

1.08

0.52

1.5

33.21

28.80

ng/l

0.33

235

2179

1.45

0.52

1.4

1.6

17.83

40.01

ng/l

0.88

Amoebiasis, including avohilmo

1.51

0.52

1.5

16.17

28.95

ng/l

—

Migraine with aura, drug-induced

1.51

0.52

1.0

2.1

35.17

23.52

ng/l

—

Burn and corrosion of wrist and hand

197

1.27

0.51

2.2

1.6

31.64

25.19

ng/l

0.45

197

Glaucoma-related operations

251

1.24

0.51

1.4

1.5

19.41

29.28

ng/l

1.25

251

Bicuspidal aortic valve syndrome

202

0.74

0.50

1.7

1.6

22.56

30.28

ng/l

0.48

202

Vascular syndromes of brain in cerebrovascular disorders

171

1.29

0.50

1.1

1.6

20.13

32.22

ng/l

0.91

171

Respiratory tuberculosis, not confirmed

136

1.33

0.49

1.3

1.6

22.60

33.25

ng/l

0.57

136

Prominent ears

1.57

0.49

1.1

1.9

13.71

26.50

ng/l

—

Other lesions of median nerve

110

1.37

0.49

1.2

1.6

20.19

25.78

ng/l

0.60

110

Muscular dystrophy

1.53

0.48

2.4

1.5

15.14

23.50

ng/l

—

Poisoning by medicine, drug-induced

1.50

0.47

1.6

17.31

29.41

ng/l

—

Social disorders starting during childhood or adolescence

1.49

0.47

1.9

1.6

17.90

20.86

ng/l

—

Respiratory tuberculosis, not confirmed, including avohilmo

137

1.32

0.47

1.3

1.6

22.60

33.21

ng/l

0.57

137

Contact with other hot metals

1.48

0.47

1.1

1.7

23.44

29.98

ng/l

—

Spontaneous abortion

321

2026

1.06

0.47

1.6

33.58

35.25

ng/l

0.11

321

2018

Arteriovenous malformation of cerebral vessels

1.47

0.47

2.3

1.6

14.56

31.41

ng/l

—

Contusion of toe(s) with damage to nail

1.47

0.47

1.6

1.4

13.21

30.86

ng/l

—

All dysplastic lesions of the vagina

120

1.34

0.46

1.4

1.7

15.78

21.79

ng/l

1.60

120

Burn and corrosion of hip and lower limb, except ankle and foot

1.39

0.46

1.4

15.77

26.85

ng/l

1.46

Congenital musculoskeletal deformities of head, face, spine and chest

0.59

0.46

1.6

1.7

13.60

40.19

ng/l

—

Other and unspecified corneal deformities and disorders

129

1.32

0.46

1.4

1.5

36.66

26.18

ng/l

0.26

129

Normotensive glaucoma

421

1.17

0.45

1.7

1.5

37.27

27.55

ng/l

0.22

421

Other protozoal intestinal diseases, including avohilmo

103

1.36

0.45

1.2

1.5

21.68

28.81

ng/l

0.51

103

Personal history of allergy to drugs, medicaments and biological substances

1.41

0.45

1.1

1.6

18.33

34.93

ng/l

—

Lesion of sciatic nerve

165

1.28

0.45

1.8

1.6

40.47

32.98

ng/l

0.17

165

Central retinal artery occlusion

1.45

0.44

1.3

1.6

16.04

44.78

ng/l

—

Tuberculosis of other organs, strict

1.45

0.44

1.3

1.2

16.70

30.85

ng/l

—

Gestational [pregnancy-induced] hypertension

169

1562

1.08

0.44

1.9

1.6

27.86

31.18

ng/l

0.36

169

1556

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.38

0.44

2.3

1.6

20.76

28.98

ng/l

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

1.38

0.44

1.6

1.5

16.50

21.89

ng/l

—

Type 1 diabetes, wide definition, subgroup 2

1.38

0.44

2.3

1.5

18.86

27.40

ng/l

—

Other and unspecified disorders of psychological development

152

1.29

0.44

2.4

1.7

22.60

24.03

ng/l

0.13

152

Other and unspecified disease of Bartholin gland

127

0.71

0.43

1.4

1.7

26.78

20.96

ng/l

—

127

Increased muscle tone

1.62

0.43

1.2

1.5

21.56

34.75

ng/l

—

Other forms of systemic lupus erythematosus

1.62

0.43

1.4

1.8

12.40

23.37

ng/l

—

Other acquired deformities of ankle and foot

1.62

0.43

5.6

1.3

77.80

22.21

ng/l

—

Open bite that required surgery (Lefort1 or BSSO)

1.62

0.43

1.4

1.5

147.42

24.55

ng/l

—

Other corneal oedema

1.57

0.42

1.0

1.3

18.54

30.84

ng/l

—

Iliotibial band syndrome

1.57

0.42

2.6

1.2

14.44

24.67

ng/l

—

Use of amantadine

1.41

0.42

2.5

1.5

16.00

27.73

ng/l

—

Use of rasagiline

0.63

0.42

1.2

1.5

19.77

37.06

ng/l

—

ILD-related respiratory insufficiency

140

1.29

0.42

1.6

1.5

22.53

34.27

ng/l

0.71

140

Other disorders of prostate

140

1.29

0.42

1.4

1.7

21.70

36.12

ng/l

0.90

140

Tuberculosis of other organs, strict, including avohilmo

1.43

0.42

1.3

1.2

16.70

31.87

ng/l

—

Birth asphyxia

1.42

0.41

2.5

1.7

16.75

20.02

ng/l

0.52

Open wound of thorax

1.38

0.41

1.4

34.04

27.99

ng/l

—

Dyshidrosis [pompholyx]

1.38

0.41

1.4

1.9

12.77

23.30

ng/l

—

Other and unspecified syphilis

0.00

0.41

0.0

1.6

—

51.33

—

Sleepwalking [somnambulism]

0.00

0.41

0.0

1.5

—

20.60

—

Injury of blood vessels at forearm level

0.00

0.41

0.0

1.5

—

51.40

—

Yaws, including avohilmo

0.00

0.41

0.0

1.5

—

43.00

—

Open wounds involving multiple body regions

0.00

0.41

0.0

1.4

—

17.87

—

Abnormal pulmonary venous return

1.50

0.41

2.6

2.0

22.00

22.47

ng/l

—

Other and unspecified syphilis, including avohilmo

0.00

0.41

0.0

1.5

—

47.94

—

Congenital malformations of cardiac chambers and connections

1.38

0.41

1.6

1.9

29.17

19.69

ng/l

0.43

Tarsal tunnel syndrome

1.48

0.40

3.8

1.8

25.20

28.85

ng/l

—

Pathological resorption of teeth

168

1.25

0.40

1.9

1.7

21.51

32.71

ng/l

0.75

168

Fetus and newborn affected by complications of placenta, cord and membranes

1.46

0.40

1.8

2.2

19.80

24.09

ng/l

—

Abnormal findings on diagnostic imaging of breast

1.32

0.39

1.1

1.4

18.48

21.54

ng/l

—

Juvenile rheumatoid arthirtis

1.35

0.39

1.5

1.6

15.21

21.44

ng/l

1.52

Acute myringitis

1.44

0.39

1.2

1.4

11.70

28.93

ng/l

—

Other injuries of spine and trunk, level unspecified

1.43

0.39

1.0

1.4

14.66

34.56

ng/l

—

Orthopaedic devices associated with adverse incidents

1.41

0.39

1.2

1.6

30.63

42.49

ng/l

—

Dermatitis herpetiformis

1.41

0.39

1.1

1.5

40.31

26.43

ng/l

—

Use of interferon beta-1a

106

0.66

0.39

1.4

1.7

13.43

24.80

ng/l

—

106

Other endophthalmitis

0.00

0.39

0.0

1.4

—

37.04

—

Benign neoplasm of other and unspecified female genital organs

187

1.23

0.39

1.3

1.5

24.64

21.39

ng/l

0.14

187

Other, unspecified and serous retinal detachments

133

1.28

0.38

1.1

1.8

53.27

32.91

ng/l

0.39

133

Assault by sharp object

1.33

0.37

1.0

1.4

41.44

28.57

ng/l

—

Pedal cyclist injured in collision with motor vehicle

134

1.27

0.37

1.3

1.6

21.30

27.05

ng/l

0.89

134

Other congenital malformations of peripheral vascular system

1.37

0.36

1.5

1.6

33.55

26.33

ng/l

0.26

Iridocyclitis in diseases classified elsewhere

1.36

0.36

1.4

15.29

26.77

ng/l

1.34

Acute nephritic syndrome

1.36

0.36

2.1

1.3

21.05

25.86

ng/l

0.47

Left hemicolectomy

1.36

0.36

2.9

1.6

49.51

41.17

ng/l

0.15

Other specified/unspecified spondylopathies

1.36

0.36

2.0

1.6

21.45

37.41

ng/l

0.57

Hereditary retinal dystrophy

1.27

0.36

1.4

1.5

23.58

24.81

ng/l

—

Unequal limb length (acquired)

1.47

0.36

1.2

1.6

16.53

59.63

ng/l

—

Other congenital malformations of male genital organs, including avohilmo

125

0.71

0.36

1.7

18.00

24.78

ng/l

—

125

Benign neoplasm of male genital organs

0.64

0.35

1.2

1.6

33.00

43.79

ng/l

—

Postdysenteric arthropathy

1.44

0.35

1.2

1.6

18.83

34.79

ng/l

—

Degenerative macular diseases

564

1.12

0.35

1.3

1.6

20.70

27.67

ng/l

1.55

564

Adenocarcinoma and ductal carcinoma of pancreas

1.32

0.35

1.1

1.5

24.29

20.80

ng/l

0.39

Alzheimer’s disease (Early onset), excluding more controls

116

0.73

0.35

1.0

1.8

19.20

31.30

ng/l

—

116

Use of teriflunomide

1.40

0.35

1.8

1.5

15.67

21.81

ng/l

—

Acute myeloid leukaemia, helper endpoint

1.40

0.35

2.0

1.4

15.83

27.68

ng/l

—

Acute myeloid leukaemia

1.40

0.35

2.0

1.4

15.83

27.68

ng/l

—

Acute myeloid leukaemia, including Hilmo

1.40

0.35

2.0

1.4

15.83

27.68

ng/l

—

Other degenerative diseases of the basal ganglia

1.38

0.34

1.4

1.5

32.43

43.76

ng/l

—

Other diseases of appendix

1.37

0.34

1.5

18.00

29.78

ng/l

—

Pedestrian injured in other and unspecified transport accidents

1.37

0.34

2.0

1.4

19.37

30.95

ng/l

—

Ventricular septal defect, a heart condition

236

1.19

0.34

1.9

25.28

21.35

ng/l

0.36

236

Undescended testis, unilateral

100

1.31

0.34

1.7

1.9

21.38

37.96

ng/l

0.68

100

Other specified/unspecified necrotizing vasculopathies

1.34

0.34

1.0

1.3

23.17

30.98

ng/l

—

Other benign neoplasm of uterus: Other parts/unspecified

145

1.24

0.33

1.0

1.4

20.73

24.63

ng/l

0.38

145

Carcinoma in situ of skin

388

1.14

0.32

1.5

26.93

28.61

ng/l

0.12

388

Clubfoot

1.28

0.32

1.3

1.6

18.50

30.74

ng/l

—

Congenital malformations of breast, including avohilmo

1.33

0.32

1.2

1.7

31.08

22.87

ng/l

0.27

Other acute skin changes due to ultraviolet radiation

128

1.25

0.32

1.4

1.6

23.03

33.79

ng/l

0.49

128

Monosomies and deletions from the autosomes, not elsewhere classified

1.34

0.31

1.6

2.0

25.71

19.81

ng/l

—

Transient global amnesia

454

0.88

0.31

1.2

1.6

53.93

28.03

ng/l

0.44

454

Respiratory disorders in diseases classified elsewhere

1.30

0.30

1.1

1.3

30.17

27.07

ng/l

—

Congenital malformations of aortic and mitral valves

259

1.16

0.30

1.8

21.57

28.29

ng/l

0.65

259

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

204

1.18

0.28

1.9

1.6

50.74

30.62

ng/l

0.38

204

Certain zoonotic bacterial diseases, including avohilmo

121

1.24

0.28

2.5

1.5

66.62

27.30

ng/l

0.43

121

Carcinoma in situ of skin of scalp and neck

103

1.27

0.28

1.5

24.46

39.55

ng/l

0.63

103

Congenital malformations of breast

1.32

0.28

1.2

1.8

32.39

22.47

ng/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.30

0.28

1.5

1.6

26.27

39.26

ng/l

0.38

Other congenital malformations of male genital organs

116

0.77

0.28

1.7

18.00

22.35

ng/l

—

116

Certain zoonotic bacterial diseases

1.27

0.28

3.4

1.4

27.54

29.79

ng/l

—

Paranoid personality disorder

1.27

0.28

2.1

1.5

27.36

30.16

ng/l

—

Other deformities of toe(s)

168

1.19

0.27

1.4

19.16

22.41

ng/l

0.42

168

Use of ropinirole

150

0.80

0.27

1.4

1.6

32.92

34.45

ng/l

0.06

150

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

1.22

0.27

4.0

1.5

45.50

21.99

ng/l

—

Diseases caused by chlamydiae, including avohilmo

0.70

0.26

1.4

1.8

28.00

26.90

ng/l

—

Dementia due to Parkinsons disease, excluding more controls

1.30

0.26

1.1

1.6

19.50

29.77

ng/l

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

132

1.22

0.25

1.6

15.04

24.82

ng/l

1.70

132

Certolizumab pegol

1.25

0.25

1.1

1.5

16.58

23.68

ng/l

—

Other congenital malformations of ear

1.24

0.25

1.1

1.8

14.22

28.56

ng/l

—

Amyloidosis

1.22

0.25

1.9

1.2

29.56

25.97

ng/l

—

Systemic sclerosis (FG)

1.25

0.24

1.2

1.6

16.33

25.11

ng/l

1.33

Failed attempted abortion

1.17

0.24

1.2

1.7

18.03

22.72

ng/l

—

Degeneration of nervous system due to alcohol

1.29

0.24

1.4

1.6

28.15

43.37

ng/l

—

Cleft lip, lip and palate or palate

0.70

0.24

1.8

1.7

25.02

26.84

ng/l

—

Disorders of muscle tone of newborn

1.34

0.24

2.2

2.0

20.40

20.20

ng/l

—

Lymphangioma, anys site

1.32

0.23

2.8

1.4

26.20

21.31

ng/l

—

Placental disorders

1.32

0.23

2.2

1.5

18.24

24.97

ng/l

—

Hypertrophy of breast

110

1037

1.06

0.23

1.6

36.83

26.81

ng/l

0.37

110

1031

Normal-pressure hydrocephalus

179

0.84

0.23

1.3

1.5

35.17

33.96

ng/l

0.03

179

Otorrhagia

1.29

0.23

1.2

1.5

28.30

29.73

ng/l

—

Systemic sclerosis

1.24

0.23

1.2

1.7

16.33

26.80

ng/l

1.74

Brain glioblastoma

1.28

0.23

1.4

1.2

20.72

23.70

ng/l

—

Renal agenesis and other reduction defects of kidney

1.26

0.22

1.2

1.8

27.20

27.72

ng/l

—

Renal agenesis and other reduction defects of kidney, including avohilmo

1.26

0.22

1.2

1.8

27.20

27.73

ng/l

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

0.75

0.22

1.4

1.7

12.86

38.71

ng/l

—

Mucinosis of skin

0.00

0.21

0.0

1.8

—

51.36

—

Ectopic testis

102

0.78

0.21

1.1

1.8

18.25

21.33

ng/l

—

102

Polyp of middle ear

0.00

0.21

0.0

1.6

—

16.80

—

Inflammatory myopathy

0.00

0.21

0.0

1.3

—

17.60

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

0.21

0.0

1.1

—

21.90

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.21

0.0

1.6

—

52.45

—

Noninfective disorders of pinna

0.00

0.21

0.0

1.6

—

21.91

—

Eccrine sweat disorders

0.00

0.21

0.0

1.6

—

19.09

—

Eclampsia

0.00

0.21

0.0

1.4

—

23.43

—

General- and plastic-surgery devices associated with adverse incidents

0.00

0.21

0.0

1.4

—

19.30

—

Multiple system atrophy (rare forms of Parkinsonism)

0.00

0.21

0.0

1.6

—

51.69

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.00

0.21

0.0

1.2

—

19.46

—

Dysplastic lesion of unknown severity of the cervix uteri

1.19

0.21

1.8

1.4

17.20

22.19

ng/l

—

Other sideroblastic anaemias

0.00

0.21

0.0

1.6

—

48.51

—

Frostbite with tissue necrosis

0.00

0.21

0.0

1.5

—

56.47

—

Pediculosis and phthiriasis

0.00

0.21

0.0

1.3

—

19.48

—

Meretoja disease

0.00

0.21

0.0

1.4

—

18.92

—

Degenerative conditions of globe

0.00

0.21

0.0

1.5

—

47.25

—

Systemic sclerosis, icd10

1.23

0.21

1.2

1.7

16.33

26.41

ng/l

1.66

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

0.21

0.0

1.5

—

44.66

—

Hypertensive encephalopathy

0.00

0.21

0.0

1.5

—

44.26

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.24

0.21

1.5

1.7

22.12

26.81

ng/l

0.45

Primary angle-closure glaucoma

173

1.16

0.21

1.1

1.5

20.11

31.81

ng/l

0.85

173

Digeorge syndrome

0.00

0.21

0.0

2.1

—

24.86

—

Carcinoma in situ of colon

117

1.20

0.20

2.5

1.6

29.15

36.50

ng/l

0.30

117

Café au lait spots

0.00

0.20

0.0

2.5

—

18.21

—

Contraceptive management

289

1955

1.03

0.20

1.5

1.6

25.63

35.79

ng/l

2.42

289

1946

Other facial nerve disorders

123

0.81

0.20

1.3

1.6

23.18

23.59

ng/l

—

123

Small plaque parapsoriasis

0.00

0.20

0.0

1.7

—

44.14

—

Organ-limited amyloidosis

0.00

0.20

0.0

1.4

—

46.47

—

Chronic hepatitis NAS

1.25

0.20

1.3

1.4

22.28

30.58

ng/l

—

Alzheimer’s disease (undefined)

0.00

0.20

0.0

1.4

—

45.39

—

Superficial injuries involving multiple body regions

108

1.21

0.20

1.3

1.5

32.67

26.49

ng/l

0.15

108

Carcinoma in situ of skin of ear and external auricular canal

1.23

0.20

2.0

1.9

23.83

52.74

ng/l

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.20

0.0

1.4

—

44.66

—

Hypertrophy of tongue papillae

1.18

0.19

1.2

1.5

16.40

27.70

ng/l

—

Loose body in joint

1.22

0.19

1.1

1.7

25.11

26.77

ng/l

0.11

Injuries involving multiple body regions

165

1.15

0.19

1.3

1.6

29.19

31.94

ng/l

0.08

165

Mixed conductive and sensorineural hearing loss

656

1.07

0.19

2.0

1.6

62.11

28.34

ng/l

0.38

656

Traumatic ischaemia of muscle

1.13

0.18

1.0

1.3

31.65

29.54

ng/l

—

Inflammatory disease of cervix uteri

301

0.90

0.18

1.2

1.5

20.87

22.59

ng/l

0.20

301

Enterobiasis, including avohilmo

156

1.16

0.18

1.1

1.7

39.70

22.21

ng/l

0.45

156

Simple and mucopurulent chronic bronchitis

166

1.15

0.18

2.1

1.8

27.99

27.98

ng/l

0.00

166

Disorders of acoustic nerve

119

1.18

0.17

1.2

1.7

22.44

36.02

ng/l

0.68

119

Dementia due to Parkinson's disease

1.22

0.17

1.1

1.5

19.50

40.99

ng/l

—

Other disorders of optic disc

1.11

0.17

1.0

1.6

37.11

30.47

ng/l

—

Laparoscopic left hemicolectomy

0.76

0.17

1.0

1.3

28.20

27.70

ng/l

—

CR(E)ST syndrome

0.73

0.17

1.2

1.8

18.60

27.97

ng/l

—

Macular hole

263

1.10

0.16

1.3

1.6

21.98

27.84

ng/l

0.48

263

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

1.20

0.16

1.5

1.4

22.63

26.48

ng/l

0.21

Adenocarcinoma of pancreas

1.10

0.15

1.0

1.5

24.30

22.02

ng/l

—

Parkinson's disease, including avohilmo

789

1.05

0.15

1.4

1.6

53.29

28.68

ng/l

0.72

789

Degeneration of the brain due to alcohol

1.21

0.15

1.4

1.6

28.15

41.97

ng/l

—

Unspecified abortion

276

0.90

0.15

2.2

1.6

22.26

21.29

ng/l

0.05

276

Fourth [trochlear] nerve palsy

1.13

0.15

1.2

1.6

21.44

39.46

ng/l

—

Psoriatic arthropathies

566

1.06

0.14

1.5

1.6

19.06

28.55

ng/l

2.46

566

Generalized epilepsy, mode (most common among epilepsy diagnosis)

169

1.13

0.14

1.2

1.6

70.95

24.59

ng/l

0.46

169

Dissection of aorta

122

1.15

0.13

2.7

1.5

39.61

37.26

ng/l

0.04

122

Generalized epilepsy, strict definition

132

1.14

0.13

1.1

1.7

85.33

25.56

ng/l

0.46

132

Other demyelinating diseases of the central nervous system

180

1.11

0.13

1.7

1.6

21.67

26.19

ng/l

0.49

180

Burn and corrosion of shoulder and upper limb, except wrist and hand

104

1.16

0.12

1.1

1.4

107.83

26.41

ng/l

0.52

104

Benign neoplasm: Vulva

1.18

0.12

1.2

1.5

16.45

21.88

ng/l

—

Viral agents as the cause of diseases classified to other chapters

114

1.14

0.12

1.7

1.5

16.73

25.55

ng/l

1.18

114

Premature separation of placenta [abruptio placentae]

114

1.14

0.12

3.0

1.4

20.85

23.23

ng/l

0.25

114

Calculus of lower urinary tract

220

1.09

0.11

2.2

1.5

17.87

37.66

ng/l

2.35

220

Use of selegiline

172

1.11

0.11

1.3

1.5

23.76

33.53

ng/l

0.63

172

Bacterial sepsis of newborn

105

1.15

0.11

1.8

2.0

14.81

18.60

ng/l

1.14

105

Feeding problems of newborn

1.17

0.11

1.9

2.1

11.50

20.49

ng/l

—

Polypectomy (DHB20)

319

1.07

0.10

1.4

1.5

25.63

31.03

ng/l

0.30

319

Evidence of alcohol involvement determined by level of intoxication

1.14

0.10

1.8

1.5

24.18

29.50

ng/l

—

Transient synovitis

1.06

0.09

2.2

1.6

17.80

46.21

ng/l

—

Carcinoma in situ of cervix uteri, endocervix

1.06

0.09

1.2

1.7

23.72

20.08

ng/l

—

Allergic contact dermatitis due to drugs in contact with skin

1.15

0.09

1.9

1.7

21.19

27.27

ng/l

—

Carcinoma in situ of rectum

1.04

0.09

1.2

1.4

27.20

29.14

ng/l

—

Myocardial infarction, unclassifiable

893

0.97

0.09

1.5

22.77

30.29

ng/l

2.11

893

Other otitis externa (chronic)

360

1.06

0.09

1.6

1.5

57.25

27.15

ng/l

0.50

360

Cellulitis of external ear

1.11

0.09

1.0

1.4

24.50

29.34

ng/l

—

Unspecified maternal hypertension

1.05

0.08

1.5

1.9

24.43

23.71

ng/l

—

Suppurative otitis media, unspecified

113

0.88

0.08

2.4

1.8

31.71

36.94

ng/l

—

113

Dislocation of lens

1.03

0.08

1.2

1.3

25.13

23.44

ng/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.82

0.08

1.0

1.2

41.04

28.43

ng/l

—

Endovascular or surgical operations to intracerebral aneurysms

273

1.06

0.08

1.4

1.6

19.64

28.07

ng/l

0.90

273

Birth trauma

1.08

0.08

1.6

1.9

28.70

29.44

ng/l

—

conjunctival degenerations and deposits

1.14

0.08

1.9

1.4

35.18

26.41

ng/l

—

Gonococcal infection, including avohilmo

154

0.91

0.08

1.2

1.7

17.50

33.09

ng/l

1.10

154

Other congenital malformations of skull and face bones

1.05

0.08

1.3

1.6

16.29

20.97

ng/l

—

LSIL lesion of the vagina

1.03

0.08

1.0

1.5

16.59

22.17

ng/l

—

Other diseases caused by chlamydiae, including avohilmo

0.84

0.07

1.3

1.8

29.50

26.90

ng/l

—

Alcohol abuse counselling and surveillance

0.86

0.07

1.8

1.3

20.95

28.33

ng/l

—

Use of glatiramer acetate

1.08

0.07

1.1

1.7

21.97

21.83

ng/l

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

1.07

0.07

1.0

1.9

15.25

20.20

ng/l

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

1.07

0.07

3.8

1.5

27.25

28.58

ng/l

—

Venous complications and haemorrhoids in pregnancy

1.05

0.07

1.8

1.6

19.87

25.71

ng/l

—

Fall involving playground equipment

112

0.89

0.07

2.2

1.8

19.45

19.17

ng/l

—

112

Other crystal arthropathies

0.84

0.07

1.7

1.4

28.56

27.79

ng/l

—

Retinoschisis and retinal cysts

1.12

0.07

1.8

1.9

25.00

38.54

ng/l

—

Other assisted single delivery

0.89

0.07

1.4

1.6

12.50

43.01

ng/l

—

Burn and corrosion of head and neck

0.85

0.06

1.0

1.3

26.85

29.18

ng/l

—

Blood alcohol or alcohol intoxication level

0.85

0.06

1.5

1.4

21.47

27.18

ng/l

—

Acute alcohol intoxication ICD-9

128

1.09

0.06

1.4

1.6

20.16

26.68

ng/l

0.83

128

Injury of muscle and tendon at ankle and foot level

0.84

0.06

1.8

1.6

15.11

28.89

ng/l

—

Other abnormal products of conception

212

1370

1.02

0.06

1.7

26.48

35.85

ng/l

1.17

212

1365

Erectile dysfunction

394

1.04

0.06

1.6

25.84

33.43

ng/l

0.98

394

Golimumab

168

1.07

0.06

1.3

1.5

17.63

26.59

ng/l

1.93

168

Parkinson's disease

761

1.03

0.05

1.3

1.6

55.12

28.60

ng/l

0.74

761

Isolated patent ductus arteriosus

137

1.08

0.05

2.1

2.0

24.87

19.98

ng/l

0.67

137

Intussusception

1.11

0.05

2.1

1.7

23.92

21.69

ng/l

—

Coarctation of the aorta

100

1.10

0.05

1.4

1.7

22.32

23.22

ng/l

0.06

100

Cyst of Bartholin Gland

179

1.06

0.05

1.3

1.6

21.34

21.54

ng/l

0.02

179

Gonococcal infection

140

0.93

0.04

1.2

1.6

17.08

33.66

ng/l

1.05

140

Parkinson's disease, strict definition

705

1.02

0.04

1.3

1.6

57.75

29.14

ng/l

0.73

705

Cholesteatoma of middle ear

220

1.05

0.03

2.1

1.5

28.57

31.08

ng/l

0.11

220

Pedestrian injured in collision with car, pick-up truck or van

1.09

0.03

1.0

1.4

27.70

27.10

ng/l

—

Carcinoma in situ of other and unspecified digestive organs

199

0.95

0.03

2.2

1.6

27.22

30.31

ng/l

0.19

199

Benign neoplasm: Long bones of lower limb

152

1.05

0.02

2.0

1.6

68.79

24.79

ng/l

0.81

152

Fetus and newborn affected by maternal complications of pregnancy

126

0.95

0.01

1.5

1.9

17.17

19.43

ng/l

0.34

126

Anisometropia and aniseikonia

174

1.03

0.00

1.6

1.7

19.09

24.22

ng/l

0.79

174

All dysplastic lesions of the cervix uteri, vagina or vulva

187

1823

1.00

0.00

1.7

1.6

37.13

31.13

ng/l

0.31

187

1817

Left ventricular outflow tract obstruction, narrow definition

327

1.01

0.00

1.8

1.7

21.31

27.45

ng/l

0.72

327

Lesion of plantar nerve

295

1.02

0.00

2.2

1.6

20.82

28.60

ng/l

1.05

295

Contusion of toe(s) without damage to nail

128

1.02

0.00

1.1

1.6

18.41

26.46

ng/l

1.38

128

Muscle strain

148

1.01

0.00

1.9

1.6

32.20

33.26

ng/l

0.03

148

Pleural plaque without asbestos

131

0.99

0.00

1.2

1.5

27.67

38.33

ng/l

0.53

131

Liveborn infants according to place of birth

1.02

0.00

1.5

2.0

70.80

22.06

ng/l

—

Abscess of Bartholin gland

137

1.02

0.00

1.2

1.6

22.99

23.41

ng/l

0.02

137

Macular cyst

137

1.02

0.00

1.4

1.5

26.43

33.52

ng/l

0.34

137

Traumatic amputation of wrist and hand

177

1.02

0.00

1.8

1.5

23.22

32.81

ng/l

0.70

177

Accidental poisoning by and exposure to alcohol

1.00

0.00

1.0

1.4

13.67

29.86

ng/l

—

Intestinal helminthiases, other/unspecified

0.00

0.0

2.2

—

92.40

—

Photocontact dermatitis [berloque dermatitis]

0.00

0.0

1.8

—

18.00

—

Other transitory neonatal endocrine disorders

0.00

0.0

2.8

—

24.40

—

Degeneration of iris and ciliary body

0.00

0.0

2.2

—

88.20

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

0.0

1.2

—

17.40

—

Duodenal ulcer - Acute without haemorrhage or perforation, drug-induced

0.00

0.0

2.2

—

88.80

—

Myiasis, including avohilmo

0.00

0.0

1.8

—

16.40

—

Benign lipomatous neoplasm of spermatic cord

0.00

0.0

1.2

—

17.50

—

Injury of muscle and tendon at neck level

0.00

0.0

1.8

—

18.67

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.0

1.6

—

23.64

—

Ascariasis

0.00

0.0

1.8

—

16.40

—

Pinta [carate], including avohilmo

0.00

0.0

2.3

—

27.00

—

Traumatic amputation of forearm

0.00

0.0

1.8

—

15.80

—

Congenital dislocation of hip, unilateral

0.94

0.00

2.0

1.8

17.60

20.95

ng/l

—

Iodine-deficiency-related goitre

0.00

0.0

1.3

—

17.86

—

Solar urticaria

0.00

0.0

1.7

—

18.67

—

Intrauterine hypoxia

0.00

0.0

1.4

—

18.60

—

Unspecified contact dermatitis due to drugs in contact with skin

0.00

0.0

1.6

—

16.40

—

Other and unspecified disorders of sclera

0.00

0.0

1.3

—

19.32

—

Congenital aortic valve stenosis

0.96

0.00

2.6

1.8

17.00

20.38

ng/l

—

Congenital syphilis, including avohilmo

0.00

0.0

2.0

—

20.80

—

Crystal arthropathies, rheuma endpoint

0.89

0.00

1.7

1.5

28.56

27.16

ng/l

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.6

—

68.57

—

Brain glioblastoma, helper endpoint

0.96

-0.00

1.4

1.3

20.72

28.96

ng/l

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.6

—

66.33

—

Disorders of visual cortex

0.00

-0.00

0.0

1.2

—

31.33

—

Merkel cell carcinoma of skin

0.00

-0.00

0.0

1.0

—

18.88

—

Pregnant state, incidental

0.00

-0.00

0.0

1.8

—

51.42

—

Kyphoscoliotic heart disease

0.00

-0.00

0.0

1.7

—

77.43

—

Adenocarcinoma of small intestine

0.00

-0.00

0.0

1.2

—

21.17

—

Rheumatic valve diseases

0.95

-0.00

1.3

19.82

26.99

ng/l

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.8

—

84.20

—

Hereditary factor IX deficiency

0.00

-0.00

0.0

1.0

—

22.50

—

Brain mixed glioma

0.00

-0.00

0.0

1.6

—

26.40

—

Amputation of ankle

0.00

-0.00

0.0

2.0

—

86.60

—

Alpha thalassaemia

0.00

-0.00

0.0

1.7

—

25.00

—

Pseudopolyposis of colon

0.00

-0.00

0.0

1.5

—

19.38

—

Rheumatic fever incl heart disease

0.98

-0.00

1.3

21.17

26.22

ng/l

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

0.00

-0.00

0.0

1.4

—

18.95

—

Yaws

0.00

-0.00

0.0

1.6

—

62.50

—

Congenital absence of the uterus

0.00

-0.00

0.0

2.0

—

77.33

—

Congenital edentulism

0.00

-0.00

0.0

1.4

—

22.80

—

Pterygium

110

1.00

-0.00

1.5

1.6

23.97

38.70

ng/l

0.64

110

Other congenital malformations of posterior segment of eye (coloboma)

0.00

-0.00

0.0

2.3

—

17.25

—

Lens-induced iridocyclitis

0.00

-0.00

0.0

1.4

—

14.80

—

Kwashiorkor

0.00

-0.00

0.0

1.4

—

14.80

—

Idiopathic pulmonary fibrosis

320

1.00

-0.00

1.4

1.5

30.05

32.44

ng/l

0.10

320

Chlamydial lymphogranuloma (venereum)

0.00

-0.00

0.0

1.0

—

43.00

—

Arthropathy in hypersensitivity reactions classified elsewhere

0.00

-0.00

0.0

1.3

—

18.86

—

Other birth injuries

0.00

-0.00

0.0

2.3

—

65.43

—

Congenital pneumonia

0.00

-0.00

0.0

1.6

—

25.29

—

Other infections specific to the perinatal period

0.97

-0.00

1.3

1.7

26.88

17.48

ng/l

—

Acné excoriée

0.00

-0.00

0.0

2.4

—

88.80

—

Chlamydial lymphogranuloma (venereum), including avohilmo

0.00

-0.00

0.0

1.0

—

43.00

—

Abnormalities of ear ossicles

0.00

-0.00

0.0

1.7

—

16.14

—

Early syphilis, including avohilmo

1.00

-0.00

1.0

1.3

26.64

32.47

ng/l

—

Acne keloid

0.00

-0.00

0.0

1.8

—

113.60

—

Acquired ichthyosis

0.00

-0.00

0.0

1.4

—

10.40

—

Tetanus, other/unspecified, including avohilmo

0.00

-0.00

0.0

1.6

—

21.32

—

Unspecified hairloss

0.00

-0.00

0.0

1.6

—

16.29

—

Congenital malformation of vitreous humour

0.00

-0.00

0.0

2.7

—

12.00

—

Myiasis

0.00

-0.00

0.0

1.8

—

16.40

—

Macular pucker, drug-induced

0.00

-0.00

0.0

1.3

—

15.17

—

Pseudofolliculitis barbae

0.00

-0.00

0.0

1.6

—

27.00

—

Other disorders of bone development and growth

0.00

-0.00

0.0

1.5

—

16.33

—

Rifle, shotgun and larger firearm discharge

0.00

-0.00

0.0

1.6

—

22.20

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.7

—

21.93

—

Crushing injury of wrist and hand

0.86

-0.00

1.2

1.7

8.82

49.29

ng/l

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

-0.00

0.0

1.5

—

77.50

—

Fracture of spine, level unspecified

0.00

-0.00

0.0

2.0

—

75.43

—

Amyloidosis, other/unspecified

0.98

-0.00

1.8

1.2

33.33

28.01

ng/l

—

Disorders of ornithine metabolism

0.00

-0.00

0.0

2.2

—

16.00

—

Injury of urinary and pelvic organs

0.98

-0.00

1.0

1.3

18.88

28.57

ng/l

—

Hypotony of eye

0.00

-0.00

0.0

1.7

—

16.50

—

Lipodystrophy, not elsewhere classified

0.00

-0.00

0.0

1.9

—

19.57

—

Disorders of amino-acid transport

0.00

-0.00

0.0

2.0

—

20.20

—

Otitis media in diseases classified elsewhere

0.00

-0.00

0.0

1.4

—

20.62

—

Disorder of amino-acid metabolism, other/unspecified

0.00

-0.00

0.0

2.0

—

17.00

—

Assault by other and unspecified firearm discharge

0.00

-0.00

0.0

1.4

—

33.50

—

Hyperchylomicronaemia

0.00

-0.00

0.0

1.5

—

61.13

—

Bacterial agents resistant to antibiotics

0.00

-0.00

0.0

1.8

—

16.00

—

Exposure to electric transmission lines

0.00

-0.00

0.0

1.2

—

16.60

—

Circumscribed brain atrophy

1.01

-0.00

1.0

1.3

18.76

27.04

ng/l

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

-0.00

0.0

1.6

—

65.13

—

Selective deficiency of immunoglobulin M [IgM]

0.00

-0.00

0.0

1.8

—

18.12

—

Brain mixed glioma, helper endpoint

0.00

-0.00

0.0

1.5

—

22.83

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.7

—

21.29

—

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

0.00

-0.00

0.0

2.0

—

15.80

—

Traumatic subcutaneous emphysema

0.00

-0.00

0.0

1.7

—

62.38

—

Discharge of firework

0.00

-0.00

0.0

1.4

—

23.40

—

Maternal care for known or suspected disproportion

220

1.00

-0.00

1.5

1.6

17.19

27.62

ng/l

1.59

220

Carcinoma in situ of penis

0.00

-0.00

0.0

1.5

—

64.75

—

Exposure to noise

0.00

-0.00

0.0

1.8

—

92.40

—

Explosion and rupture of other specified pressurized devices

0.00

-0.00

0.0

1.2

—

38.80

—

Exposure to excessive natural heat

0.00

-0.00

0.0

1.1

—

19.57

—

Assault by drugs, medicaments and biological substances

0.00

-0.00

0.0

1.4

—

21.09

—

Benign neoplasm: Penis

0.00

-0.00

0.0

1.3

—

18.63

—

Other and unspecified disorders of refraction

0.00

-0.00

0.0

1.5

—

23.00

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.3

—

18.17

—

Accident to watercraft causing drowning and submersion

0.00

-0.00

0.0

1.3

—

13.83

—

Benign neoplasm of mesothelial tissue

0.00

-0.00

0.0

1.4

—

17.50

—

Inhalation of gastric contents

0.00

-0.00

0.0

1.9

—

57.11

—

Urethral discharge

0.00

-0.00

0.0

1.2

—

18.00

—

Benign neoplasm: Male genital organ, other/unspecified

0.00

-0.00

0.0

1.2

—

17.40

—

Unicornuate uterus

0.00

-0.00

0.0

1.8

—

25.25

—

Legal intervention and operations of war

0.00

-0.00

0.0

1.0

—

43.40

—

Disorders of other visual pathways

0.00

-0.00

0.0

2.4

—

16.40

—

Exposure to high and low air pressure and changes in air pressure

0.00

-0.00

0.0

1.4

—

21.00

—

Drug-induced autoimmune haemolytic anaemia

0.00

-0.00

0.0

1.5

—

13.33

—

Burn and corrosion of respiratory tract

0.00

-0.00

0.0

1.4

—

26.40

—

Intentional self-harm by other and unspecified firearm discharge

0.00

-0.00

0.0

1.2

—

20.00

—

Legal intervention

0.00

-0.00

0.0

1.0

—

43.40

—

Progressive osseous muscle inflammation

0.00

-0.00

0.0

2.1

—

67.71

—

Psoriatic arthropathies, strict definition

0.00

-0.00

0.0

1.0

—

18.00

—

Injury of heart

0.00

-0.00

0.0

1.7

—

72.00

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

20.20

—

Ascariasis, including avohilmo

0.00

-0.00

0.0

1.7

—

19.17

—

Hypergammalglobulinemia, unspecified

0.00

-0.00

0.0

1.6

—

20.29

—

Other degenerative disorders of eyelid and periocular area

0.00

-0.00

0.0

1.4

—

58.56

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

-0.00

0.0

1.1

—

21.44

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Corticotropin [Mass/volume] in Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS